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ABSTRACT 
Background: People with psychosis can experience significant social functioning impairments. 
Virtual reality (VR) can extend traditional assessment and treatment of social functioning 
impairments in an ecologically valid environment. VR assessments and treatments (either 
‘immersive’ VR, using a head mounted display, or ‘non-immersive’ VR, using a 2D screen) are 
increasingly being evaluated in psychosis research. The aim of this systematic review was to 
evaluate whether VR can improve assessment and treatment of social functioning impairments 
in people with psychosis. Method: PsycINFO, MEDLINE, Embase, Web of Science, Cochrane 
Library, ProQuest, and Scopus were searched. The Effective Public Health Practice Project 
(EPHPP) Quality Assessment Tool for Quantitative Studies method and tool was used to assess 
the quality of studies. Results: Database searching identified 2212 titles. A total of 105 studies 
were screened; 32 studies published between 2005 and 2015 were included in the review (12 
immersive VR; 20 non-immersive VR). 75% of studies received an EPHPP global rating of 
strong. Discussion: VR has potential as a tool to improve assessment and treatment of both 
cognitive and behavioural components of social functioning impairments in people with 
psychosis. Treatment packages have focused on general social skills or job interview/vocational 
skills. Limitations such as small sample sizes, lack of large RCTs, lack of novel VR-specific 
results, cybersickness, and scope of studies and technology are discussed; and potential 
advantages of egocentric encoding enabled by immersive VR are explored. 
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1.1 Social functioning in psychosis 
Social functioning has been defined as an individual's interactions with their environment and 
their ability to fulfil their role within environments such as work, social activities, and 
relationships with partners and family (Bosc, 2000). Social functioning impairments can be  a 
long standing problem in people with psychosis (Addington et al., 2008; Swartz et al., 2007). 
They are associated with poor outcome and reduced activities of daily living, when compared 
with the general population (Viertiö et al., 2012). Furthermore, social functioning impairments 
are related to high prevalence of early life trauma (Stain et al., 2013); underpinned by 
neurocognitive deficits (Carrión et al., 2011; Mancuso et al., 2011); and are, in themselves, a 
risk factor for developing psychosis (Cornblatt et al., 2011). In general, the onset of psychosis is 
strongly associated with prolonged experiences of social isolation (Reininghaus et al., 2008), 
diminished social networks (Garety et al., 2001), and impairments in social cognition (Bertrand 
et al., 2007; Couture et al., 2006). In particular, there is evidence that social cognition mediates 
the relationship between cognitive and social functioning (Addington et al., 2006); and a chronic 
and prolonged experience of social defeat has been shown to increase the risk of schizophrenia 
(Selten & Cantor-Graae, 2005).  
 
As a consequence, interventions that support social relationships, functioning, and performance 
in the context of psychosis have been shown to be instrumental to subjective recovery (Gayer-
Anderson & Morgan, 2013; Tew et al., 2011) and to improving psychological wellbeing (Schrank 
et al., 2014). Similarly, family interventions have been shown to have an important role in the 
treatment of psychosis (Bird et al., 2010; Pilling et al., 2002). However, the presence of social 
anxiety, negative self-statements, and negative symptoms continue to provide obstacles to 
these interventions.  
 
1.2 Virtual reality and social functioning 
Virtual reality (VR) has been defined as ‘human immersion in a synthetic system’ (Seidel & 
Chatelier, 2013). VR technologies are considered to be a promising supplement to traditional 
psychotherapy. Computer-generated social environments simulate real experiences and trigger 
anxiety in similar ways to conventional exposure therapy, and at the same time they allow the 
therapist to manipulate the social environment and tailor it to the needs of the patient 
(Eichenberg & Wolters, 2012).  
 
VR has been cited as the most fully developed, innovative emerging technology (Thornhill-Miller 
& Dupont, 2016) and is already employed in clinical practice to treat cognitive, emotional, and 
behavioural problems (Bohil et al., 2011; Gregg & Tarrier, 2007; Riva, 2005). Whereas 
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traditional psychological assessment methods employ self-report measures, video feedback, 
and role-play, which may have limited ecological validity, VR can provide ecologically valid 
therapeutic environments that enable clinicians to manipulate VR design and real-time 
environmental conditions (Parsons, 2011). Psychological assessment and treatment methods 
that employ VR have been shown to elicit cognitive, emotional and behavioural responses 
similar to those triggered by real situations, while virtual characters can be perceived as real 
human beings (Ku et al., 2006). VR provides researchers and clinicians with the facility to 
manipulate environmental triggers that elicit distress in people with mental health problems, 
potentially allowing them to learn to better manage their difficulties (Gregg & Tarrier, 2007; Riva, 
2005). 
 
Notable VR innovations in mental health include research and treatments in post-traumatic 
stress disorder (Gonçalves et al., 2012), anxiety disorders (Meyerbröker & Emmelkamp, 2010), 
specific phobias (Parsons & Rizzo, 2008), eating disorders (Brownley et al., 2007), depression 
(Falconer et al., 2016), and psychosis (Freeman, 2008; Veling et al., 2014). VR treatments for 
mental health conditions have focused prominently on social functioning impairments. The 
advantage of VR interventions has been to improve the ecological validity of existing methods of 
assessing social functioning. Unlike role plays and self-report measures, the ecological validity 
of VR is derived from the real time presentation and control of perceptual stimuli. In anxiety 
disorders, for example, VR exposure therapy has been shown to be a realistic and acceptable 
intervention. One study found VR exposure therapy effective for treating social fears, while 
improvement was maintained at one year follow-up (Anderson et al., 2013). In general, reviews 
have found that VR exposure elicits psychophysiological fear reactions in patients and healthy 
subjects, from which it was concluded that VR is a promising treatment for anxiety disorders 
(Diemer et al., 2014). Another key area where social skills have been targeted using VR is 
autism: studies have also found that VR is a promising tool for improving social skills, cognition, 
and functioning (Kandalaft et al., 2013). 
 
1.3 Using virtual reality to research, assess, and treat aspects of social functioning in 
psychosis 
Psychosis is a growing area for VR assessment and treatment. Early VR studies (Ku et al., 
2006; Ku et al., 2005) observed that patients with schizophrenia felt uncomfortable wearing 
HMDs. With the development of increasingly lightweight VR technology, other research groups 
have used HMDs with people with psychosis (Valmaggia et al., 2015). VR is emerging as a 
treatment option for psychosis (Freeman, 2008; Veling et al., 2014). Research participants with 
psychosis have found immersive VR acceptable and experienced few side effects (Fornells-
Ambrojo et al., 2008; Freeman, 2008; Stinson et al., 2010). One review highlights that VR 
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applications for assessment and treatment of psychotic disorders appear to have a great 
potential for increasing our understanding of psychosis (Veling et al., 2014). Another review of 
VR in schizophrenia shows that VR is safe to use in this area and promises to add to existing 
treatments (Macedo et al., 2015). VR has been shown to allow the assessment of beliefs about 
the social environment in people with psychosis (Fornells-Ambrojo et al., 2008; Freeman, 2008). 
Immersive VR social scenarios have been shown to be acceptable and sufficiently realistic for 
people with psychosis (Veling et al., 2015), while social skills-based interventions that have 
figured prominently include emotion recognition (Souto et al., 2013), eye gaze (Choi et al., 2010; 
Han et al., 2014), interpersonal distance (Kim, Ku, et al., 2009), assertiveness (Park et al., 
2011), and social cognition (Rus-Calafell et al., 2014). 
 
1.4 Immersive and non-immersive virtual reality 
Existing VR research highlights ambiguity in the term ‘virtual reality’ because it has been used to 
describe a wide array of interactive computer technologies and interventions, some involving 
interaction with a 2D computer screen, while others use an immersive, 3D head mounted 
display (HMD). Immersive VR technologies that use a HMD are becoming more widely available 
and the hardware lighter and more comfortable. Immersive VR is deemed more ecologically 
valid (Seidel & Chatelier, 2013) and has been described as ‘combining computers, head-
mounted displays (HMDs), body tracking sensors, specialized interface devices, and real time 
graphics to immerse a participant in a computer-generated simulated world that changes in a 
natural way with the head and body motion’ (Rizzo et al., 2013). However, it has been argued 
that if the degree of immersion within a synthetic reality is relative to tasks to be performed or 
the skills developed, rather than relative to the level of perceptual experience, then a wider 
variety of environments could be called ‘virtual’ (Seidel & Chatelier, 2013). One example of a 
broader definition is multi-user domains (MUDS), internet-based virtual environments which do 
not require a HMD (Kamarainen et al., 2015) and have generally fallen under a broad definition 
of VR. Such broader definitions highlight the interactivity of the medium and the presence of the 
VR user (Steuer, 1992). While 2D interactivity in non-immersive VR may facilitate presence, it 
undoubtedly constitutes a qualitatively different experience of perceived reality to immersive VR. 
Immersive VR, by contrast, is likely to facilitate greater immersion and ecological validity given 
that it is ‘a medium in which people respond with their whole bodies, treating what they perceive 
as real’ (Slater, 2009). Future advances in VR technologies, including the developments of 
augmented reality (Barfield, 2015), mean that the definition of VR is in flux. Nevertheless, a 
convention in the current VR literature is to regard both immersive and non-immersive-VR as 





There is no previous systematic review of VR assessment and treatments that is specific to 
social functioning in psychosis. The evidence to date suggests that VR offers an effective 
assessment and treatment method for social functioning impairments in psychosis.  The present 
review aims to synthesise the available research exploring the use of VR to assess and treat 
social functioning in psychosis, to determine whether VR assessment and treatment improve 
social functioning in people with psychosis. This review takes the pragmatic stance of including 
studies that authors describe as VR, where interactivity and presence are indicated; and given 
the differences in media, adheres to the widely used distinction between immersive VR 
technologies that use a HMD and non-immersive VR that uses a 2D computer screen. 
 
2. METHODS 
2.1 Selection procedure 
A systematic review was conducted of VR studies that tested the assessment or treatment of 
social functioning for people with psychosis. Studies were included in the review if they were (a) 
peer-reviewed publications; (b) experimental; (c) written in the English language; (d) N>5; (e) 
used VR (either immersive or non-immersive); and (f) assessed or treated social functioning 
impairments in people with psychosis. People at ultra-high risk (UHR) of psychosis were 
included as UHR is associated with a very high risk of developing psychosis within the first three 
years of clinical presentation (Fusar-Poli et al., 2012). 
 
2.2 Search criteria  
Search terms were agreed by researchers (SR, LV, PG). Truncations and wild cards were used 
to identify mutations of terms. Studies for review were identified following a keyword search for 
the terms “virtual real*” OR “VR” OR “virtual enviro*” OR “virtual character*” OR “VCs” OR 
“avatar*” AND “social function*” OR “social dysfunction*” OR “social skill*” OR “social avoid*” OR 
“social cognit*” OR “social adapt*” OR “social behav*” OR “social inter*” OR “social stress*” OR 
“social learn*” OR “social percept*” OR “interpersonal” OR “inter-personal” AND “psycho*” OR 
“schiz*” OR “bipol*” OR “at risk mental state” OR “high risk” OR “early intervention” OR 
“paranoi*” OR “delus*” OR “halluci*”. 
 
2.3 Procedure 
The OvidSP platform was used to search PsycINFO, MEDLINE (Pubmed), and Embase. 
Additional searches were conducted using Web of Science, Cochrane Library, ProQuest, and 
Scopus. All database searches searched keyword, title, and abstract information for studies in 
English. For applicable databases (e.g. PsycINFO), key subject headings were exploded on 
OvidSP to identify studies that may not have been captured by the initial search strategy. See 
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Appendix I for the search strategy on OvidSP and Web of Science. Reference lists of key 
papers were screened to identify studies that may not have been captured by the initial search 
strategy. CRD guidance for systematic reviews was followed throughout. Reference 
management software Endnote was used to screen records. Unpublished dissertations, 
conference proceedings and abstracts without locatable full texts were excluded. A PRISMA 
flow chart was used to record studies that were excluded at each stage.  
 
2.4 Quality assessment 
The Effective Public Health Practice Project (EPHPP) Quality Assessment Tool for Quantitative 
Studies method and tool was developed for use in public health. This tool was used to assess 
the quality of studies. EPHPP assesses six methodological dimensions: selection bias; study 
design; confounders; blinding; data collection methods; withdrawals and dropouts. A global 
rating for the paper is described as follows: Strong=no weak ratings; Moderate=one weak rating; 
Weak=two or more weak ratings on the subscales (the EPHPP is available online 
hpp.ca/tools.html). The EPHPP has good content and construct validity, and good inter-rater 
reliability (Thomas et al., 2004). One feature of the EPHPP scoring is that a study can score 
‘strong’ overall even if it scores ‘moderate’ on all subscales.  
 
3. RESULTS 
3.1 Information extraction 
Studies were identified on 30 January 2016. Database searching identified 2212 titles. Titles 
were reviewed manually. After removing duplicates and manuscripts not available in English, a 
total of 105 potential studies were identified for screening. Two further studies were identified by 
searching reference lists of key papers. After screening, 32 studies were included in the review. 
12 studies were immersive VR and 20 studies were non-immersive VR. See Fig. 1.  
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 
diagram of selected studies 
 
See Appendix II for screening results by individual database. At full-text review, five studies 
were excluded due to not satisfying the exclusion criteria: Chan et al. (2010) (Hong Kong, non-
immersive VR, N=27 older adults with schizophrenia) was excluded for not testing social 
functioning impairments; Cho et al. (2007) (Korea, N=10 patients with schizophrenia) was 
excluded because the text was not in the English language; Delevoye-Turrell et al. (2011) 
(France) was excluded for not using VR; and Peyroux and Franck (2014) (France) and 




3.2 Study characteristics  
The review identified 32 studies published between 2005 and 2015. Thirteen (41%) of the 
studies occurred in 2014 or 2015. Overall, seventeen (53%) studies were from Asia (Fifteen 
Korea, one China, and one Hong Kong); ten (31%) studies were from Europe (three Spain, two 
United Kingdom, two France, one Germany, one Portugal, and one Netherlands); and five (16%) 
studies were from USA. 
 
3.3 Quality assessment 
Quality assessment was completed by three independent reviewers (SR, LV, MR-C). 
Disagreements were resolved through discussion. 24 (75%) studies received an EPHPP global 
rating of strong; seven (22%) were rated as moderate, and one (3%) was rated as weak. See 
Tables 1 and 2 for study characteristics and breakdown of quality assessment for both 
immersive and non-immersive VR studies. 
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Table 1. Immersive VR study characteristics 
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Table 2. Non-immersive VR study characteristics 
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2D screen Job interview 
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VAS 1 (N) Patients had a positive 
response to the 
simulation 
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emotion 
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reaction times in 
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Moderate 
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attributional style in 
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difficulty than controls 
identifying facial emotions 
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screen  
PANSS 1 (N) Severity of negative 
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spontaneous (‘‘online’’) 
empathic processing in 
association with lower 
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group 2 (44% 























10 (Y: 1 
month) 
VR group performed 




memory, attention and 
self-efficacy 
Strong 
* Study identified through other sources; ** Studies present the same data 
 
KEY: Demographics: M=male; F=female; Conditions: SF=social functioning; SZ=schizophrenia; FEP=first episode psychosis; UHR=ultra-high risk; BD=bipolar disorder; SAD=schizoaffective disorder; MDD=major 
depressive disorder; PTSD= post-traumatic stress disorder; BPD=borderline personality disorder; SMI=serious mental illness; Virtual Reality: VR=virtual reality; HMD=head mounted display; Measures: AI: Assertion 
inventory; AHQ: Annett's handedness questionnaire; BARS: Barnes akathisia rating scale; BLERT: Bell-Lysaker emotion recognition task; BNCE: Brief neuropsychological cognitive examination; CAARMS: 
Comprehensive assessment of the at risk mental state; Co-PQ: Co-presence questionnaire; CPT II: Continuous performance test; DACOBS: Davos assessment of cognitive biases scale; DASS: Depression, Anxiety and 
Stress Scale; DVT: Digit vigilance test; EPHPP: Effective public heath practice project quality assessment tool; EPT: Emotional perspective-taking; GAF: Global assessment of functioning scale; GPTS: Green paranoid 
thoughts scale; HAMD: Hamilton depression rating scale; IPQ: Igroup presence questionnaire; IPSM: Interpersonal sensitivity scale; ITQ: Immersive tendency questionnaire; LSAS: Liebowitz social anxiety scale; LSHS: 
Launay-Slade hallucinations scale; MMSE: Mini mental state examination; NART: National adult reading test; PANAS: Positive and negative affect schedule; PANSS: Positive and negative symptoms scale; PQ: 
Presence questionnaire; PrQ: Prodromal questionnaire; PS: Paranoia scale; PSPS: Personal and social performance scale; RAS: Rathus assertiveness scale; RBANS: Repeatable battery for the assessment of 
neuropsychological status; RBMT: Rivermead behavioural memory test; RCS: Relationship change scale; RPM: Raven’s progressive matrices; RSES: Rosenberg self-esteem scale; SADS: Social avoidance and distress 
scale; SARS: Simpson-Angus rating scale; SAS: Social anhedonia scale; SBS: Social behavior scale; SCID: Standard clinical interview for DSM disorders; SCIP: Screen for cognitive impairment in psychiatry; SC–LFS: 
Strauss–Carpenter level of functioning scale; SCS: Social comparison scale; SEDS: Social entrapment and defeat scales; SERS: Self-esteem rating scale; SES: Self-efficacy scale; SFS: Social functioning scale; SIAS: 
Social interaction anxiety scale; SPM: Standard progressive matrices; SPSI-R: Social problem solving inventory-revised; SSIT: Simulated social interaction test; SSPS: Social state and paranoia scale; SSQ: Simulator 
sickness questionnaire; STAI: Spielberger state-trait anxiety inventory; SUS: Sense of presence scale; TAS-20: Toronto Alexithymia Scale; TMTB: Trail making test b; VAS: Visual analogical scales; VCRT: Vocational 
cognitive rating scale; VRQ: Virtual reality questionnaire; VREQ: Virtual reality experience questionnaire; WAIS: Wechsler adult intelligence scale; WCST: Wisconsin card sorting test; YMRS: Young mania rating scale 
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3.4 Immersive virtual reality studies 
There were twelve immersive VR studies published between 2007 and 2015. Eleven (92%) 
studies had an EPHPP global rating of strong and one (8%) was rated as moderate. In terms of 
the six methodological dimensions, six studies received a moderate rating for all dimensions; 
two studies received 1/6 strong ratings; and four studies received 2/6 strong ratings. See 
Appendix IV for a full breakdown of quality results. 
 
Country of origin 
Six studies were from Asia and six studies were from Europe. See Table 3 for breakdown of 
studies’ country of origin. 
 
Table 3. Country of origin of immersive VR studies  
Country N 
Asia  
     Korea 6 
Europe  
     Netherlands 1 
     Portugal 1 
     Spain 2 
     United Kingdom 2 
 
Participant diagnoses 
Studies have been mainly conducted with people with schizophrenia. See Table 4 for 
breakdown of participant diagnoses. 
 
Table 4. Participant diagnoses for immersive VR studies 
Diagnosis N 
Bipolar disorder 1 
First episode psychosis 1 
Schizophrenia 8 
Ultra-high risk of psychosis 2 
 
Treatment and assessment domains 
There were eight assessment studies and four treatment studies. See Table 5 for breakdown of 
assessment and treatment domains. 
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Table 5. Assessment and treatment domains of immersive VR studies 
Country N 
Assessment  
     Eye gaze 4* 
     Interpersonal distance  2* 
     Social cognition/emotion recognition 1 
     Paranoid ideation 3 
Treatment  
     Conversation skills  2 
     Social cognition/emotion recognition 2 
*Two studies assessed both eye gaze and interpersonal distance 
 
Assessment 
Assessment studies have sought to assess behavioural indicators of social functioning, such as 
eye gaze and interpersonal distance; and cognitive indicators of social functioning, such as 
social cognition and paranoid ideation. Studies have been cross-sectional and all studies 
reported positive results. The behavioural studies of eye gaze and interpersonal distance show 
that people with schizophrenia use less eye contact (Choi et al., 2010; Han et al., 2014) and 
greater interpersonal distance (Park, Ku, Kim, et al., 2009) in social situations with virtual 
humans when compared with healthy controls. A similar result has been replicated for people 
with bipolar disorder (Kim, Ku, et al., 2009). In terms of the cognitive research, one study has 
assessed emotion recognition and found inferior performance on a facial stimuli emotion 
recognition task in people with schizophrenia when compared with healthy controls (Souto et al., 
2013). Studies of paranoid ideation and social defeat show that VR social situations are 
acceptable and do not in themselves cause negative outcomes (Valmaggia et al., 2007); that 
people at ultra-high risk of psychosis report greater paranoid ideation and social defeat 
(Valmaggia et al., 2015) when compared with healthy controls. A similar result for paranoid 
ideation was reported for people with first episode psychosis (Veling et al., 2015).  
 
Treatment 
Treatment studies have mainly been small pilots, two with control groups and two without, which 
have sought to develop social skills with behavioural and cognitive components for people with 
schizophrenia by targeting conversation skills (Park et al., 2011; Park, Ku, Park, et al., 2009) 
and social cognition (Rus-Calafell et al., 2014; Rus-Calafell et al., 2013). All studies reported 
positive results. Participants reported that VR social skills training had high acceptability and 
verisimilitude (Rus-Calafell et al., 2013) and the pilot of the intervention brought about reduction 
in negative symptoms and improvement in social skills (Rus-Calafell et al., 2014). Immersive VR 
conversation role-plays were shown to produce improvement in functional skills in people with 
schizophrenia. One study was a randomised controlled trial with a moderate sample size (Park 
et al., 2011); it found that VR roleplays were effective in developing verbal social skills. Sample 
sizes have otherwise been small. 
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3.5 Non-immersive virtual reality studies 
There were twenty non-immersive VR studies published between 2005 and 2015. Two 
separately published studies (Ku et al., 2006; Ku et al., 2005) presented the same data. Thirteen 
(65%) studies had an EPHPP global rating of strong, six (30%) were rated as moderate, and 
one (5%) was rated as weak. In terms of the six methodological dimensions, two studies 
received 1/6 strong ratings; and three studies received 2/6 strong ratings, and one study 
received 3/6 strong ratings. All other studies received either all moderate ratings or a 
combination of moderate and weak. See Appendix IV for a full breakdown of quality results. 
 
Country of origin 
Eleven studies were from Asia; 5 studies were from North America; and 4 studies were from 
Europe. See Table 6 for breakdown of studies’ country of origin. 
 
Table 6. Country of origin of non-immersive VR studies 
Country N 
Asia  
     China 1 
     Hong Kong 1 
     Korea 9 
Europe  
     France  2 
     Germany 1 
     Spain 1 
North America  
     Unites States of America 5 
 
Participant diagnoses 
Studies have been mainly conducted with people with schizophrenia, or with schizophrenia and 
other diagnoses. See Table 7 for breakdown of participant diagnoses. 
 
Table 7. Participant diagnoses for non-immersive VR studies 
Diagnosis N 
Bipolar disorder 1 
Schizophrenia 13 
Schizophrenia and other 
serious mental illnesses 
6 
 
Treatment and assessment domains 
There were 14 assessment studies and 6 treatment studies. See Table 8 for breakdown of 
assessment and treatment domains. 
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Table 8. Assessment and treatment domains of non-immersive VR studies 
Country N 
Assessment  
     Empathic processing 1 
     Interpersonal distance  2 
     Social cognition/emotion recognition 9 
     Social perception 1 
     Vocational skills 1 
Treatment  
     Conversation skills  1 
     Job interview skills 5 
 
Assessment 
Assessment studies have mainly assessed cognitive indicators of social functioning, with a 
particular focus on social cognition. Studies have been cross-sectional and all studies reported 
poorer performance in people with psychosis. Studies show that people with schizophrenia have 
found VR emotion recognition task acceptable (Oker et al., 2015); they are poorer at emotion 
recognition (Kim et al., 2007); and show delayed reaction times and reduced activation in the 
mirror neuron system (Kim, Jung, et al., 2009). 
 
Treatment 
Treatment interventions have largely focused on job interview training and simulations. These 
have mainly been pilot studies with small sample sizes. Interventions are shown to be 
acceptable (Bell & Weinstein, 2011; Ku et al., 2007); extended treatments that use 5-10 
sessions of job interview training have shown improved job interview performance compared 
with service users who did not receive the intervention (Smith, Ginger, Wright, Wright, Bell, et 
al., 2014). Results have been sustained at follow up (Smith, Fleming, Roberts, et al., 2015; 
Tsang & Man, 2013).  
 
4. DISCUSSION 
4.1 Main findings 
This review of the literature on VR assessment and treatments for social function in psychosis 
shows that VR has potential. Studies show positive findings but evidence is limited. A large 
majority of studies received an EPHPP global rating of strong but analysis of individual 
methodological domains on the EPHPP reveals that studies have methodological weaknesses, 
which will be discussed below. Key social functioning domains in assessment studies tend to 
divide into those that target cognitive abilities, such as social cognition or emotion recognition; or 
those that target behavioural indicators, such as eye gaze and interpersonal distance. 
Treatment packages have been shown to be effective but they have been fewer in number and 
focused on general social skills or job interview/vocational skills. VR studies in this area have 
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predominantly included people with schizophrenia as participants, with very few studies on 
bipolar disorder, first episode psychosis, or ultra-high risk. The majority of the studies have been 
conducted in Asia, specifically in Korea, with fewer in Europe and the USA.  
 
4.2 Assessment 
This review indicates that VR can be used to measure impairments in emotion recognition, 
processing, or general social cognition. Theory of mind deficits can be a marker of psychosis. 
People with psychosis have been shown to have severe and persistent problems with emotion 
recognition (Daros et al., 2014). This deficit is present early and tends to be present for the 
course of the illness (Comparelli et al., 2013). Social cognitive impairments interfere with social 
connections and have been shown to be strong determinants of the degree of impaired daily 
functioning in people with schizophrenia (Green et al., 2015). Emotion recognition impairments 
have been shown to be different across psychotic disorders (Ruocco et al., 2014) so it may be 
important to consider this in the future development of such VR tests. VR studies show that eye 
gaze and interpersonal distance are a key avoidance behaviour of socially anxious people within 
a highly controlled situation (Wieser et al., 2010). In psychosis, the behavioural studies showing 
reduced eye gaze and increased interpersonal distance have been replicated in four immersive 
studies, all with N>40 (Choi et al., 2010; Han et al., 2014; Kim, Ku, et al., 2009; Park, Ku, Park, 
et al., 2009). However, identifying such inferior performance does not constitute a novel finding: 
eye gaze and interpersonal distance in psychosis have been studied using non-VR tasks, 
sometimes with results that conflict with the VR findings (Hooker & Park, 2005; Nechamkin et 
al., 2003; Ponizovsky et al., 2013). Using eye and positioning tracking technology in conjunction 
with a controlled immersive VR environment might appear to be an optimal way of measuring 
eye gaze or interpersonal distance. However, a general problem in this field is that VR tasks 
have not been validated in comparison with other methods. Future studies need to determine if 




Supporting social relationships and employment opportunities has been shown to be 
instrumental to recovery (Gayer-Anderson & Morgan, 2013; Shanks et al., 2013; Tew et al., 
2011) and improving wellbeing (Schrank et al., 2014; Slade, 2012) for people with psychosis. 
The ten VR treatment studies (four immersive VR; six non-immersive VR) have mainly used a 
multi-session intervention. They have been mostly pilots, not randomised, and sometimes 
without a control condition. Studies provide some initial evidence that VR tasks can improve 
social skills in people with psychosis. One VR social skills package was shown to effectively 
improve negative symptoms, social anxiety and pro-social activities although it did not use a 
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control condition (Rus-Calafell et al., 2014). In another VR social skills training package, 
improvements were observed only in conversational skills but not in vocal and nonverbal skills 
(Park et al., 2011). VR studies have led to tangible outcomes such as higher success at job 
interviews compared with a control group (Smith, Fleming, Wright, Roberts, et al., 2015). The 
area of job interview training has figured prominently in the VR treatment literature. Other 
studies have shown that VR job interview simulations are acceptable for people with psychosis 
(Bell & Weinstein, 2011) and they do better in real-world interview roleplays after VR training 
(Humm et al., 2014). In addition, an important finding is that these positive gains in social skills 
have been maintained at follow-up (Rus-Calafell et al., 2014; Smith, Fleming, Wright, Jordan, et 
al., 2015). However, it is acknowledged that sample sizes have been small and interventions 
relatively short (Park, Ku, Park, et al., 2009). Several social skills simulations have been 
acceptability and feasibility pilots and only used one session (Bell & Weinstein, 2011; Ku et al., 
2007). In general, the evidence suggests that the ecological validity of VR has the potential to 
provide therapist-assisted treatment conditions but studies are limited in scope.  
 
4.4 Immersive and non-immersive virtual reality 
Immersive VR that uses a lighter HMD is now a more widely available and economically viable 
option that appears to be acceptable to people with psychosis; thus dispelling earlier concerns 
that the HMD would be too heavy and uncomfortable (Ku et al., 2006; Ku et al., 2005). It has 
been argued that immersive VR offers a fundamentally different intervention to non-immersive 
VR by enabling participants greater verisimilitude (Rus-Calafell et al., 2013) and egocentric 
encoding of a scene they are immersed in, rather than allocentric encoding on a computer 
screen (Kozhevnikov et al., 2013). Similarly researchers have argued that immersive VR can 
support effective co-presence in constrained situations (Steed & Schroeder, 2015); while it 
allows a direct feeling of objects and events that are physically out of reach; and supports 
training in safe environments that avoid potential real dangers (Freina & Ott, 2015). The 
evolution of immersive VR technology appears to offer greater ecological validity and reduces 
potentially intrusive by-products of social interventions, such as the ‘uncanny valley’ (Ho, 2015). 
The added ecological validity of immersive VR appears to offer a promising option for VR 
interventions targeting social functioning, compared with non-immersive VR, although 
comparisons have generally been between VR and non-VR.  
 
One advantage of immersive VR with a HMD and head tracking technology may be to allow 
researchers to investigate behavioural indicators of social functioning that have previously been 
harder to measure. One example is eye gaze and interpersonal distance (Kim, Ku, et al., 2009; 
Park, Ku, Kim, et al., 2009) although there have been limitations in this area.  
 
26 
4.5 Limitations  
This is a relatively small area of research with few studies; many studies are pilots with small 
sample sizes, few have control groups and there are very few RCTs. There is only one 
immersive VR RCT (Park et al., 2011) and only 6 non-immersive VR RCTs. The validity of the 
assessment tools used in VR not yet been fully established and there is a lack of replication, 
especially in treatment studies. Since most studies create new environments there is a real 
challenge to establish validity and reliability. Some studies fail to report important participant 
demographic information, such as age (Gutierrez-Maldonado et al., 2012; Oker et al., 2015; 
Park, Ku, Park, et al., 2009), experience of cybersickness, which has proven to be a difficult 
concept to measure (Davis et al., 2014); and provide little information about apparatus (Humm 
et al., 2014). Many treatment studies have not included a follow up (Park et al., 2011; Rus-
Calafell et al., 2013), which would give greater credence to the findings. 
 
Many studies have limitations in that they do not produce novel findings but they do replicate 
results established with non-VR tasks. This suggests that VR might have similar benefits in 
comparison to real life social situation tasks to assess social functioning. For instance, an 
advantage of VR facial stimuli emotion recognition tasks might be to provide a controlled 
environment against which to test impairments, such as social cognition or emotion recognition 
deficits. VR has the advantage of being conducted in a lab, can be manipulated, controlled, 
tailored, and is potentially more cost-effective.  
 
VR studies on social functioning impairments in psychosis have only twice used people with 
bipolar disorder (Kim, Jung, et al., 2009; Kim, Ku, et al., 2009) so this remains an under-
researched area. Equally, some studies include a mixed sample of participants with psychosis 
or other serious mental illnesses, which makes it difficult to draw diagnosis-specific conclusions. 
Studies have been conducted worldwide so cross-cultural factors must also be considered when 
comparing studies.  
 
In part due to technological limitations, studies have been fairly narrow in scope. Assessment 
research has tended to focus on discrete indicators of social functioning, such as eye gaze or 
interpersonal distance. From this research, there is evidence that VR can be used as an 
effective research tool, but it unclear whether general conclusions about social functioning can 
always be drawn. The concept of social functioning includes components focused on work, 
social activities, and relationships with partners and family. Similarly, treatment research has 
tended towards a narrow focus on job interview or vocational skills, or general social skills with 
new people (represented by avatars). While this research shows promising results, albeit mostly 
in small and uncontrolled studies, it remains to be seen how the ecological validity and evolving 
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technology of VR can be harnessed to expand to more sophisticated interventions that target 
family, friendships, and romantic relationships, as well as how VR technology can be harnessed 
to accommodate the reciprocal nature of social interactions.  
 
Limitations of the EPHPP quality assessment tool should be acknowledged. For instance, 
studies have shown that EPHPP and Cochrane Collaboration Risk of Bias Tool perform 
differently when evaluating the risk of bias or methodological quality of studies (Armijo‐Olivo et 
al., 2012). In the present review, the methodology for generating overall ratings has resulted in a 
high number of strong studies, especially when compared to the proportionately low number of 
strong methodological dimensions of the same studies and to the fact that the analysis of study 
characteristics shows that the majority of studies are pilots with relatively small sample sizes. 
Consequently, the individual methodological dimensions may represent a better way of 
evaluating the studies and has been taken into account in the present review.  
 
4.6 Future research 
Future VR research on social functioning in psychosis might seek to develop more 
comprehensive, standardised, methods of assessment, which attempts to establish their validity 
and reliability, and similarly for evidence-based treatments; and to broaden the demographic of 
participants and the range of social functioning indicators. Central to this aim will be the 
development of more interactive, multi-avatar social situation tasks, in which real-time 
therapeutic treatments for social functioning impairments can be tested and carried out, and 
correlates and key mechanisms identified.  
 
As technology evolves, it will be important for researchers to broaden the focus of social 
functioning to include dynamics within existing personal relationships. Technological limitations 
currently impede this process, although non-immersive VR studies have already shown that 
people with psychosis can create an avatar of an entity known to them (Leff et al., 2014; Leff et 
al., 2013). Outside of psychosis research, the range of VR social functioning studies is broader, 
including areas such as VR dating (Frost et al., 2008). The next stage in VR mental health 
research may be the development of technology that allows clinicians to work with participants 
to co-create more sophisticated avatars in immersive VR. Virtual worlds may increasingly be 
harnessed by immersive VR for social interventions (Bainbridge, 2007). Communication and 
social networking is expected to be transformed in the age of virtual reality (Blascovich & 
Bailenson, 2011). Future technologies may seek to further blend what is ‘real’ and what is 
‘virtual’ in ways already being seen with the development of augmented reality and gamification 
(Kapp, 2012).  
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4.7 Clinical recommendations 
Evidence is limited but VR tasks can be used to measure impairments in emotion recognition, 
processing, or general social cognition, and can improve social skills in people with psychosis. 
The ecological validity of VR has the potential to provide therapist-assisted treatment conditions. 
Levels of immersion and cybersickness are important factors for clinicians to consider when 
administering VR tasks.   
 
4.8 Conclusion 
Evidence suggests that VR can be used to improve the assessment and treatment of aspects of 
social functioning in people with psychosis but, given study limitations and the lack of follow up 
results, more research is needed to be able to draw robust conclusions.  
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OvidSP Search Strategy 
1 virtual real*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
2 vr.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
3 virtual enviro*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
4 virtual character*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
5 VCs.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
6 avatar*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
7 1 or 2 or 3 or 4 or 5 or 6 
8 social function*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
9 social dysfunction*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
10 social skill*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
11 social avoid*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
12 social adapt*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
13 social behav*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
14 social inter*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
15 social stress*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
16 social learn*.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
17 social percept*.mp. [mp=title, abstract, heading word, table of contents, key concepts, 
original title, tests & measures] 
18 interpersonal.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
19 inter-personal.mp. [mp=title, abstract, heading word, table of contents, key concepts, original title, tests & measures] 
20 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 
21 7 and 20 
22 exp Virtual Reality/ 
23 7 or 22 
24 exp social behavior/ 
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25 20 or 24 
26 23 and 25 




Web of Science Search Strategy 
 
Web of Science Core Collection 1900-2016 
# 23 763  #21 AND #20  
Refined by: LANGUAGES: ( ENGLISH )  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 22 776  #21 AND #20  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 21 133,082 #19 OR #18 OR #17 OR #16 OR #15 OR #14 
OR #13 OR #12 OR #11 OR #10 OR #9 OR
#8 OR #7  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 20 42,759  #6 OR #5 OR #4 OR #3 OR #2 OR #1  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 19 677  TOPIC: (inter-personal)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 18 45,522  TOPIC: (interpersonal)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 17 2,963  TOPIC: (“social percept*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 16 5,747  TOPIC: (“social learn*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 15 4,561  TOPIC: (“social stress*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 14 28,785  TOPIC: (“social inter*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 13 20,037  TOPIC: (“social behav*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 12 1,122  TOPIC: (“social adapt*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
Edit Select to 
combine sets. 
Select to 
delete this set. 
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CPCI-S, CPCI-SSH, ESCI Timespan=All years 
  
 
# 11 15,479  TOPIC: (“social cognit*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 10 511  TOPIC: (“social avoid*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 9 7,321  TOPIC: (“social skill*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 8 777  TOPIC: (“social dysfunction*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 7 11,344  TOPIC: (“social function*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 6 3,445  TS=(“avatar*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 5 1,674  TOPIC: (VCs)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 4 837  TOPIC: (“virtual character*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 3 13,877  TOPIC: (“virtual enviro*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 2 11,486  TOPIC: (VR)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




delete this set. 
 
 
# 1 20,866  TOPIC: (“virtual real*”)  
Indexes=SCI-EXPANDED, SSCI, A&HCI, 
CPCI-S, CPCI-SSH, ESCI Timespan=All years 




































Table 9. Database search results 
Database Results 
PsycINFO 1806 to January Week 4 2016 329 
MEDLINE(R) 1946 to January Week 3 2016 135 
Embase 1974 to 2016 Week 05 648 
PsycARTICLES 370 
Web of Science Core Collection 1900 to 2016 205 
Cochrane Library 18 
Scopus 485 
ProQuest Social Sciences Premium Collection (Subject 
Headings): Scholarly Journals 
22 
Total 2212 
Total after deduplication function used in Endnote 1701 
































































































Table 10. Immersive VR studies quality assessment  
 
Study A. Selection bias B. Study 
design 
C. Confounders D. Blinding E. Data collection 
method 
F. Withdrawals and drop out Overall rating 
Choi et al, 
2010 
(Q1) 2. Somewhat 
likely 







(Q1) No. No difference in gender, age, 
education and IQ. Other potential 
confounders not mentioned 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 




Han et al, 
2014 
(Q1) 2. Somewhat 
likely 







(Q1) No. No difference in age and 
education. There was a difference in 
reasoning ability and attention. Other 
potential confounders not mentioned 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 




Kim, Ku at al, 
2009 
(Q1) 2. Somewhat 
likely 







(Q1) No difference in gender, age, 
education, IQ, state anxiety, trait anxiety, 
(Q2) 1. 80-100% (most) 
=STRONG 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 




Park et al, 
2011 
(Q1) 2. Somewhat 
likely 








(Q1) No. No difference in gender, age, 
marital status, previous social skills 
treatments, medications, age at illness 
onset, education, previous psychiatric 
admissions, baseline scores on outcome 
measures 
(Q2) 1. 80-100% (most) 
=STRONG 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 




Park et al, 
2009 
(Q1) 2. Somewhat 
likely 







(Q1) No. No difference in gender, age, age 
at illness onset, education, baseline scores 
on outcome measures 
(Q2) 1. 80-100% (most) 
=STRONG 
(Q1) 3. Can’t ell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 2. 80-100% (33/39=85%) 
=STRONG 
1. STRONG 
Park, Ku, Kim 
et al, 2009 
(Q1) 2. Somewhat 
likely 







(Q1) Yes. No differences in gender, 
employment, and marital status. 
Differences in education and intellectual 
function. 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 2. No. 
(Q2) 5. Not applicable 




et al, 2013 
(Q1) 2. Somewhat 
likely 




(Q1) 3. Can’t tell 
(Q2) 4. Can’t tell 
=WEAK 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 






et al, 2014 
(Q1) 3. Somewhat 
likely 






(Q1) 1. Yes 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 1. Yes 
=STRONG 
(Q1) 1. Yes 
(Q2) 1. 80-100% (12/15=80%) 
=STRONG 
1. STRONG 
Souto et al, 
2013 
(Q1) 2. Somewhat 
likely 







(Q1) Yes. No difference in age and 
gender. Difference in Marital status, 
education, and employment. 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 






(Q1) 2. Somewhat 
likely 







(Q1) Yes. No difference in age, gender, 
ethnicity. There was a difference in 
employment, education, reading ability. 
These confounders were controlled for in 
analysis. 
(Q2) 1. 80-100% (most) 
=STRONG 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 1. Yes 
=STRONG 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 






(Q1) 2. Somewhat 
likely 




(Q1) 1. Yes 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 1. Yes 
=STRONG 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 




Veling et al, 
2014 
(Q1) 2. Somewhat 
likely 







(Q1) 1. Yes 
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. one 
time surveys or interviews) 






Table 11. Non-immersive VR studies quality assessment  
 
Study A. Selection bias B. Study 
design 
C. Confounders D. Blinding E. Data collection 
method 
F. Withdrawals and drop 
out 
Overall rating 
Dyck et al. 
(2010) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 2. No. No difference in age, gender, 
education, and parental education. Other 
potential confounders not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 






et al. (2012) 
(Q1) 2. Somewhat 
likely  




(Q1) 3. Can’t tell 
(Q2) 4. Can’t tell 
=WEAK 
(Q1) 1. Yes 
(Q2) 3. Can’t tell  
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Humm et al. 
(2014) 
(Q1) 2. Somewhat 
likely  








(Q1) 3. Can’t tell 
(Q2) 4. Can’t tell 
=WEAK 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 





et al. (2009) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 2. No. No difference in age, gender, 
education, and IQ. Other potential confounders 
not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Kim et al. 
(2005) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 2. No. No difference in age, gender, and 
computer-using experience. Other potential 
confounders not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Kim et al. 
(2007) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 2. No. No difference in age, gender, and 
computer-using experience. Other potential 
confounders not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Ku et al. 
(2007) 
(Q1) 2. Somewhat 
likely  




(Q1) 1. Yes. No difference in gender. Other 
potential confounders not mentioned  
(Q2) 3. Less than 60% (few or none) 
=WEAK 
(Q1) 1. Yes 
(Q2) 3. Can’t tell  
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 





Ku et al. 
(2006); Ku 
et al. (2005) 
(Q1) 2. Somewhat 
likely  




(Q1) 1. Yes. No difference in gender. Other 
potential confounders not mentioned  
(Q2) 3. Less than 60% (few or none) 
=WEAK 
(Q1) 1. Yes 
(Q2) 3. Can’t tell  
=MODERATE 
 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Oker et al. 
(2015) 
(Q1) 4. Can’t tell 
(Q2) 5. Can’t tell 
=WEAK 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 4. Can’t tell 
=WEAK 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
 
=WEAK 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 





Park, Kim et 
al, 2009 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 1. Yes. No difference in age, gender, and 
education duration. There was a difference in 
IQ. Other potential confounders not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Park et al. 
(2014) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 1. Yes. No difference in age, gender, and 
social anxiety. There was a difference in 
education and self-esteem. Other potential 
confounders not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Shin et al. 
(2015) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 1. Yes. No difference in age, gender, and 
education. There was a difference in IQ and 
social anhedonia. Other potential confounders 
not mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 









(Q1) 2. Somewhat 
likely  








(Q1) No. No difference in demographic 
characteristics and clinical, cognitive, and 
vocational histories.  
(Q2) 1. 80-100% (most) 
=STRONG 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 









(Q1) 2. Somewhat 
likely  










(Q1) No. No difference in demographic 
characteristics and clinical, cognitive, and 
vocational histories.  
(Q2) 1. 80-100% (most) 
=STRONG 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 










(Q1) 2. Somewhat 
likely  








(Q1) Yes. No difference in demographic 
characteristics and clinical, cognitive, and 
vocational histories. There were between 
groups differences in gender and level of 
major depressive episode.  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 




Song et al. 
(2015) 
(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 1. Yes. No difference in age, gender, and 
education. Other potential confounders not 
mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 





(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 






(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
4. Case control 
Not randomised 
=MODERATE 
(Q1) 1. Yes. No difference in age, gender, and 
handedness. Other potential confounders not 
mentioned  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 
(Q2) 2. No 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 






(Q1) 2. Somewhat 
likely  










(Q1) 1. Yes. No difference in demographic 
characteristics and baseline outcome 
measures. There were group differences in 
gender and illness duration.  
(Q2) 2. 60-79% (some) 
=MODERATE 
(Q1) 3. Can’t tell 





(Q1) 1. Yes 







(Q1) 2. Somewhat 
likely  
(Q2) 5. Can’t tell 
=MODERATE 
5. Cohort (Q1) 1. Yes. No difference in gender. 
Differences in age, ethnicity, marital status, 
and employment. Other potential confounders 
not mentioned  
(Q2) 3. Less than 60% (few or none) 
=WEAK 
(Q1) 3. Can’t tell 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 1. Yes 
(Q2) 3. Can’t tell 
=MODERATE 
(Q1) 4. Not applicable (i.e. 
one time surveys or 
interviews) 
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ABSTRACT 
Background: Paranoid ideation and social performance impairments overlap significantly. 
Virtual reality (VR) can enable assessment of cognitions, emotions, and behaviour in an 
ecologically valid social environment. This project, in two linked studies, aimed: to recruit a 
general population sample; test for paranoid ideation and its correlates with cognitive, affective, 
and behavioural components of social performance (fear of negative evaluation, interpersonal 
sensitivity, and social avoidance and distress); then to pilot a new VR ‘social situation’ paradigm 
in non-clinical participants with high and low paranoid ideation; and to investigate whether fear 
of negative evaluation, interpersonal sensitivity, and social avoidance and distress, and mood 
are associated with increased paranoid ideation in a VR ‘social situation’ task. Method: In 
Study 1, a general population online survey (N=609) investigated how trait paranoia relates to 
fear of negative evaluation, interpersonal sensitivity, and social avoidance and distress, and 
mood. In Study 2, two groups were formed based on Study 1 data. Participants who scored 
high and low in trait paranoia (N=89) entered a VR ‘social situation’ task to evaluate the 
acceptability of the new VR paradigm and the relationship between paranoid ideation and fear 
of negative evaluation, interpersonal sensitivity, and social avoidance and distress. Results: As 
hypothesised, in Study 1, trait paranoia was associated with fear of negative evaluation, 
interpersonal sensitivity, and social avoidance and distress; and was consistent with previous 
findings. As hypothesised, in Study 2, participants found the VR environment acceptable and 
immersive; exposure to the VR environment elicited fear of negative evaluation, interpersonal 
sensitivity, and social avoidance and distress; high trait paranoia participants reported higher 
state paranoia and greater negative CSP in VR. Discussion: The VR social situation task has 
assessment and exposure therapy treatment applications for people with psychosis, who can 
experience significant paranoia in social situations. 
 
KEYWORDS: virtual reality; social performance; social functioning; paranoia; psychosis 
59 
CONTENTS 
1. INTRODUCTION .......................................................................................................................... 62 
1.1 Social performance and psychosis .......................................................................................... 62 
1.2 Paranoid ideation .................................................................................................................... 63 
1.3 Virtual reality assessment and treatment in mental healthcare and psychosis .......................... 64 
1.4 Study aims .............................................................................................................................. 65 
1.5 Research questions ................................................................................................................ 66 
1.6 Hypotheses............................................................................................................................. 66 
2. METHOD ..................................................................................................................................... 67 
2.1 Design .................................................................................................................................... 67 
2.2 Procedure ............................................................................................................................... 68 
2.3 Stakeholder involvement ......................................................................................................... 69 
STUDY 1. ONLINE SURVEY OF PARANOIA IN THE GENERAL POPULATION ............................. 70 
3. INTRODUCTION .......................................................................................................................... 70 
4. METHOD ..................................................................................................................................... 70 
4.1 Design .................................................................................................................................... 70 
4.2 Procedure ............................................................................................................................... 70 
4.3 Participants ............................................................................................................................. 70 
4.4 Participant recruitment ............................................................................................................ 70 
4.5 Online survey construction ...................................................................................................... 71 
4.6 Online survey measures ......................................................................................................... 71 
4.7 Informed consent .................................................................................................................... 73 
4.8 Participation incentives ........................................................................................................... 73 
4.9 Potential risks ......................................................................................................................... 73 
4.10 Participant confidentiality....................................................................................................... 73 
4.11 Freedom to withdraw............................................................................................................. 74 
4.12 Participation benefits ............................................................................................................. 74 
4.13 Projected sample size ........................................................................................................... 74 
4.14 Research approvals .............................................................................................................. 74 
4.15 Statistical analysis ................................................................................................................. 74 
5. RESULTS .................................................................................................................................... 75 
5.1 Sample characteristics ............................................................................................................ 75 
5.2 Recruitment ............................................................................................................................ 76 
5.3 Reliability analysis .................................................................................................................. 76 
5.4 Paranoia measurement ........................................................................................................... 76 
5.5 Associations between paranoia and fear of negative evaluation, interpersonal sensitivity, 
and social avoidance and distress (Hypothesis 1) ......................................................................... 77 
5.6 Summary of main findings of Study 1 ...................................................................................... 77 
6. DISCUSSION ............................................................................................................................... 78 
6.1 Strengths ................................................................................................................................ 78 
6.2 Limitations .............................................................................................................................. 79 
STUDY 2. VIRTUAL REALITY ‘SOCIAL SITUATION’ TASK ............................................................. 80 
7. INTRODUCTION .......................................................................................................................... 80 
8. METHOD ..................................................................................................................................... 80 
8.1 Design .................................................................................................................................... 80 
8.2 Procedure ............................................................................................................................... 80 
8.3 Participants ............................................................................................................................. 80 
8.4 Participant recruitment ............................................................................................................ 81 
8.5 Informed consent .................................................................................................................... 81 
8.6 Participant confidentiality ........................................................................................................ 81 
8.7 Participation incentives ........................................................................................................... 81 
8.8 Potential risks ......................................................................................................................... 82 
8.9 Freedom to withdraw .............................................................................................................. 82 
8.10 VR data collection instruction manual .................................................................................... 82 
8.11 Virtual environment ............................................................................................................... 82 
8.12 Apparatus ............................................................................................................................. 83 
8.13 Pre-VR measures ................................................................................................................. 83 
8.14 Post-VR measures ................................................................................................................ 84 
8.15 VR task fidelity measures ...................................................................................................... 85 
8.16 Researchers ......................................................................................................................... 86 
60 
8.17 Piloting of measures ............................................................................................................. 86 
8.19 Pilot phase ............................................................................................................................ 86 
8.20 Statistical analysis ................................................................................................................. 86 
9. RESULTS .................................................................................................................................... 87 
9.1 Paranoia analysis and sample identification ............................................................................ 87 
9.2 High and low paranoia sample characteristics ......................................................................... 89 
9.3 Data collection process ........................................................................................................... 89 
9.4 Pilot phase .............................................................................................................................. 90 
9.5 High and low paranoia VR group paranoia scores ................................................................... 90 
9.6 High and low paranoia VR group characteristics...................................................................... 90 
9.7 VR task fidelity ........................................................................................................................ 93 
9.8 Reliability analysis .................................................................................................................. 93 
9.9 VR acceptability and sense of presence (Hypothesis 2) .......................................................... 93 
9.10 VR exposure elicits emotional changes and increased heart rate (Hypothesis 3) ................... 94 
9.11 Higher paranoia before VR predicts higher paranoia in VR (Hypothesis 4) ............................. 94 
9.12 High trait paranoia associated with greater negative components of social performance 
in VR (Hypothesis 5) ..................................................................................................................... 95 
9.13 Summary of main findings of Study 2 .................................................................................... 95 
10. DISCUSSION ............................................................................................................................. 96 
10.1 Strengths .............................................................................................................................. 96 
10.2 Limitations ............................................................................................................................ 96 
11. OVERALL SUMMARY AND GENERAL DISCUSSION ............................................................... 97 
11.1 Clinical implications ............................................................................................................... 97 
11.2 Future research .................................................................................................................... 98 
REFERENCES .............................................................................................................................. 100 
Appendix I   Service user review .................................................................................................... 106 
Appendix II   Research Ethics Committee documents ..................................................................... 108 
Appendix III   Study 1 recruitment tools .......................................................................................... 113 
Appendix IV   Study 1 online survey BOS output, information sheet, and consent form ................... 117 
Appendix V   Study 2 recruitment tools ........................................................................................... 150 
Appendix VI   Study 2 information sheet and consent form ............................................................. 153 
Appendix VII   Instruction manual for VR data collection procedure ................................................. 157 
Appendix VIII   Information for IoPPN receptionists ......................................................................... 169 
Appendix IX   Pre-VR measures BOS output .................................................................................. 171 
Appendix X   VR scenario stills ....................................................................................................... 178 
Appendix XI   VR fidelity and heart rate measures BOS output ....................................................... 180 
Appendix XII   Post-VR measures BOS output ............................................................................... 184 
Appendix XIII   Post-VR interview ................................................................................................... 196 
Appendix XIV   Paranoia leaflet ...................................................................................................... 199 




LIST OF TABLES  
Table 1. Demographic characteristics of online survey sample ......................................................... 75 
Table 2. Participant recruitment sources ........................................................................................... 76 
Table 3. Internal consistency of scales ............................................................................................. 76 
Table 4. Sample paranoia and components of social performance characteristics ............................ 77 
Table 5. Associations between GPTS, fear of negative evaluation, interpersonal sensitivity, and 
social avoidance and distress, and mood ......................................................................................... 77 
Table 6. High and low paranoia samples’ paranoia characteristics .................................................... 87 
Table 7. Demographic characteristics of higher and lower paranoia samples .................................... 89 
Table 8. High and low paranoia samples recruitment sources ........................................................... 89 
Table 9. High and low paranoia VR group paranoia characteristics ................................................... 90 
Table 10. Demographic characteristics of high and low paranoia groups in VR study ........................ 91 
Table 11. VR participant recruitment sources ................................................................................... 91 
Table 12. Previous VR and gaming experience of VR participants .................................................... 91 
Table 13. VR task fidelity .................................................................................................................. 93 
Table 14. Internal consistency of VR study scales ............................................................................ 93 
Table 15. VR acceptability and sense of presence ............................................................................ 94 
Table 16. Pre- and post-VR mood and heart rate .............................................................................. 94 
Table 17. Post-VR paranoia scores between HP-VRG and LP-VRG ................................................. 95 
Table 18. Post-VR components of social performance ...................................................................... 95 
 
 
LIST OF FIGURES 
Figure 1. Overview of Study 1 and Study 2 procedure ...................................................................... 68 
Figure 2. Identification of high paranoia sample (HPS) and low paranoia sample (LPS) .................... 88 






1.1 Social performance and psychosis 
There is a well-established link between positive social relationships and good health (Cacioppo 
& Cacioppo, 2014; House et al., 1988). Meaningful engagement with others has been shown to 
be an important factor in the pursuit of psychological wellbeing (Schueller & Seligman, 2010); 
while positive relationships with family, friends, neighbours and colleagues appear to be 
robustly related to happiness and life satisfaction (Ryan & Deci, 2000). Conversely, the 
experience of prolonged social isolation and lack of quality social relationships is a major risk 
factor for developing serious mental health conditions, such as major depression (Teo et al., 
2013) and psychosis (de Sousa et al., 2015); abusive parent-child relationships have been 
associated with the onset of depression, anxiety and post-traumatic stress disorder (PTSD), 
and psychosis (Bebbington et al., 2004; Fisher et al., 2009), while maternal emotional 
unavailability in early life was associated with suicide attempts in adolescence (Weich et al., 
2009). 
 
Social performance has been demonstrated to involve subcategories of cognitive performance, 
emotional performance, and behavioural performance. Components of social performance, 
such as fear of negative evaluation (Leary, 1983), interpersonal sensitivity (Boyce & Parker, 
1989), and social avoidance and distress (Watson & Friend, 1969), are indicators of an 
individual’s capacity to initiate and enter into social relationships. Fear of negative evaluation 
has been defined as apprehension of the prospect of being judged negatively and has been 
associated with reduced social functioning in schizophrenia (Blanchard et al., 1998); 
interpersonal sensitivity is a personality trait described as ‘excessive awareness of both the 
behaviour and feelings of others’, which has been associated with people at risk of psychosis 
(Masillo et al., 2012; Masillo et al., 2016); and social avoidance and distress is an indicator of 
social anxiety and is associated with increased paranoid ideation (Martin & Penn, 2001). Social 
performance impairments and the experience of social anxiety can have serious effects on role 
functioning and quality of life (Kessler, 2003). For instance, people who experience high social 
anxiety have been shown to possess a bias towards identifying others' emotional expressions 
as negative, thus impairing relationships (Winton et al., 1995); while lack of perceived social 
acceptance predicts subsequent explicit social anxiety and fear of negative evaluation 
(Teachman & Allen, 2007).  
 
The onset of psychosis is strongly associated with prolonged experiences of social isolation 
(Reininghaus et al., 2008), diminished social networks (Garety et al., 2001), impairments in 
social cognition (Bertrand et al., 2007), and mood disorders (Pini et al., 2001). In particular, a 
chronic and prolonged experience of social defeat has been shown to increase the risk of 
schizophrenia (Selten & Cantor-Graae, 2005). As a consequence, interventions that support 
social relationships, functioning, mood, and performance in the context of psychosis have been 
shown to be instrumental to subjective recovery (Gayer-Anderson & Morgan, 2013; Tew et al., 
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2011) and to improving psychological wellbeing (Schrank et al., 2014). Similarly, family 
interventions have been shown to have an important role in the treatment of psychosis (Bird et 
al., 2010; Pilling et al., 2002).  
 
1.2 Paranoid ideation 
Paranoid ideation has been conceptualised as a cognitive response to the perception of 
interpersonal threat (Morrison et al., 2005); and can be understood as a spectrum of beliefs 
comprising ideas of reference and persecution, related to appraisals of changed and confusing 
experiences of anomalous internal states (Freeman et al., 2013). Negative judgements about 
the self, related to paranoid ideation, have been shown to mediate adaptation to the social 
world (Fowler et al., 2006). Paranoid ideation has implications for psychological wellbeing, 
mood, functioning, and social inclusion (Freeman et al., 2011); has been shown to be related to 
insecure attachment styles (Pickering et al., 2008); and can significantly impact on social 
performance (Combs & Penn, 2004; Gilbert et al., 2005; Valmaggia et al., 2007).  
 
Paranoid ideation is experienced by both clinical and non-clinical populations (Bebbington et al., 
2013; Fonseca-Pedrero et al., 2012). It has been hypothesised that paranoid ideation may be 
as common as symptoms of anxiety and depression: an online study of the general population 
found that approximately a third of the sample experienced regular paranoid ideation (Freeman 
et al., 2005). Paranoid ideation has been shown to be associated with the ‘jumping to 
conclusions’ reasoning bias in both clinical and non-clinical samples (Freeman & Garety, 2014; 
Freeman, Pugh, & Garety, 2008). Paranoid ideation and social anxieties have been shown to 
be highly correlated in people with depression and anxiety: both have been shown to be related 
to social rank perceptions, power and submissive behaviour (Gilbert et al., 2005), and high 
rates of mood disorders have been shown in people with psychosis (Freeman & Garety, 2003; 
Martin & Penn, 2001). Similarly, there is a strong association between paranoid ideation and 
social stress (Kesting et al., 2013). 
 
People with psychosis commonly experience paranoid ideation (Fowler et al., 2006), which can 
involve both cognitive (Garety et al., 2015) and emotion-related processes (Bentall et al., 2009). 
Such dysfunctional negative schemas have been shown to be associated with levels of 
emotional distress (Garety et al., 2001) and specific delusions can be linked with specific 
emotions (Freeman & Garety, 2003). Paranoid ideation about the social world may be 
instrumental to psychosis: studies show that there is a link between trauma and psychosis 
mediated by negative beliefs about self and others (Gracie et al., 2007); and in one study 
almost half of the variance in paranoia scores was explained by negative interpersonal self-
concepts and the interaction between negative interpersonal self-concepts and dysfunctional 
acceptance beliefs (Lincoln et al., 2010).  
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1.3 Virtual reality assessment and treatment in mental healthcare and psychosis 
Virtual reality (VR) has been cited as the most fully developed, innovative emerging technology 
(Thornhill-Miller & Dupont, 2016) and is currently employed in clinical practice to treat cognitive, 
emotional, and behavioural problems (Bohil et al., 2011; Gregg & Tarrier, 2007; Riva, 2005). 
Whereas traditional psychological assessment methods employ self-report measures, video 
feedback, and role-play, which may have limited ecological validity, VR can provide ecologically 
valid therapeutic environments that enable clinicians to manipulate VR design and real-time 
environmental conditions (Parsons, 2011). Notable VR innovations in mental health include 
research and treatments in PTSD (Gonçalves et al., 2012), anxiety disorders (Meyerbröker & 
Emmelkamp, 2010), specific phobias (Parsons & Rizzo, 2008), eating disorders (Brownley et 
al., 2007), depression (Falconer et al., 2016), and psychosis (Freeman, 2008; Veling et al., 
2014). Optimising validity and efficacy of VR interventions across mental healthcare will depend 
on immersion or ‘sense of presence’ (Cummings & Bailenson, 2015; Diemer et al., 2015; 
Sanchez-Vives & Slater, 2005), reducing side-effects, such as cybersickness (Rosa et al., 
2016), and demonstrating acceptability of VR across patient groups.  
 
VR is emerging as a treatment option for psychosis (Freeman, 2008; Veling et al., 2014). 
Research participants with psychosis have found some immersive VR environments acceptable 
and experienced few side effects (Fornells-Ambrojo et al., 2008; Freeman, 2008; Stinson et al., 
2010) and a very recently published study has shown proof-of-principle evidence of reductions 
in clinical paranoia following a cognitive therapy exposure to VR environments (Freeman et al., 
2016). This offers great potential for clinical practice in psychosis as research has focused on 
key difficulties such as social impairments and paranoid ideation. Immersive VR social 
scenarios have been shown to be acceptable and sufficiently realistic for people with psychosis 
(Veling et al., 2015), while social skills-based interventions that have figured prominently 
include emotion recognition (Souto et al., 2013), eye gaze (Choi et al., 2010; Han et al., 2014), 
interpersonal distance (Kim, Ku, et al., 2009), assertiveness (Park et al., 2011), and social 
cognition (Rus-Calafell et al., 2014). In addition to cognitive and behavioural measures, stress 
or arousal has also been measured by physiological response, such as heart rate (Allen et al., 
2007; Castro et al., 2008; Veling et al., 2015).  
 
The growth of paranoia research has seen the development of psychological treatments 
(Garety & Freeman, 2013) and measurement tools, such as the Green et al Paranoid Thoughts 
Scales (GPTS), which was developed for use across the general population-psychopathology 
continuum (Green et al., 2008), and the State Social Paranoia Scale (SSPS), which measures 
paranoid ideation about a specific social situation, including VR scenarios (Freeman et al., 
2007). VR research in psychosis has targeted auditory hallucinations (Leff et al., 2014; Leff et 
al., 2013), persecutory delusions (Fornells-Ambrojo et al., 2008), and its relationship with social 
comparison (Freeman et al., 2014). A strength of VR research has been to provide a controlled 
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environment in which to assess paranoid ideation (Freeman, Pugh, Antley, et al., 2008; 
Freeman et al., 2010).  
 
Research on paranoid ideation in social situations has shown that paranoia can be predicted by 
baseline social defeat (Valmaggia et al., 2015); higher paranoia can impact negatively on 
interpersonal trust (Fornells-Ambrojo et al., 2016); and heightened sensitivity to environmental 
social stress may be associated with the onset and course of psychosis (Veling et al., 2016). In 
both clinical and non-clinical populations, delusional ideation (Kinoshita et al., 2011) is 
associated with fear of negative evaluation (Watson & Friend, 1969), social distress (Boyce & 
Parker, 1989), perceived social threat (Taylor & Stopa, 2013), less social engagement, fewer 
social contacts, and impaired social perception and social skills (Kurtz & Mueser, 2008; Penn et 
al., 2002). Although social anxiety is a significant comorbidity in psychosis, evidence suggests it 
is associated with a separate causal pathway (Michail & Birchwood, 2009), indicating that 
paranoid ideation may impair social performance independently of concurrent social anxiety. 
 
1.4 Study aims 
VR interventions for social performance in psychosis have been either non-immersive (Smith, 
Fleming, Wright, Roberts, et al., 2015) or focused predominantly on one-to-one interactions 
(Rus-Calafell et al., 2014). The next stage for VR research is to examine the role of cognitive 
processes, such as paranoid ideation, as well as associated emotional and physiological 
response (heart rate), within an immersive, interactive, multi-avatar social situation. This will 
serve as a means to develop real-time therapeutic treatments that target social performance 
impairments in realistic social settings. This two-part study at the Institute of Psychiatry, 
Psychology & Neuroscience (IoPPN), King’s College London, aimed to address this need by 
recruiting non-clinical participants with high and low paranoia and piloting a new VR ‘social 
situation’ platform.  
 
In Study 1, the aim was to conduct an online survey of the general population in order to 
investigate associations between trait paranoia and components of social performance. Given 
their previous use in psychosis research, as outlined above, components of social performance 
included cognitive (fear of negative evaluation), affective (social distress), and behavioural 
(social avoidance) components. Standard measures of mood (depression, anxiety) were also 
used. In Study 2, the aim was first to form two groups using Study 1 data: then, participants 
who scored high and low on trait paranoia, as measured by GPTS, were compared to see if a 
VR social situation task elicited greater feelings of state paranoia, fear of negative evaluation, 
interpersonal sensitivity, social avoidance and distress, and higher heart rate in people with 
high trait paranoia. The VR social situation task had not been tested before and so it was 
important to pilot it with a non-clinical sample to determine the potential for any adverse 
experiences before it can be used with clinical populations. 
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Research shows that social media is a viable, efficient, and cost-effective method for recruiting 
research participants (Fenner et al., 2012; Frandsen et al., 2014; Ramo & Prochaska, 2012; 
Yuan et al., 2014) but this has yet to be fully demonstrated for a VR study of this kind. 
Furthermore, studies on paranoia in the general population have used online recruitment 
effectively (Freeman et al., 2005). Throughout its design and method this study sought to 
harness new technologies and test the feasibility of their use, employing online programs for 
recruitment, participant bookings, and data collection in both Studies 1 and 2. A subsidiary aim 
of this project was therefore to pilot online participant recruitment for a VR study.  
 
The research questions and hypotheses were as follows: 
 
1.5 Research questions 
Study 1: Examining the association between trait paranoia and fear of negative evaluation, 
interpersonal sensitivity, and social avoidance and distress  
Question 1. Is higher trait paranoia associated with higher levels of fear of negative evaluation, 
interpersonal sensitivity, and social avoidance and distress and greater negative mood 
(depression, anxiety) in a non-clinical sample? 
 
Study 2: Using VR to assess paranoid ideation and components of social performance 
Question 2. Do participants find the new VR experience acceptable and immersive? 
Question 3. Does exposure to the VR environment elicit higher levels of emotional response 
and increased heart rate? 
Question 4. Does higher trait paranoia predict higher state paranoia in the VR environment? 
Question 5. Is higher trait paranoia related to higher levels of fear of negative evaluation, 
interpersonal sensitivity, and social avoidance and distress in the VR environment? 
 
1.6 Hypotheses  
Study 1: Examining the association between trait paranoia and components of social 
performance 
Hypothesis 1. Trait paranoia will be associated with higher levels of fear of negative evaluation, 
interpersonal sensitivity, and social avoidance and distress and greater negative mood 
(depression, anxiety). 
 
Study 2: Using VR to assess paranoid ideation and components of social performance 
Hypothesis 2 The majority of participants will find the new VR experience acceptable and 
immersive.  
Hypothesis 3. Exposure to the VR environment will elicit higher levels of emotional response 
and increased heart rate. 
Hypothesis 4. Higher trait paranoia will be associated with higher state paranoia in VR. 





Study 1 was a cross-sectional cohort study to recruit and establish levels of trait paranoia and 
associations with fear of negative evaluation, interpersonal sensitivity, and social avoidance and 
distress and mood in the general population. Study 2 was a cross-sectional comparison study: 
participants with high and low trait paranoia, recruited from Study 1, were compared to establish 
levels of state paranoia and fear of negative evaluation, interpersonal sensitivity, and social 



































Figure 1. Overview of Study 1 and Study 2 procedure 
 
Figure 1 gives a general overview of the study design. A Method, Results, and brief Discussion 
section for each of Study 1 and 2 will be presented in sequence below. This will be followed by 
a Discussion and Overall Summary of both studies. See specific Method sections of Studies 1 
and 2 for full details and Figure 3 for a full analysis of Study 2 processes.  
 
General population online survey 
Trait paranoia, components of social performance, mood 
Participant recruitment 
Online, social media, posters 
STUDY 1 
Participant recruitment 
Based on online survey paranoia scores 
STUDY 2 
Pre-VR measures 
State paranoia, mood, heart rate 
VR ‘social situation’ task 
Post-VR measures 
State paranoia, components of social performance, mood, heart rate 
High paranoia group Low paranoia group 
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2.3 Stakeholder involvement 
The study proposal was presented to service user researchers and service users who consult 
on research at the Service User Advisory Group (SUAG), Biomedical Research Centre (BRC), 
IoPPN. The SUAG reviewed all stages of the proposal and provided general feedback on 
applications of VR in mental health assessments and treatments, and specifically for people 
with psychosis. The SUAG gave a favourable verdict on the study. See Appendix I for a full 
description of this review.  
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STUDY 1. ONLINE SURVEY OF PARANOIA IN THE GENERAL POPULATION 
 
3. INTRODUCTION 
The aim of Study 1 was to test associations between trait paranoia and fear of negative 
evaluation, interpersonal sensitivity, and social avoidance and distress and mood (depression, 




This was a cross-sectional cohort study of the general population.  
 
4.2 Procedure 
Participants completed an online survey, which was advertised as a survey of thoughts and 
feelings about social situations. Survey piloting established that the survey took approximately 
15-20 minutes and could be completed on any computer, tablet, or smartphone.  
 
4.3 Participants 
Participants were working age adults (aged 18-65), fluent English speakers, and willing to be 
invited to the IoPPN in the event that they were selected for the VR study. Participants were 
excluded if they reported they had been diagnosed with a serious mental health condition (e.g. 
psychosis or bipolar disorder), a neurological disorder, learning disability, or epilepsy. People 
with epilepsy were excluded because there is evidence that an epileptic episode could be 
triggered by VR exposure. Participants ticked boxes on page 1 of the online survey to confirm 
that they complied with inclusion and exclusion criteria. Age limits were applied because of the 
future aim to apply this research to adults (aged 18-65) with psychosis. These age parameters 
therefore adhere to a convention of how NHS mental health services are organised, i.e. <18 
years old; 18-65, and >65. 
 
4.4 Participant recruitment 
Participants were recruited online and through social media. Regular bulletins (approximately 
daily) were posted on Twitter (www.twitter.com). Other Twitter users retweeted these Tweets or 
were observed to Tweet independently about the study. Additional bulletins were posted to 
other social media, such as LinkedIn (www.linkedin.com) and Academia.edu 
(www.adademia.edu); and local web forums, such as The East Dulwich Forum 
(www.eastdulwichforum.co.uk), craigslist London (www.craigslist.com), and URBAN75 
(www.urban75.com). Advertisement emails were twice posted on fortnightly King’s College 
London bulletin email for research studies currently recruiting volunteers. Circular emails were 
sent to the Psychology Department and the Health Services and Population Research 
Departments, both King’s College London, as well as to other colleagues. Colleagues, friends, 
and participants offered to circulate advertisements to friends and colleagues by email or social 
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media, such as Facebook (www.facebook.com). Bulletins and advertisements provided a web 
link to the online survey. Posters and flyers were distributed around King’s College London 
university buildings and in the local South-East London area. 
 
4.5 Online survey construction 
The survey was constructed using Bristol Online Surveys (BOS). BOS is an online survey 
program that enables development and analysis of surveys via the Web 
(www.onlinesurveys.ac.uk). Survey settings eliminated the possibility of missing or repeated 
data. Participants could freely access the survey via a web link on the Internet. See Appendix 
IV for BOS output of online survey. 
 
4.6 Online survey measures 
Demographics. Age, gender, ethnicity, level of education, employment status, 
relationship/marital status, living arrangements, and way of finding out about the study were 
recorded. See Appendix IV and data tables for breakdown of each domain.  
 
Green et al. Paranoid Thoughts Scales (GPTS). GPTS measures trait paranoia. It consists of 
32 items measured on a 5-point scale, from 1 (‘Not at all’) to 5 (‘Totally’), referring to the past 
month. Part A consists of 16 items that assess ideas of reference (GPTSREF). Part B consists of 
16 items that assess ideas of persecution (GPTSPERS). Higher total scores for the whole 
measure (GPTSTOTAL) indicate greater levels of paranoid thinking. The minimum total score is 
32 and the maximum score is 160. No items are reverse scored. It demonstrates good 
psychometric properties, with good internal consistency, test–retest reliability (Freeman et al., 
2009), and convergent validity with the Paranoia Scale (Fenigstein & Vanable, 1992). 
Participants were given the following instructions: ‘Please read each of the statements carefully. 
They refer to thoughts and feelings you may have had about others over the last month. Think 
about the last month and indicate the extent of these feelings from 1 ("not at all") to 5 ("totally"). 
N.B. Please do not rate items according to any experiences you may have had under the 
influence of drugs.’ A sample item from Part A (Ideas of reference) is ‘I spent time thinking 
about friends gossiping about me’. A sample item from Part B (Ideas of persecution) is ‘Certain 
individuals have had it in for me’. 
 
Social Avoidance and Distress scale (SAD). SAD measures state and trait social avoidance and 
distress (Watson & Friend, 1969). It consists of 28 items with a response format of ‘True’ or 
‘False’. Participants scored 1 for an answer that matched the score key and 0 for an answer 
that did not match the score key. It demonstrates good psychometric properties, with good 
construct validity and alpha coefficients (García-López et al., 2001). Participants were given the 
following instructions: ‘The statements below inquire about your personal reactions to a variety 
of situations. Consider each statement carefully. Then indicate whether the statement is true or 
72 
false with regard to your typical behaviour.’ A sample item is ‘I feel relaxed even in unfamiliar 
social situations’. 
 
Brief Fear of Negative Evaluation scale (BFNE). BFNE measures apprehension of being 
negatively evaluated by other people (Leary, 1983). It consists of 12 items measured on a 5-
point scale, from 1 (‘Not at all characteristic of me’) to 5 (‘Extremely characteristic of me’). Items 
2, 4, 7, and 10 are reverse scored. It demonstrates good psychometric properties that are 
nearly identical to those of the full-length scale (Watson & Friend, 1969) and correlates 
significantly with depression and loneliness scales (Duke et al., 2006). Participants were given 
the following instructions: ‘Read each of the following statements carefully and indicate how 
characteristic it is of you.’ A sample item is ‘I worry about what other people will think of me 
even when I know it doesn't make any difference’. 
 
Interpersonal Sensitivity Scale (IPSM). IPSM measures interpersonal sensitivity (Boyce & 
Parker, 1989). The authors define interpersonal sensitivity as “undue and excessive awareness 
of and sensitivity to, the behaviour and feelings of others” (p. 342). The measure consists of 36 
items measured on a 4-point scale, from 1 (‘Very unlike you) to 4 (‘Very like you’). No items are 
reverse scored. IPSM generates a total score as well as five sub-scale scores of interpersonal 
awareness, need for approval, separation anxiety, timidity and fragile inner-self. It demonstrates 
good psychometric properties and has been shown to be a valid and reliable instrument for its 
assessment in social anxiety disorder (Harb et al., 2002). Participants were given the following 
instructions: ‘A number of statements are listed below which relate to how you might feel about 
yourself and other people in your life. Please indicate with a tick in the appropriate place how 
each one applies to you – i.e. whether it is “very like you”, “moderately like you”, “moderately 
unlike you”, or “very unlike you”. Respond to each statement in terms of how you are 
GENERALLY and not necessarily just at present. There are no right or wrong answers.’ A 
sample item is ‘I feel insecure when I say goodbye to people’. 
 
Patient Health Questionnaire-8 (PHQ8). PHQ8 measures current depression (Kroenke & 
Spitzer, 2002). It consists of 8 items measures on a 4-point scale, from 0 (‘Not at all’) to 3 
(‘Nearly every day’), referring to the last two weeks. No items are reverse scored. A score ≥10 
can be used for defining current depression. It demonstrates good psychometric properties and 
has been shown to be a useful depression measure for population-based studies, with either its 
diagnostic algorithm or a cutpoint ≥10 being used for defining current depression (Kroenke et 
al., 2009). Participants were given the following instructions: ‘Over the last 2 weeks, how often 
have you been bothered by any of the following?’ A sample item is ‘Little interest or pleasure in 
doing things’. 
 
Generalised Anxiety Disorder 7 (GAD7). GAD7 measures current generalised anxiety (Spitzer 
et al., 2006). It consists of 7-items measured on a 4-point scale, from 0 (‘Not at all’) to 3 (‘Nearly 
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every day’), referring to the last two weeks. No items are reverse scored. It demonstrates good 
psychometric properties and has been shown to perform well as a measure of anxiety symptom 
severity (Beard & Björgvinsson, 2014). Participants were given the following instructions: ‘Over 
the last 2 weeks, how often have you been bothered by any of the following?’ A sample item is 
‘Feeling nervous, anxious or on edge’. 
 
Participants also completed the UCLA Loneliness Scale (Peplau & Cutrona, 1980) but this was 
not included in the present study and was used in another study. 
 
See Appendix IV for BOS output of Online Survey. 
 
4.7 Informed consent 
An Information Sheet and Consent Form was integrated within the online survey. Participants 
consented by typing ‘I consent’. Participants could take as much time as needed to decide if 
they wished to take part and did not have to notify researchers if they decided not to take part.  
 
4.8 Participation incentives 
Participants were entered into a prize draw to win one of four £25 Amazon vouchers and 
informed that they may be invited for the VR study. 
 
4.9 Potential risks 
Participants were made aware that the online survey could raise difficult thoughts or feelings. 
On the final page of the online survey, participants were advised to contact their GP, their local 
IAPT service, or the Samaritans if the survey raised difficult feelings. Phone numbers and web 
links were included. See Appendix IV.  
 
4.10 Participant confidentiality  
Survey responses were confidential. When completing the online survey, participants were 
asked to provide a contact email address so they could be contacted for the VR study or the 
Amazon vouchers. Participants were also given the option of providing their name and a phone 
number. Participants were made aware that no other identifying information, such as IP address 
or home address, was collected. All data was stored in a secure, password protected electronic 
format and contact detail(s) were stored separately from survey data. Participants were 
identified by a participant number only for all analyses. Participants were assigned a unique, 3-
digit participant number based on the order in which they completed the survey (e.g. the third 
person to complete the survey was ‘Participant 003’). Order of online survey completion was 
selected as it was an arbitrary criterion on which to assign participant numbers. Personal data 
was only accessible to the research team. Participants were made aware that study results 




4.11 Freedom to withdraw 
Participants were free to withdraw from the study at any time, without giving a reason. If 
participants decided that they no longer wanted their data to be used after taking part, they 
were entitled to ask the research team to remove their data from the study. Participants were 
made aware that there would be no consequences if they withdrew from the study at any time. 
Partially completed questionnaires were not used.  
 
4.12 Participation benefits 
Participants were made aware that the results of the study would inform the future development 
of a novel and effective assessment and treatment approach to help people with serious mental 
health problems facing difficulties with social situations.  
 
4.13 Projected sample size 
This is a pilot study and, as such, it aimed to recruit sufficient participants to address our 
research questions concerning feasibility and acceptability and to provide reasonable estimates 
of key parameters for a future study, rather than determining sample size based on a power 
calculation using data from previous studies (which are not available) to detect statistically 
significant differences between groups. An a priori power calculation was therefore not 
conducted. Based on the GPTS study (Green et al., 2008), which used a similar methodology, 
this pilot aimed to recruit a minimum of 300 participants to the online survey in Study 1 to 
ensure a representative spread of paranoia scores; and then, in Study 2, to recruit a subsample 
of 70 participants from the online survey (35 high paranoia and 35 low paranoia scorers) to take 
part in the VR task. 
 
4.14 Research approvals 
The study was approved by the Psychiatry, Nursing and Midwifery (PNM) Research Ethics 
Subcommittee (RESC) at King's College London (Ref: HR-14/15-0859). Approval was also 
granted by the Clinical Psychology Department, IoPPN.  
 
4.15 Statistical analysis 
Analyses were conducted using SPSS, volume 22 (SPSS Inc., Chicago, USA; www.spss.com). 
Data was explored for normality using histograms, QQ plots, and statistical tests. 
Nonparametric tests were used as a sensitivity analysis where normality was violated. Internal 
reliability of scales was calculated using Cronbach’s α. Evaluating test-retest reliability of 
measures was not part of the study. As GPTS data were non-parametric, Spearman’s 
correlation coefficient was used for all correlation analyses. Effect sizes (Spearman’s r) were 
measured at .1 (small effect), .3 (medium effect), and .5 (large effect) (Field, 2009).  
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5. RESULTS 
5.1 Sample characteristics 
The online survey was open for two months, from 20 September 2015 to 16 November 2015, 
during which time 609 people completed the survey. Mean age of participants was 29.33 (SD 
9.24, range 18-65). 72% of participants were female. 76% of participants were white. 37% of 
participants were students and 49% were in fulltime employment. 41% were single and 55% 
were in a relationship (either cohabiting, non-cohabiting, or married). Table 1 summarises 
demographic characteristics for the whole sample.  
 
Table 1. Demographic characteristics of online survey sample 
Demographic Whole sample 
N=609 
Age (years) Mean (SD, range) 
 29.33 (9.24, 18-65) 
Gender N (%) 
     Male 166 (27.3) 
     Female 439 (72.1) 
     Other gender identity 4 (0.7) 
Ethnicity  
     Asian/Asian British 67 (11) 
     Black African/Caribbean/British 19 (3.1) 
     White 463 (76) 
     Mixed/Multiple ethnic groups 30 (4.9) 
     Other ethnic group 30 (4.9) 
Level of education  
     No formal qualifications 1 (0.2) 
     O-Levels, GCSEs, GCEs 15 (2.5) 
     AS-, A-levels, (G)NVQ 124 (20.4) 
     Undergraduate degree 219 (36) 
     Master’s degree 181 (29.7) 
     Doctorate 69 (11.3) 
Employment status  
     Student 226 (37.1) 
     Full-time paid employment 298 (48.9) 
     Part-time paid employment 47 (7.7) 
     Full-time unpaid employment 3 (0.5) 
     Part-time unpaid employment 5 (0.8) 
     Unemployed 18 (3) 
     Other employment status 12 (2) 
Relationship/marital status  
     Single 225 (41) 
     In a relationship but not cohabiting 112 (18.4) 
     Cohabiting 127 (20.9) 
     Married 95 (15.6) 
     Separated 3 (0.5) 
     Divorced 8 (1.3) 
     Widowed 2 (0.3) 
     Other relationship status 7 (1.1) 
Living arrangements  
     Live with parents 65 (10.7) 
     House/flat owner 156 (25.6) 
     Renting house/flat 223 (36.6) 
     Renting bedsit 9 (1.5) 
     Renting room in house share 134 (22) 
     Staying in hostel 12 (2) 
     Homeless 1 (0.2) 




Overall, 84% of participants found out about the study online or on the Internet. Table 2 
summarises the ways participants found out about the study. 
 
Table 2. Participant recruitment sources 
Way of finding out about study N=609 
     Twitter 71 (11.7) 
     Facebook 36 (5.9) 
     Other online social network*  6 (1) 
     Messaging/chat service** 31 (5.1)  
     Website 29 (4.8) 
     Email 304 (49.9) 
     Online advert 10 (1.6) 
     Online forum 23 (3.8) 
     Poster/flyer 15 (2.5) 
     Verbally informed 55 (9) 
     Other 25 (4.1) 
     Prefer not to say 4 (.7) 
*not Twitter or Facebook; **E.g. SMS, WhatsApp  
 
5.3 Reliability analysis 
All scales and subscales demonstrated adequate internal consistency. Cronbach’s α values for 
the scales are given in Table 3.  
 
Table 3. Internal consistency of scales 
 
Scale 











5.4 Paranoia measurement 
GPTS scores are given in Table 4.  
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 Mean (SD, range) 
GPTSREF  27.60 (11.724, 16-78) 
GPTSPERS  20.62 (9.768, 16-75)  
GPTSTOTAL  48.22 (19.84, 32-152) 
SAD 9.05 (6.90, 0-28) 
BFNE 38.92 (10.527, 12-60) 
ISPM 95.13 (14.84, 53-132) 
PHQ8 5.66 (5.04, 0-24) 
GAD7 5.05 (4.79, 0-21) 
 
The mean (SD) GPTS scores for the present online survey sample (GPTSREF=27.60 (11.724); 
GPTSPERS=20.62 (9.768); GPTSTOTAL=48.22 (19.84)) were markedly similar to the non-clinical 
sample in the original GPTS study (GPTSREF=26.8 (10.4); GPTSPERS=22.1 (9.2); GPTSTOTAL 
48.8 (18.7)) (Green et al., 2008).  
 
5.5 Associations between paranoia and fear of negative evaluation, interpersonal 
sensitivity, and social avoidance and distress (Hypothesis 1) 
GPTS and its subscales positively correlated with SAD, BFNE, ISPM, PHQ8, and GAD 7. The 
associations were greater for ideas of reference than persecution. In GPTSTOTAL and GPTSREF, 
effect sizes were large for PHQ8 and GAD7, and medium for SAD, BFNE and ISPM. In 
GPTSPERS, effect sizes were medium for PHQ8 and GAD7, and small for SAD, BFNE and 
ISPM. Therefore, hypothesis 1, that trait paranoia would be associated with greater fear of 
negative evaluation, interpersonal sensitivity, and social avoidance and distress, was 
supported. See Table 5.  
 
Table 5. Associations between GPTS, fear of negative evaluation, interpersonal 
sensitivity, and social avoidance and distress, and mood 
SCALES GPTSREF GPTSPERS GPTSTOTAL SAD BFNE ISPM PHQ8 GAD7 
GPTSREF -        
GPTSPERS .686* -       
GPTSTOTAL .981* .786* -      
SAD .335* .219* .325* -     
BFNE .352* .158* .328* .457* -    
ISPM .424* .257* .417* .459* .751* -   
PHQ8 .512* .369* .512* .488* .443* .526* -  
GAD7 .499* .380* .496* .485* .510* .572* .786* - 
*Correlation rs is significant at the .01 level (1-tailed). 
 
5.6 Summary of main findings of Study 1  
Participants (N=609) ranged the working age lifespan but were generally younger adults with a 
mean age in the late twenties. Three quarters of participants were female; three quarters were 
of white ethnicity; half were in fulltime employment and just over two thirds were students; while 
just over half were in a relationship. All scales and subscales demonstrated adequate internal 
consistency. As hypothesised, trait paranoia, and its subscales measuring ideas of reference 
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and persecution, positively correlated with social avoidance and distress, fear of negative 
evaluation, interpersonal sensitivity, depression, and generalised anxiety. With trait paranoia 
and ideas of reference, effect sizes were large for correlations with depression and generalised 
anxiety, and medium for correlations with social avoidance and distress, fear of negative 
evaluation, and interpersonal sensitivity. Effect sizes were numerically lower for ideas of 
persecution when compared with ideas of reference. With ideas of persecution, effect sizes 
were medium for depression and generalised anxiety, and small for social avoidance and 
distress, fear of negative evaluation, and interpersonal sensitivity. 
 
6. DISCUSSION  
The aim of Study 1 was to test the association between trait paranoia and components of social 
performance and mood (depression, anxiety) in the general population. The online survey 
method provided data on levels of paranoid ideation and associated constructs across a broad 
range of demographics within the general population. The mean GPTS scores were very similar 
to those of the original GPTS study, which was recruited in person rather than online supporting 
the findings of the original study. We therefore tentatively conclude that the paranoia scores of 
this sample are likely to be broadly representative of a general population sample, while using a 
predominantly online recruitment (though see limitations discussed below). Consistent with 
previous studies, some degree of paranoid ideation was shown to be common in the general 
population (Freeman et al., 2005); and further support was given to the thesis that there is a 
continuum of beliefs in the population, from more to less paranoid ideation, rather than a 
distinction in kind, between people who experience paranoid ideation and those who do not 
(Peters et al., 1999).  
 
It was possible to recruit for a VR study online. This was shown to be a time-saving, cost-
effective means of recruitment (Kraut et al., 2004). Trait paranoia was associated with fear of 
negative evaluation, interpersonal sensitivity, and social avoidance and distress and mood, as 
hypothesised. The study shows that people higher in trait paranoia are more likely to 
experience social avoidance and distress, fear of negative evaluation, interpersonal sensitivity, 
depression, and anxiety. These findings build on similar associations with paranoid ideation that 
have been found in both clinical (Fowler et al., 2011) and non-clinical (Fisher et al., 2012; Martin 
& Penn, 2001) populations. Results will be discussed in more depth in the General Discussion.  
 
6.1 Strengths 
The results add to our understanding of paranoid ideation in the general population. Building on 
the original GPTS study, they constitute a novel finding for a sample recruited predominantly 
online. Furthermore, the data provides a clear depiction of how paranoid ideation is associated 
with a negative impact on fear of negative evaluation, interpersonal sensitivity, and social 
avoidance and distress; and the consequential impact on psychological wellbeing. 
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The study confirms that the Internet and social media is a viable and promising method of 
participant recruitment for VR studies. The growth and increasingly ubiquity of Internet use 
suggests that web-based recruitment may enable researchers to reach larger and more diverse 
samples. According to Office of National Statistics data, the internet was accessed every day, 
or almost every day, by 78% of adults (39.3 million) in Great Britain in 2015, although social 
networking was used by 61% of adults. These figures are expected to rise in future. 
Consequently, the present sample is likely to be fairly representative but may also explain the 
fairly young demographic. The present study also builds on previous studies by not being based 
on a predominantly student sample (Freeman et al., 2005; Green et al., 2008). 
 
6.2 Limitations 
Studies of paranoid ideation in the general population have highlighted limitations of cross-
sectional data, insofar as directions of effect cannot be substantiated and associations could be 
a consequence of other unmeasured variables (Freeman et al., 2011). The present study 
suffers from similar limitations. In addition, it is possible the present sample was 
disproportionally interested in VR when compared with the general population, given that the 
study design included within its initial recruitment a potential invitation for a VR task. 
Furthermore, despite the demographic diversity, the recruitment strategy still employed some 
degree of convenience sampling and disproportionately targeted students and university 
employees within London. Although student numbers still only constituted a minority, this 
selection bias may have reduced representativeness. It has also been suggested that people 
who self-select for questionnaires of this type may be more prone to psychological disturbance, 
or the stigma of appearing to have psychological difficulties might skew the sample in the 
opposite direction (Freeman et al., 2005). In addition, the gender distribution of participants is 
notable. There may be a difference in characteristics between those recruited via social media 
and those recruited in other ways. Selection bias through use of social media could be explored 
further but it is not possible in the present study due to low numbers of people recruited by 
other means. Equally, future research might explore social class or economic background in 
determining how representative a sample recruited predominantly through social media might 
be. Overall, one should draw epidemiological conclusions with caution. 
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STUDY 2. VIRTUAL REALITY ‘SOCIAL SITUATION’ TASK 
 
7. INTRODUCTION  
The aim of this study was first to form two groups using Study 1 data: a subsample of 
participants who scored high and low on trait paranoia, as measured by GPTS, were then 
compared to see if a VR social situation task elicited greater feelings of state paranoia, mood, 
fear of negative evaluation, interpersonal sensitivity, and social avoidance and distress, and 
physiological response (heart rate) in those people with higher trait paranoia. The overall aim of 




This was a cross-sectional comparison study with an experimental manipulation: participants 
with high and low trait paranoia, recruited from Study 1, were compared to establish levels of 
state paranoia and fear of negative evaluation, interpersonal sensitivity, and social avoidance 
and distress, mood and heart rate, following exposure to a VR social environment. 
 
8.2 Procedure 
A subsample of Study 1 participants who were high or low in trait paranoia were recruited. They 
completed a VR social situation task. Measures of state paranoia, fear of negative evaluation, 
interpersonal sensitivity, and social avoidance and distress, mood and heart rate were 
completed pre- and post-VR.  
 
8.3 Participants 
Participants were working age adults (aged 18-65), fluent English speakers, who had not been 
diagnosed with a serious mental health condition, neurological disorder, learning disability, or 
epilepsy. In order to identify eligible participants for Study 2, total GPTS scores for the online 
survey sample were placed in ascending order. The higher paranoia sample (HPS) were 
identified from participants ≥85th percentile. The lower paranoia sample (LPS) were identified 
from participants ≤15th percentile. These percentiles were chosen as cut-offs at the extreme 
ends of the ranges of scores and designed to provide a pool from which two large roughly equal 
subsamples would be selected with significantly different GPTS scores. Once groups were 
identified, participant number lists for HPS and LPS were each randomised. Randomisation 
was used to reduce the likelihood of introducing unmeasured confounding variables. Two 
random samples of 35 participants from both HPS and LPS were identified to be invited for the 
VR task. Then the two sets of 35 participant numbers were randomised together. Participant 
identity and contact details were only revealed to the researcher once the HPS and LPS 
subsamples had been randomised together. This ensured that researchers were blinded to 
participant group status. Two ordered ‘reserve lists’ for both HPS and LPS were also identified. 
If an invited participant was unable or unwilling to attend, a reserve list participant was invited to 
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replace them. Reserve list participants were invited in batches, which enabled the process of 
randomisation and blinding to be followed for HPS and LPS reserve list participants. During the 
VR task, all researchers and participants were blind to participant group status. 
 
A matched pair design using minimisation randomisation was rejected given the relatively small 
sample size of 35 participants per group. Such a small sample size makes matching according 
to key demographic criteria difficult while also retaining the two distinct higher and lower 
paranoia groups. It also risks introducing unmeasured confounding variables by matching 
according to arbitrarily selected demographic criteria, thus distorting the true sample. Given the 
limited resources available to the study, a matched pair design was also rejected on pragmatic 
grounds: the key problem was that a matched pair design would unblind researchers to 
higher/lower paranoia identities as all higher paranoia participant data would need to be 
collected before their lower paranoia participant pairs could be identified. 
 
8.4 Participant recruitment 
Participants were contacted by email to invite them to take part in the VR task at IoPPN at a 
time of their convenience. Time slots on weekdays, weekday evenings and weekends were 
made available and emailed to eligible participants. Appointment scheduling was conducted 
with Doodle (www.doodle.com/en_GB). Doodle is an Internet calendar tool for time 
management and coordinating meetings. Participants were able to book their own time slots by 
accessing Doodle online. Participants were given at least 2 weeks to decide if they wished to 
participate in the VR study before participants from the reserve list were invited. This 
recruitment process continued until both higher paranoia VR group (HP-VRG) and lower 
paranoia VR group (LP-VRG) reached their totals of 35, or until all scheduled appointments 
were completed.  
 
8.5 Informed consent 
Paper Information Sheets and Consent Forms were used for Stage 2. Both documents were 
emailed to participants in advance of participation. Informed consent was signed for with a 
researcher present.  
 
8.6 Participant confidentiality 
When booking their VR appointments, participants were asked to enter only their unique, 3-digit 
participant number on a Doodle Poll to reserve a time slot. They did not need to supply any 
other identifying information. Consent forms were stored in a secure, locked cabinet at the 
IoPPN and were stored separately from VR data and Study 1 survey data. 
 
8.7 Participation incentives 
Participants who attended a VR appointment were paid £10 to compensate for approximately 
an hour of their time.  
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8.8 Potential risks 
Participants were made aware that some people can experience cybersickness in VR. This was 
explained in the Information Sheet. The Information Sheet recommended that participants did 
not drive a car, motorcycle, or use any piece of complicated machinery in the four hours 
immediately following being in virtual reality. It stated that participants should not drink alcohol 
or take recreational drugs in the 8 hours before the VR task and reiterated warnings about 
epileptic episodes. See Appendix VI. 
 
8.9 Freedom to withdraw 
Participants were free not to opt in to the VR study and free to withdraw or terminate the VR 
task at any time without giving a reason.  
 
8.10 VR data collection instruction manual 
An instruction manual for VR data collection was developed by SR and finalised in line with 
training role plays and research team discussion. See Appendix VII.  
 
8.11 Virtual environment  
The newly created VR ‘social situation’ task was a ‘party’ in a pub, with computer-programmed 
avatars (Lucia Valmaggia, project lead supervisor, was the lead for a separate study on the 
design and scripting of the environment). Participants saw images in 3D using a head-mounted 
display (HMD) and heard sound through headphones. Participants were initially in a street and 
invited to look around the street, using the joypad to move themselves forward to a mark on the 
ground. This part of the task served as a demo. Participants were directed to a pub that they 
were to enter. Participants were told that in the pub they were to look for more marks on the 
ground and move around the pub according to the marks on the ground. Following a previous 
study, all participants were given the instruction: ‘While you are in the pub please try to get an 
impression of what the people in the pub think about you and what you think about them. If 
someone asks you a question, try to reply to them’ (Valmaggia et al., 2015). Participants were 
met by the host of the party who invited them to meet the other guests. Participants 
experienced one individual greeting and four brief group interactions that were positive, 
negative or neutral. The environment was populated by female and male avatars. All avatars 
looked in their 20s or early 30s and different ethnicities (White, Black, Asian) were represented. 
The initial greeting with the host and the final conversation both had an interactive component 
where participants were invited to speak out loud in response to questions they were asked by 
avatars in the VR. At the initial greeting, participants were invited to introduce themselves and 
then avatars in the pub turned towards them and greeted them in return. At the final 
conversation, participants were invited to a table by a male avatar. Once at the table, a female 
avatar asked the participant what their favourite television program was and asked them to tell 
her about it. Background audio of the people at the party played throughout and had some 
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ambiguous stimuli with positive (‘she’s so nice’), negative (‘what a loser!’) or neutral 
interpretations (‘what a joke!’). The scene lasted approximately 5 minutes. See Appendix X for 
stills of the VR environment. 
 
8.12 Apparatus 
Head-mounted display. Participants wore an Oculus Rift Developer version 2 VR headset or 
head-mounted display (HMD) that gave them a fully immersive, 3D visual experience.  
 
Software. Participants entered a VR street and pub commissioned by King’s College London, 
designed by software company Virtualware, using the Unity VR platform.  
 
Headphones. Participants wore full-size, noise cancelling headphones that covered and 
surrounded their ears. These were worn over the top of the HMD. 
 
Control pad. Participants could move themselves forward and backwards in the VR using a 
computer console control pad with inbuilt joystick. Fluid, 360 degree movement was attained by 
participants turning their body direction in combination with manipulation of the control pad. 
 
Microphone. Researchers were able to speak in to participants’ headphones with the aid of a 
microphone.  
 
Desktop computer. An Alienware PC was used by the researcher to run and control the VR 
scenario.  
 
Tablets. All measures were completed by participants on 7” tablets provided by researchers. 
Two tablets were used.  
 
Oximeter. Participants wore an oximeter on their forefinger immediately before and immediately 
after the VR task in order to test heart rate.  
 
8.13 Pre-VR measures  
State Paranoia Measure (SPM). SPM is a measure of state paranoia constructed from 7 items 
tapping state paranoia (Garety et al., 2015). It consists of 6 VAS items on a 10-point scale, from 
1 (‘Not at all’) to 10 (‘Totally’). A seventh item, which assesses delusional conviction, was 
removed for the present study as participants were not being asked to identify a specific 
delusional thought. SPM demonstrates good psychometric properties (Garety et al., 2015). 
Participants were given the following instructions: ‘For the following statements, please rate 
how you feel “right now” from 1 ("not at all") to 10 ("totally")’. A sample item is ‘There is a 
conspiracy against me’.  
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Stress, Anxiety, Sadness, and Happiness Visual Analogue Scales (VAS). The VAS consisted of 
4 items on a 10-point scale, from 1 (‘Not at all’) to 10 (‘Extremely’). Participants were given the 
following instructions: ‘For the following questions, please rate how you feel “right now” from 1 
("not at all") to 10 ("extremely")’. A sample item is ‘How stressed do you feel right now?’ 
 
Patient Health Questionnaire-8 (PHQ-8). PHQ8 was repeated, as described in ‘Online survey 
measures’. 
 
Generalised Anxiety Disorder 7 (GAD7). GAD7 was repeated, as described in ‘Online survey 
measures’.  
 
All measures were completed by participants on a tablet immediately before the VR task. 
 
Heart rate. Heart rate was measured using a finger pulse oximeter to obtain an objective 
measure of autonomic response. Measurement was recorded by a researcher on a tablet 
immediately before the VR task. 
 
8.14 Post-VR measures 
State Social Paranoia Scale (SSPS). SSPS measures paranoid ideation about a social situation 
(Freeman et al., 2007). It comprises 20-items measured on a 5-point scale, from 1 (‘Do not 
agree’) to 5 (Totally agree), with higher scores indicating higher endorsement. In addition to 
examining persecution (10 items, range 10-50), neutral (5 items, range 5-25) and positive (5 
items, range 5-25) ideation about the avatars is explored. No items are reverse scored. SSPS 
demonstrates good psychometric properties: it has excellent internal reliability, adequate test-
retest reliability, clear convergent validity, and showed divergent validity with measures of 
positive and neutral thinking (Freeman et al., 2007). Participants were given the following 
instructions: ‘We are interested in your views of the other people who were in the social 
situation. Please circle how much you agree or disagree with the following statements based 
upon your thoughts when you were in the social situation’. A sample item is ‘Someone was 
hostile towards me’.  
 
Visual Analogue Scales (VAS) to measure components of social performance and mood. The 4 
Pre-VR VAS were repeated, as described in ‘Pre-VR measures’ to assess stress, anxiety, 
sadness, and happiness. An additional 11 VAS measured situation-specific paranoia, 
friendliness of other people, neutrality of other people, hostility of other people, anxiety in the 
social situation (measuring SAD), desire to avoid social interaction (measuring SAD), fear that 
other people would disapprove (measuring BFNE), worries of saying or doing the wrong thing 
(measuring BFNE), how positively or negatively other people were thinking, sense of presence, 
and enjoyment. The VAS consisted of 15 items on a 10-point scale, from 1 (‘Not at all’) to 10 
(‘Extremely’). Participants were given the following instructions: ‘For the following questions, 
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please rate how you feel “right now” from 1 ("not at all") to 10 ("extremely")’. A sample item is 
‘How paranoid did you feel in the social situation?’ 
 
Slater-Usoh-Steed Sense of Presence Questionnaire (SUS). SUS measures sense of presence 
in VR (Slater et al., 1994). It comprises 6 items measured on a 7-point rating scale. SUS 
demonstrates good psychometric properties for virtual environments (Usoh et al., 2000). Minor 
modifications to the original measure ensured that it applied to the VR ‘social situation’ used in 
this study. A sample item is ‘To what extent were there times during the experience when the 
social situation was the reality for you? "There were times during the experience when the 
social situation was the reality for me... 1. At no time ... 7. Almost all the time."’ 
 
State Paranoia Measure (SPM). SPM was repeated, as described in ‘Pre-VR measures’. 
 
Heart rate. Measurement of heart rate was repeated immediately after the VR task, as 
described in ‘Pre-VR measures’.  
 
VR experience. To identify potential confounders, participants were asked if they had used VR 
before and if they played computer games regularly.  
 
Participants also completed a short, audiotaped semi-structured interview designed for 
measuring persecutory ideation in VR environments (Freeman et al., 2003) but this was not 
included in the present study and was used in another study. Minor modifications ensured that 
the measure applied to the VR ‘social situation’. 
 
All measures were completed by participants immediately after the VR task. 
 
8.15 VR task fidelity measures 
Task completion. This measure assessed whether participants fully completed the VR task. 
Post-VR, researchers were asked ‘Did the participant complete the VR task?’ and given options 
‘Completed task’, ‘Partially completed task’, or ‘Did not do task’. Partial or non-completion 
constituted a breach of task fidelity. Participants who partially completed or did not complete the 
task were excluded from the analysis.  
 
Researcher-participant communication in VR. This measure assessed whether researchers 
spoke to participants through the microphone during the VR task. Once researchers had fully 
explained the VR task and equipment to participants, researchers explained to participants that 
they would not speak to them during the VR task unless they needed to communicate for any 
reason. The aim was for researchers to optimise participants’ sense of presence in VR by not 
speaking to participants during the VR task. Researchers only spoke to participants if 
participants were failing to complete the task or if participants asked the researcher a question. 
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Post-VR, researchers were asked ‘Did you speak to the participant while they were in the pub?’ 
and given options ‘Yes’ or ‘No’. Speaking to participants constituted a minor breach of fidelity 
with regard to sense of presence. If researchers spoke to participants this was recorded but 
data were still used in the analysis. 
 
8.16 Researchers  
Research assistants received 5 training sessions that covered overview of the study, study 
documents, the VR task, data collection, and role play of the whole process. See Appendix VII.  
 
8.17 Piloting of measures 
Three separate BOS surveys were constructed to host the Pre-VR questions, VR task validity 
measures, and the Post-VR measures. All surveys were piloted before beginning data 
collection.   
 
8.18 Participant debriefing 
Participants were debriefed on the study after the Post-VR measures were completed. All 
participants were consulted about any experience of cybersickness. Participants were told that 
the study was researching paranoia and other emotional responses in VR; that people of higher 
and lower paranoia had been invited; and that researchers were blinded to participant group 
identity. Participant questions were answered and Information leaflets that normalise paranoia 
in the general population were given to participants if necessary. See Appendix XIV for 
Information leaflet. If participants reported any distressing feelings and felt that they wished to 
discuss this further, they were signposted to contact their GP. See Appendix VII for full 
description of debriefing. 
 
8.19 Pilot phase 
Previous VR studies have shown that it can be efficacious to incorporate a pilot phase in data 
collection in order to establish software applications parameters (sound; colour; movement of 
virtual characters) and to ensure that the VR task runs as intended in order to address research 
questions (Reid & Campbell, 2006). The pilot phase employed in this study comprised 
approximately the first 10 participants in the VR task. The aim was that if the VR needed to be 
modified in line with study requirements after the pilot, then a further 70 participants would be 
sought and these 10 participants would be excluded from the target of 70.  
 
8.20 Statistical analysis 
Analyses were conducted using SPSS, volume 22 (SPSS Inc., Chicago, USA; www.spss.com). 
Data was explored for normality using histograms, QQ Plots, and statistical tests. 
Nonparametric tests were used as a sensitivity analysis where normality was violated. Internal 
reliability of scales was calculated using Cronbach’s α. Evaluating test-retest reliability of 
measures was not part of the study. Demographic differences between groups were calculated 
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using chi-square tests for categorical data or independent samples t-tests for continuous data. 
Independent samples t-tests were used to test mean differences between the two groups. 
Paired samples t-tests were used to test mean differences within the whole group between two 
time points. Effect sizes (Cohen’s d) for independent samples t-tests were calculated using t-
values and degrees of freedom, and for paired samples t-tests were calculated using means 
and standard deviations. Effect sizes were measured at .1 (small effect), .3 (medium effect), 
and .5 (large effect) (Field, 2009).  
 
9. RESULTS 
9.1 Paranoia analysis and sample identification 
Ninety-six participants comprised the HPS (≥85th percentile, mean GPTS=86.35) and 100 
participants comprised the LPS (≤15th percentile, mean GPTS=32.44). Table 6 summarises 
HPS and LPS scores for GPTSTOTAL, GPTSREF, and GPTSPERS.  
 









 Mean (SD, range)    
GPTSREF  47.97 (10.834, 26-78) 16.42 (.496, 16-17) t(194)=29.091* .90 
GPTSPERS  38.39 (14.076, 17-75) 16.02 (.141, 16-17) t(194)=15.890* .75 
GPTSTOTAL  86.35 (20.035, 64-152) 32.44 (.499, 32-33) t(194)=26.905* .89 
*p<.001 (2-tailed) 
 
All mean group differences were statistically significant with large effect sizes. LPS was tightly 
clustered whereas the HPS had a wide range. Mean GPTS scores for GPTSPERS (38.39, SD 
14.076) and GPTSTOTAL (86.35, SD 20.035) in HPS were lower than GPTSPERS (55.4, 15.7) and 




Figure 2. Identification of high paranoia sample (HPS) and low paranoia sample (LPS) 
Intermediate paranoia sample 
N=413 
Mean GPTS 43.18 (range 34-63) 
High paranoia sample 
N=96 
Mean GPTS score 86.35 
(range 64-152) 
 




9.2 High and low paranoia sample characteristics 
The mean age for HPS was 28.36 (SD 9.793, range 18-62) and for LPS was 34.05 (SD 10.631, 
range 21-65). Both groups had a similar 2:1 gender ratio in favour of females and large 
majorities of white ethnicity. Therefore non-white ethnicity categories were collapsed into a 
single black and minority ethnic (BME). Table 7 summarises demographic characteristics of 
HPS and LPS.  
 








Age (years) Mean (SD, 
range) 
  






Gender N (%)   
     Male 31 (32.3) 28 (28) X2(1)=0.3712, p=.5424 
     Female 65 (67.7) 71 (71)  
     Other gender identity 0 (0) 1 (1)  
Ethnicity    
     White 72 (75) 88 (88) X2(1)=5.521, p<.05 
     Black and minority ethnic 24 (25) 12 (12)  
Level of education    
     Secondary or higher education 34 (35) 13 (13) X2(1)= 27.9888, p<.00001 
     Undergraduate degree 39 (40.6) 27 (27)  
     Postgraduate degree(s) 23 (24.0) 60 (60)  
Employment status    
     Student 38 (39.6) 22 (22) X2(1)=9.1636, p<.05 
     In paid employment 48 (50) 71 (71)  
     Unpaid/unemployed 10 (10.4) 7 (7)  
Relationship status    
     In a relationship 44 (45.8) 69 (69) X2(1)=10.7671, p<.01 
     Not in a relationship 52 (54.2) 31 (31)  
 
The group difference for gender was not statistically significant. Group differences for age, 
ethnicity, education, employment status, and relationship status were statistically significant.. 
 
The majority of participants found out about the study online. Table 8 summarises the ways 
participants found out about the study. 
 
Table 8. High and low paranoia samples recruitment sources 
Way of finding 






Online 79 (82.3) 77 (77) X2(194)=0.8444, p=.358 
Offline 17 (17.7) 23 (23)  
 
The group difference in way of finding out about the study was not significant.  
 
9.3 Data collection process 
All 96 HPS participant were invited to the VR task and 45 attended: 36 in the high paranoia VR 
group (HP-VRG), 8 in the pilot, and 1 dropped out during VR task. Seventy-four out of 100 LPS 
participants were invited to the VR task and 44 attended: 40 in the low paranoia VR group (LP-
VRG) and 4 in the pilot.  
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9.4 Pilot phase  
Twelve participants (8 high paranoia, 4 low paranoia) took part in a pilot phase. Participant 
feedback was used to modify the VR audio to ensure equal quantities of positive, neutral, and 
negative stimuli. As the VR task was modified, pilot data were not included in the study data and 
analyses. Researchers and participants were blind to participant group allocation during the 
pilot phase. 
 
9.5 High and low paranoia VR group paranoia scores 
The scores for those who participated in the VR study were as follows: HP-VRG mean 
GPTS=81.08 and LP-VRG; mean GPTS=32.53. Table 9 summarises HP-VRG and LP-VRG 
scores for GPTSTOTAL, GPTSREF, and GPTSPERS. 
 









 Mean (SD, range)    
GPTSREF  44.58 (10.168, 26-78) 16.50 (.506, 16-17) t(74)=17.457* .90 
GPTSPERS  36.50 (11.612, 19-74) 16.03 (.158, 16-17) t(74)=11.159* .79 
GPTSTOTAL  81.08 (18.433, 64-152) 32.53 (.506, 32-33) t(74)=16.666* .89 
*p<.001 (2-tailed) 
 
All mean group differences were statistically significant with large effect sizes.  
 
9.6 High and low paranoia VR group characteristics 
Mean age for HP-VRG was 28.86 (SD 9.84, range 18-54) and for LP-VRG was 33.78 (SD 










Age (years) Mean (SD, range)   
 28.86 (9.84, 18-
54) 
33.78 (11.04, 24-65) t(74)=-2.039, p<.05 
Gender N (%)   
     Male 13 (36.1) 14 (35) X2(1)=.0102, p=.9195 
     Female 23 (63.9) 26 (65)  
     Other gender identity 0 (0) 0 (0)  
Ethnicity    
     White 29 (80.6) 36 (90) X2(1)=1.3653, p=.243 
     Black and minority ethnic 7 (19.4) 4 (10)  
Level of education    
     Secondary or higher education 10 (27.8) 3 (7.5) X2(1)=14.084, p<.0001 
     Undergraduate degree 16 (44.4) 9 (22.5)  
     Postgraduate degree(s)  10 (27.8) 28 (70)  
Employment status    
     Student 14 (38.9) 9 (22.5) X2(1)=5.3073, p= .070 
     In paid employment 17 (47.2) 29 (72.5)  
     Unpaid/unemployed 5 (13.9) 2 (5)  
Relationship status    
     In a relationship  14 (38.9) 27 (67.5) X2(1)=6.243, p<.05 
     Not in a relationship 22 (61.1) 13 (32.5)  
 
Group differences for gender, ethnicity, and employment status were not statistically significant. 
Group differences for age, education, and relationship status were statistically significant.  
 
The majority of participants found out about the study online. Table 11 summarises the ways 
participants found out about the study. 
 
Table 11. VR participant recruitment sources 
Way of finding 






Online 30 (83.3) 30 (75) X2(1)=0.7917, p=.374 
Offline 6 (16.7) 10 (25)  
 
Group difference in way of finding out about the study were not statistically significant. Table 12 
summarises participants’ VR and gaming experience. 
 
Table 12. Previous VR and gaming experience of VR participants 





Previous used VR (%) 11 (30.6) 10 (25.0) X2(1)=0.2924, p=.589 
Play computer games regularly (%) 15 (41.7) 13 (32.5) X2(1)=1.8456, p=.174 
 
Group differences in VR and gaming experience were not statistically significant.  
 


































































High paranoia sample identified 
 GPTS ≥85th%ile: N=96 
Mean GPTS=86.35 (SD 20.035, 
range 64-152) 
Low paranoia sample identified 
GPTS ≤15th%ile: N=100 
Mean GPTS=32.44 (SD .499, range 
32-33) 
VR study random order invitation 
96/96 invited 
VR study random order invitation 
74/100 invited 
VR pilot phase 
N=8; VR modified 
VR pilot phase 
N=4; VR modified 
VR high paranoia group 
N=37* 
Mean GPTS=81.08 (SD 
18.433, range 64-152) 
*1 did not complete task 
VR low paranoia group 
N=40 
Mean GPTS=32.53 (SD 
.506, range 32-33) 
Did not opt in 
N=51 
28 did not reply to 
invitation, 14 
withdrew from study 






reason given=3); 8 
booked to attend but 
cancelled or did not 
attend; 1 could not 




Did not opt in 
N=30 





time=4; too far to 
travel=2; no 
reason given=2); 
3 booked to 
attend but 
cancelled or did 
not attend  
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9.7 VR task fidelity 
All 76 VR participants completed all parts of the VR task. Data from one additional HP-VRG 
participant who dropped out before the Pre-VR measures was removed from the analysis. A 
researcher spoke to participants during the VR task in 18.4% of cases. A researcher speaking 
to participants during VR was more frequent in the HP-VRG (25%) than in LP-VRG (12.5%). 
Table 13 summarises VR task fidelity. 
 










Participant completed VR task (%) 76 (100) 36 (100) 40 (100)  
Researcher spoke to participant during VR (%) 14 (18.4) 9 (25) 5 (12.5) X2(1)=2.147, 
p=0.143 
 
Group differences of task fidelity were not statistically significant.  
 
9.8 Reliability analysis 
Cronbach’s α values for the scales are given in Table 14.  
 







PHQ8 .817 .716 .869 
GAD7 .834 .684 .869 
SPMPreVR .853 .191 .869 
SPMPostVR .825 .417 .821 
SSPSPERS .919 .827 .913 
SSPSPOS .581 .732 .717 
SSPSNEU .709 .702 .704 
SUS .889 .898 .894 
 
Scales and subscales demonstrated adequate internal consistency for the total sample, apart 
from SPM, which demonstrated low internal consistency for LP-VRG.  
 
9.9 VR acceptability and sense of presence (Hypothesis 2) 
Sense of presence (Immersion) and enjoyment were measured for the whole sample. 
Independent-samples t-tests compared mean immersion and enjoyment scores between HP-
VRG and LP-VRG. See Table 15. 
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Table 15. VR acceptability and sense of presence 










    
SUS1 4.53 (1.519) 4.61 (1.536) 4.45 (1.518)   
SUS2 3.93 (1.636) 4.03 (1.748) 3.85 (1.545)   
SUS3 4.20 (1.862) 4.19 (1.704) 4.20 (2.015)   
SUS4 4.34 (1.694) 4.33 (1.690) 4.35 (1.718)   
SUS5 4.45 (1.587) 4.42 (1.610) 4.48 (1.585)   
SUS6 3.76 (1.607) 3.81 (1.653) 3.73 (1.585)   
SUSTOTAL 25.21 (8.021) 25.39 (7.980) 25.05 (8.155) t(74)=.183, p=.856 .02 
Presence VAS 6.09 (2.39) 6.17 (2.274) 6.03 (2.516) t(74)=.256, p=.798 .03 
Enjoyment VAS 6.91 (2.246). 6.64 (2.016) 7.15 (2.434) t(74)=-.99, p=.325 .11 
All p-values 2-tailed 
 
Sense of presence and enjoyment were at acceptable levels. Scores were comparable with the 
original SUS study (Usoh et al., 2000). Group differences were not statistically significant. 
Therefore, hypothesis 2, that the majority of participants would find the new VR experience 
acceptable and immersive, was supported.  
 
9.10 VR exposure elicits emotional changes and increased heart rate (Hypothesis 3) 
Paired-samples t-tests compared Pre-VR and Post-VR mean VAS scores and heart rate for the 
whole sample. See Table 16. 
 
Table 16. Pre- and post-VR mood and heart rate  
Scale Pre-VR Post-VR Test Effect size 
 Mean (SD) 
   
Stress VAS 2.57 (1.644) 3.30 (1.987) t(75)=-3.499** .40 
Anxiety VAS 2.42 (1.56) 3.43 (2.15) t(75)=-4.809** .52 
Sadness VAS 1.79 (1.236) 2.01 (1.669) t(75)=-2.06* .15 
Happiness VAS 5.82 (2.108) 5.45 (2.241) t(75)=-1.746, p=.085 -.17 
Heart rate 83.55 (15.431) 86.76 (16.55) t(75)=-2.131* .20 
*p<.05; **p<.001 (all p-values 2-tailed) 
 
The VR task elicited a statistically significant change in stress (medium effect), anxiety (large 
effect), sadness (small effect), and heart rate (small effect) for the whole sample. Therefore, 
hypothesis 3, that exposure to the VR environment would elicit emotional changes and a 
change in heart rate, was supported. 
 
9.11 Higher paranoia before VR predicts higher paranoia in VR (Hypothesis 4) 
An independent-samples t-test compared mean Pre-VR SPM scores between HP-VRG and LP-
VRG to evaluate validity of high and low paranoia groupings. There was a significant difference 
between HP-VRG (10.47, SD 6.25) and LP-VRG (6.15, SD .483); t(74)=4.363, p<.01. 
Independent-samples t-tests compared mean post-VR paranoia scores between HP-VRG and 
LP-VRG. See Table 17. 
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Table 17. Post-VR paranoia scores between HP-VRG and LP-VRG 






 Mean (SD)    
SPM 10.39 (6.33) 6.43 (1.43) t(74)=3.855*  .41 
Paranoia VAS 4.78 (2.474) 2.7 (1.757) t(74)=4.253* .44 
SSPSPERS 21.19 (8.998) 14.35 (5.137) t(74)=4.124* .43   
SSPSPOS 12.67 (2.859) 15.35 (3.80) t(74)=-3.448* .37 
SSPSNEU 10.92 (3.842) 11.40 (3.727) t(74)=-.556, p=.58 .06 
*p<.001 (all p-values 2-tailed) 
 
Post-VR, HP-VRG were significantly higher in state paranoia (SPM and VAS) and paranoia 
about the VR social situation (SSPS) than LP-VRG. All had medium effect sizes. Therefore, 
hypothesis 4, that higher trait paranoia predicts higher state paranoia in VR, was supported. 
 
9.12 High trait paranoia associated with greater negative components of social 
performance in VR (Hypothesis 5) 
Independent-samples tests were conducted to compare Post-VR fear of negative evaluation 
and social avoidance and distress mean scores between HP-VRG and LP-VRG. See Table 18. 
 
Table 18. Post-VR components of social performance 








   
Friendliness of people 3.78 (1.681) 3.98 (1.527) t(74)=-.543, p=.589 .06 
Neutrality of people 4.36 (1.759) 4.68 (1.913) t(74)=-.742, p=.461 .09 
Hostility of people 4.58 (2.02) 4.18 (2.438) t(74)=.790, p=.432 .09 
Socially anxious (SAD) 5.86 (2.416) 4.75 (2.509) t(74)=1.962, p=.054 .22 
Social avoidance (SAD) 5.64 (2.84) 4.08 (2.702) t(74)=2.459*   .27 
Others not approve (BFNE) 4.94 (2.529) 2.98 (2.27) t(74)=3.578*** .38 
Say wrong thing (BFNE) 5.72 (2.7) 4.05 (2.511) t(74)=2.797**  .31 
Others thought of me 
positively 
4.22 (1.758) 4.90 (1.878) t(74)=-1.619, 
p=.110 
.18 
*p<.05; **p<.01; ***p<.001 (all p-values 2-tailed) 
 
HP-VRG were significantly more socially avoidant, more concerned that others would not 
approve, and more concerned they would say the wrong thing. All had medium effect sizes. 
Group differences in appraisals of friendliness, neutrality, and hostility of avatars, and of social 
anxiety were not significant. Therefore, hypothesis 5, that high trait paranoia would be 
associated with greater negative fear of negative evaluation and social avoidance and distress 
in VR, was partially supported. 
 
9.13 Summary of main findings of Study 2 
High paranoia and low paranoia samples were identified (N=196). Ninety-six of the 96 high 
paranoia sample were invited to the VR task and 45 attended: 36 in HP-VRG, 8 in the pilot, and 
1 dropped out during VR task. Seventy-four of the 100 low paranoia sample were invited to the 
VR task and 44 attended: 40 in LP-VRG and 4 in the pilot. Mean group differences of trait 
paranoia were statistically significant with large effect sizes. All 76 VR participants completed all 
96 
parts of the VR task. Group differences of task fidelity were not statistically significant. All scales 
and subscales used in the study demonstrated adequate internal consistency for the total 
sample, apart from SPM, which demonstrated low internal consistency for LP-VRG. Sense of 
presence and enjoyment were at acceptable levels. Therefore, the research question about the 
feasibility and acceptability and the related hypothesis 2, that the majority of participants would 
find the new VR experience acceptable and immersive, was supported. The VR task elicited a 
statistically significant change in stress (medium effect), anxiety (large effect), sadness (small 
effect), and heart rate (small effect) for the whole sample. Therefore, hypothesis 3, that 
exposure to the VR environment would elicit an emotional response and increased heart rate, 
was supported. After the VR task, HP-VRG were significantly higher in state paranoia than LP-
VRG. All had medium effect sizes. Therefore, hypothesis 4, that higher trait paranoia predicts 
higher state paranoia in VR, was supported. In the VR task, HP-VRG were significantly more 
socially avoidant, more concerned that others would not approve, and more concerned they 
would say the wrong thing. All had medium effect sizes. Therefore, hypothesis 5, that higher 
trait paranoia would be associated with greater negative CSP in VR, was partially supported. 
HP-VRG had higher state paranoia and CSP at both pre- and post-VR.  
 
10. DISCUSSION  
This study aimed to compare participants of high and low trait paranoia in a VR social situation 
task to assess whether a VR social situation task would elicit greater feelings of state paranoia, 
components of social performance, and physiological response in people with high trait 
paranoia. The VR task was carried out as planned and VR task fidelity was very high. As 
hypothesised, participants found the VR environment acceptable and immersive. Immersion on 
SUS was higher in 5/6 items than the virtual reality in a previous study (Usoh et al., 2000). 
Exposure to the VR environment elicited a range of components of social performance; and 
high paranoia participants reported higher paranoia in VR. While participants found the VR 
social situation task somewhat anxiety-provoking, effects sizes for overall stress and sadness 
elicited by the task were modest. This shows that the VR has the potential to be applied to real-
time behavioural experiments with clinicians and can be done so safely. 
 
10.1 Strengths 
A key strength of the study is that it explored the link between paranoid ideation and 
components of social performance in an ecologically valid and standardised VR social 
environment that has the potential to be manipulated experimentally. Participants found the VR 
social situation task acceptable. The study controlled for certain potential confounders, such as 
group differences of gender, ethnicity, employment status, way of finding out about the study, 
and previous VR or gaming experience, which were not statistically significant. 
 
10.2 Limitations 
Group differences of age, education, and relationship status were statistically significant. It is 
possible that these differences contributed to the effects on components of social performance 
and paranoia. Low internal consistency on the state paranoia measure (SPM) was notable. It is 
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possible that some items on the scale reflect more severe paranoia than that experienced by 
the non-clinical sample used in the present study. A small minority of participants experienced 
mild cybersickness. However, this was not formally measured in the study so it was not possible 
to determine if cybersickness was higher in those with high or low paranoia. 
 
11. OVERALL SUMMARY AND GENERAL DISCUSSION 
In Study 1, the aim was to conduct an online survey of the general population in order to 
investigate associations between trait paranoia, as measured by GPTS, and components of 
social performance. Components of social performance included cognitive (fear of negative 
evaluation), affective (social distress), and behavioural (social avoidance) components. 
Standard measures of mood (depression, anxiety) were also used. In Study 2, the aim was two 
form two groups using Study 1 data: participants who scored higher and lower on trait paranoia, 
as measured by GPTS, were compared to see if a VR social situation task elicited greater 
feelings of state paranoia, components of social performance, and physiological response in 
those people with higher trait paranoia. The study also used new technologies throughout its 
method: online programs for recruitment, participant bookings, and data collection in both 
Studies 1 and 2.  
 
Study 2 has shown that trait paranoia was associated with components of social performance; 
participants in a VR social situation task found the VR environment acceptable and immersive; 
exposure to the VR environment elicited a range of components of social performance; and 
higher trait paranoia participants reported higher state paranoia and greater negative 
components of social performance in VR. The use of technology was shown to be an effective 
way of recruiting for and conducting the study.  
 
11.1 Clinical implications 
This VR study recruited people from the general population with high paranoid ideation. It 
shows that the VR social situation task has the potential for assessment and treatment 
applications for people with psychosis, who can experience significant paranoia in social 
situations. In terms of assessment applications, it shows that VR has the potential to allow 
clinicians to assess cognitive, behavioural and physiological components of social performance 
in a controlled environment; and with treatments, it shows that VR has the potential to allow 
clinicians to conduct ecologically valid exposure work, behavioural experiments, or develop 
social skills within the safe space of clinical sessions, rather than as homework or through 
roleplay, and to be able to interact with patients during this process. These potential 
developments in psychosis could build on effective developments in VR exposure therapy seen 
in other areas of mental health (Morina et al., 2015; Opriş et al., 2012) 
 
In particular, the positive correlations identified in the present study between trait paranoia and 
social avoidance and distress, fear of negative evaluation, interpersonal sensitivity, depression, 
and anxiety all have important clinical applications for treatments in psychosis, where negative 
cognitions impact negatively on social functioning (Voges & Addington, 2005) and co-morbid 
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social anxiety is associated with increased shame (Michail & Birchwood, 2009). Firstly, it 
provides scope for experimental interventions targeted on these specific cognitive, emotional 
and behavioural correlates in VR and the opportunity to test, under tightly controlled conditions, 
both whether they can be changed and therefore whether they individually or collectively play a 
causal or mediating role in paranoia (Freeman & Garety, 2014). Secondly, this study highlights 
the fact that it will be important for clinicians to conduct a thorough assessment of social 
functioning impairments when working with people with psychosis and normalise paranoia by 
acknowledging the ubiquity of paranoid ideation in the general population (Freeman et al., 
2005). Finally, VR interventions can provide an ecologically valid environment in which to tackle 
social avoidance and distress; and to test beliefs about being negatively evaluated. In this 
sense, VR is a therapeutic tool that may be integrated with existing treatments that target 
components of social performance in psychosis (Penadés et al., 2006). 
 
11.2 Future research 
A future aim is to test the acceptability of the VR social situation task in people with psychosis. 
Existing VR social skills training packages (Park et al., 2011; Rus-Calafell et al., 2014) can be 
developed further with greater ecological validity and therapist interaction. A key advancement 
would be increasing clinicians’ capacity to manipulate VR design to target specific processes 
and real-time environmental conditions. In this regard, psychosis might follow developments in 
the more advanced field of VR exposure therapy for combat-related PTSD (Reger et al., 2015; 
Rizzo et al., 2015). Similar studies for psychosis are underway (Freeman et al., 2016; Pot-
Kolder et al., 2016).  
 
The findings of this study are consistent with recent VR studies for psychosis that examined 
social stress (Veling et al., 2016). In testing the VR social situation task used in this study with 
people with psychosis, it will be important to consider how a clinical sample may differ from the 
non-clinical sample in the present study, especially with regard to paranoid ideation. In the 
online survey, mean GPTS scores for GPTSREF in HPS compared significantly with the clinical 
sample (N=50) in the original GPTS study (Green et al., 2008). By contrast, the mean GPTS 
scores for GPTSPERS and GPTSTOTAL in HPS were lower than GPTSPERS and GPTSTOTAL for the 
clinical sample. Therefore, while the sample in HPS was comparable to a psychosis sample in 
terms of ideas of reference, it was lower in terms of persecutory beliefs. Given the very wide 
range of our HPS there is overlap with clinical scores and some of HPS had total scores in the 
clinical range (one SD of our total scores are at the clinical mean) suggesting that it can be 
taken as a partial comparator to a clinical sample. It is notable that no adverse effects were 
reported in the present study, also suggesting that this is a safe intervention. However, a future 
study involving participants with psychosis should be aware that persecutory beliefs may be 
higher than were found in the present sample. 
 
Future research into paranoid ideation might investigate in greater depth its phenomenological 
properties and its relationship to emotional concerns. These data support Freeman and 
colleagues’ hypothesised hierarchical arrangement of paranoid ideation that builds on common 
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emotional concerns, noting that our high paranoia non-clinical sample scored more highly on 
ideas of reference which are less severe and more common concerns than persecution 
(Freeman et al., 2005). The range of components of social performance was necessarily limited 
due to study resources; however, further associations that might be explored in order to develop 
our understanding of paranoid ideation in social situations may include self-esteem (Thewissen 
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BRC Service User Advisory Group review, IoPPN, 6th August 2014 – Notes on meeting by SR 
The Service User Advisory Group felt that VR interventions could be very useful in clinical practice. 
Members of the group reported that the flexibility of the therapeutic setting would be a particular 
advantage and that this opened doors to having therapeutic sessions in a variety of contexts. In 
particular, members of the group identified exposure therapy in anxiety and phobias as particularly useful 
ways to employ this technology, given the fact that VR would allow clients to be put into settings that 
would otherwise be difficult or impossible to achieve. In general, they felt that the VR could be a useful 
tool for giving clients positive experiences. Several members of the group disclosed that they had a 
diagnosis of psychosis and had always found it extremely challenging to conjure up mental imagery when 
asked to do so by a therapist. These group members reported that a VR intervention could be very useful 
to them if VR could act as a proxy for mental imagery.  
 
The group highlighted that VR would provide the opportunity to replay, rerun, or pause behavioural 
experiments. They felt that the therapist as avatar would be useful to consult and as a source of support if 
they were in the VR environment together during this process. In general they found the idea of the 
therapist entering the VR to be an acceptable and even a helpful one. One group member felt that the 
therapist moving from the real world into the VR and clearly identifying themselves would be comforting 
and would retain the idea of feeling like you were talking to a real person. This was contrasted with the 
scenario in the Avatar study which, the group member felt, could be alarming for some participants and 
would not feel like they were talking to a real person.  
 
In terms of the study information sheets, the group suggested that it would be important to be clear that 
the technology, and therefore the specific features of the virtual environment, is completely under the 
control of the researcher, and therefore also the participants. In other words, all events that occurred in 
the virtual environment would be known by the researcher in advance and could be explained to the 
participant. In terms of study design, the group felt it would be useful to ask participants at the outset 
about their level of presence in ordinary life. Suggested examples included how present/immersed 
participants felt playing computer games and watching films or television.  
 
The group were keen to see how immersive the virtual reality technology could be and stated that they 
did not feel that the VR avatars needed to be too real in order for presence to be felt. The group found it 
acceptable that the therapist avatar could bear a reasonable resemblance to the actual therapist. They 
found it acceptable that this could be achieved with gender, similar build, and clothing. In this regard, one 
member of the group referenced the thesis of the ‘uncanny valley’ which, in this context, might suggest 
that some participants may recoil if avatars are too lifelike and that an approximate likeness may be 
preferable. 
 
Several members, who disclosed that they had a diagnosis of psychosis, stated that they would be keen 


















































Sample online bulletin text – long 
"VIRTUAL REALITY AND SOCIAL SITUATIONS STUDY 
This is a study in two stages taking place at the Institute of Psychiatry, Psychology & Neuroscience, 
King’s College London. 
 
Stage 1: Online Survey 
An online survey of working age adults is being carried out to understand the thoughts and feelings that 
people experience, especially about social situations. It takes approximately 30 minutes and can be 
completed on any computer or handheld device. Everyone who completes the survey will be entered into 
a prize draw to win one of four £25 Amazon vouchers. The survey data will then be analysed to improve 
our understanding of how people think and feel about social situations. 
 
Stage 2: Virtual Reality 
A selection of those who complete the survey will be invited to take part in a virtual reality study at the 
Institute of Psychiatry, Psychology & Neuroscience. This will involve piloting a new virtual reality platform 
and aims to understand how people respond when entering a social environment in virtual reality. The 
results of the study will inform the future development of a novel and effective assessment and treatment 
approach to help people with serious mental health problems facing difficulties with social situations. 
 
Click here to enter the online survey [Link to survey]."  
 
Sample online bulletin text – brief 
"Recruiting participants for new #VirtualReality study @Kingspsychol @KingsIoPPN in #London. Fill in 
survey to enter [Link to survey]" 










We are looking for study participants  
at King’s College London 
 
Enter the study here 
https://kings.onlinesurveys.ac.uk/vrandsocialsituations 
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Sample recruitment email text 
 




Thank you very much for entering the Virtual Reality and Social Situations study and completing Stage 1 
(online survey).  
 
We would like to invite you for Stage 2 (Virtual Reality) at the Institute of Psychiatry, Psychology 
& Neuroscience (IoPPN), King’s College London, De Crespigny Park, Denmark Hill, London SE5 
8AF. 
 
This part of the study will involve piloting a new Virtual Reality (VR) platform and aims to understand how 
people respond when entering a social environment in virtual reality. If you choose to accept this 
invitation, you will be paid £10 for approximately 1 hour of your time. I attach an Information Sheet 
and Consent Form for Stage 2 of the study. Please read the Information Sheet and decide if you would 
like to take part in the VR study.  
 
Booking your VR Appointment 
We use the Internet calendar tool Doodle to schedule appointments. This means that you can book 
yourself in for an appointment that is most convenient to you. In order to book your appointment, you will 
need the unique, 3 digit participant number that has been assigned to you.  
 
Your participant number is: [Insert number] 
 
Click the links below to book your appointment. Simply enter your unique 3-digit participant number in 
your chosen timeslot (where it says ‘your name’). You do not need to enter any other information. We 
currently have appointment times on the following dates: 
 
[Insert dates and time periods] 
[Insert Doodle poll links] 
 
Expand the poll if needed to see all appointment times. Please reserve just one appointment. If you book, 
change or cancel an appointment less than 24 hours before the appointment is due to take place, I would 
be very grateful if you could email me in addition to amending the Doodle. 
 
On your VR Appointment Day 
If your appointment is between 10am and 4pm on a weekday, please come to reception of the Henry 
Wellcome Building (reception phone no: 020 7848 0033). If your appointment is 4pm or afterwards on a 
weekday or is on the weekend, please come to reception of the Institute of Psychiatry, Psychology and 
Neuroscience: Main Building, 16 De Crespigny Park, SE5 8AF London (reception phone no: 020 7848 
0002). These two building are next to each other. You will be met by a member of the research team. 
  








Please bring a signed copy of the consent form if it is convenient for you. If this is not possible, blank 
copies will be available on the day. 
 
Please do not consume any alcohol or drugs for at least 8 hours before your appointment.  
 
If you do not wish to participate in Stage 2 (VR) or are unable to attend 
I would be very grateful if you would let me know this as soon as possible. If I do not hear from you within 
2 weeks, I will assume that you do not wish to participate in Stage 2. 
 







































































VR DATA COLLECTION 
INSTRUCTION MANUAL 
 





VR DATA COLLECTION EQUIPMENT 
 
Ring Binder 1 (Blank Forms) 
Information Sheets 
Consent Forms 
Semi-structured interview form 
Paranoia leaflet 
Payment Claim Form 
Confirmation of Participation Form 
 
Ring Binder 2 (Completed Participant Packs) 
Signed Consent Forms 
Completed semi-structured interview forms 
Completed payment claim forms 
















VR DATA COLLECTION ITINERARY AND RESEARCH EQUIPMENT FOR ONE PARTICIPANT 
 
TIME POINT BEFORE: YOU WILL NEED KEY TASK AFTER: YOU SHOULD HAVE LAB RESEARCHER 
T1 • Information Sheet 
• Consent Form 
• Tablet 1 
• Meet participant in reception 
(Main Building or HWB) 
• Brief participant 
• Discuss Information Sheet 
• Sign Consent Form 
• Pre-VR survey (on tablet) 
• Take participant to holding 
area 





T2 • VR headset 
• Desktop computer 
• Oximeter 
• Tablet 2 
• Collect participant from holding 
area 
• Brief participant 
• Oximeter reading 1 
• VR task 
• Oximeter reading 2 
• Post-VR survey (on tablet) 






T3 • Semi-structured 
interview form 
• Dictaphone 
• Paranoia leaflet 
• Payment Claim Form 
• Confirmation of 
Participation Form 
• Collect participant from holding 
area 
• Post-VR interview (5 minutes, 
audio recorded) 
• Debrief – any questions? 
• Explain what the study is 
about 
• Offer paranoia leaflet (if 
needed) 
• Complete payment claim form 
• Complete confirmation of 
participation form 











PUTS THE ABOVE 4 
DOCUMENTS TOGETHER 
INTO A CLEAR ENVELOPE 















R1. Meet participant in reception of HWB or main building. Bring them up to Interview 
room.  
 
R1. Interview room 
• Briefing: Sample script: “Thank you for coming to do the virtual reality study today. You 
were sent an Information Sheet. Did you read the Information Sheet? [If yes:] Did you 
have any questions? [Use information sheet as prompt and answer questions.] [If no:] 
Would you like to have a quick read of it now? Take your time … Did you have any 
questions? [If participant would like a summary, key points in brief are:] “The purpose of 
today is to do a virtual reality task and ask you a few questions before and after about 
how you found the experience. The virtual reality scenario is a social situation. All of the 
information that we collect today is completely confidential. You are free to stop the 
study or take a break at any time.” [If the participant asks any questions about the 
design of the study or how they were selected:] “I’m afraid I can’t answer that question 
before you do the virtual reality task but there will be a debriefing afterwards where I will 
be able to answer any questions.”  
• Consent form: Sign or collect signed copy. Researcher to sign and retain 1 copy. Make 
sure participant has completed all sections correctly before you sign. Ask participant if 
they would also like a copy for their records and, if so, complete a second consent form. 
• Questions on tablet: Sample script: “We would just like to ask you a few questions 
before you do the virtual reality task. We have the questions on this tablet. They are 
similar to the questions you answered in the online survey. Let me know if you have any 
questions …” [If participant finds question formatting on tablet difficult:] “You may find it 
easier to switch to ‘tableless mode’.” 
• End: Sample script: “It is now time to do the virtual reality task with my colleague. I will 
take you through to them” 





On screen: VR PARTICIPANT > RUN (Loading). VR headset must be facing the screen while scenario is 
loading. 
 
R2. VR lab 
• Introduction: Sample script: “This is the part of the study where we will do the virtual 
reality task” 
• Oximeter reading 1: Sample script: “First of all, we would just like to take reading of 
your heart rate using this device that goes on your finger. It does not hurt at all.” 
Demonstrate putting on the oximeter. “We will take another reading of your heart rate 
after you’ve done the virtual reality task”. [Enter Oximeter reading 1 on tablet. Top figure 
is blood oxygen, bottom figure is heart rate – if blood oxygen is less than 90, contact 
Lucia.] 
• Explain VR equipment: Before putting on the headset, show the participant the Oculus 
headset and the joypad. Show them which button on the joypad they will be able to use. 
Tell the participant: “You will be able to move around with a combination of turning with 
your body and by using the joypad. Move around slowly at first as you get used to the 
virtual environment; otherwise you might feel dizzy. If you’ve used a joypad before, it 
might be a bit different to what you are used to as you will be partially guided in your 
movement and cannot move completely freely” Demonstrate this to participant while 
holding the joypad. 
• Start VR: Get participant into position, holding joypad and wearing VR headset. Make 
sure headset cable is not tangled. Sample script: “Don’t worry about the cable. I will 
make sure you do not get tangled.” Blue light on headset must be on. Once the 
participant is comfortable and ready, press PLAY.  
• Demo VR exercise: [Now read the following:] “You will first be in a street. Have a look 
around the street slowly … When you are ready, use the joypad to move yourself to the 
green circle on the ground … You will get to a pub. Turn your body to the right to face 
the pub … In the pub look for more green circles on the ground. You will need to go from 
one green circle to another. If you cannot find a green circle, have a look around for it. 
When you get to a green circle, you will need to stop for a little while. While you are in 
the pub please try get an impression of what the people in the pub thinks about you and 
what you think about them. If someone asks you a question, try to reply to them” 
[Everyone MUST get this instruction.] “Do you have any questions?” 
• Main VR task:  
Press PLAY at pub doorway 
‘PAUSE’ > CONTINUE 
AFTER PATRICK > CONTINUE 
2ND INTERACTION > WALK AROUND 
AFTER TV PROGRAMME > CONTINUE 
CLOSING INSTRUCTION > CONTINUE 
• FIDELITY: Record on tablet. DO NOT SPEAK TO PARTICIPANT WHILE IN THE PUB 
UNLESS NECESSARY. 
• Oximeter reading 2: As soon as VR task ends, while participant is still wearing VR 
headset, take another heart reading. Sample script: “We would just like to take another 
reading of your heart rate using the same device as before” 
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• Remove VR equipment 
• Questions on tablet: “Now that you’ve done the virtual reality task, we would just like to 
ask you a few more questions on this tablet. … [If participant finds question formatting 
on tablet difficult:] You may find it easier to switch to ‘tableless mode’. 
• End: Sample script: “Thank you for doing the virtual reality task. I am just going to take 
you back to my colleague who has a few more questions for you and can answer any 
questions you might have” 





R1. Interview room 
• Post-VR semi-structured interview: See form for script. 
• General debrief: Sample script: “Now that you’ve completed the main parts of the 
study, I wanted to give you a little more information about the research. It’s also an 
opportunity for you to ask any further questions. This study is looking at the various 
emotional responses that people have in a virtual reality social situation. In particular, we 
are looking at how the virtual reality scenario of a social situation affects peoples’ 
experience of paranoia. In order to do this we selected some participants of higher 
paranoia and some participant of lower paranoia, based on their answers on the online 
survey, to come and do the virtual reality task [Pause for any questions] Given that all 
participant data is anonymised, we do not know which participants that do the virtual 
reality are higher or lower. Do you have any questions about study?  
• [Optional] Normalise paranoia: [If participant has any concerns about their paranoia, 
normalise paranoia in the general population:] “Paranoia is very common. Everyone 
experiences some degree of paranoia.”  
• [Optional] Paranoia leaflet/signpost to GP: [If participant has further concerns about 
their paranoia, give them the paranoia leaflet. If participant has still further concerns and 
feels they need to discuss this with someone, signpost them to contacting their GP:] 
Sample script: “If you feel that this has raised any difficult thoughts or feelings for you 
and that you would like to discuss them further with someone, we would suggest that 
you discuss this with your GP.”  
• [Optional] Results of study: [If participants would like to know about the results of the 
study:] Sample script: “We will be happy to send you the final report when it is 
completed. We can have it emailed to you” [Record on tablet that participant would like 
published report/paper emailed to them].  
• Keeping debrief confidential: Sample script: “If you happen to know other participants 
in the virtual reality study, we would be very grateful if you do not share this explanation 
with them until the virtual reality data collection is completed.”   
• Payment: Fill out details for bank transfer or cheque payment 
• Participation confirmation: Complete Confirmation of participation form 
• End: Sample script: “Thank you very much for coming today. I will show you out” 








Thursday day = 09.20-18.00 (11 slots) 
Friday day = 09.20-17.40 (10 slots) 
Monday evening = 17.20-21.20 (6 slots) 
Wednesday evening = 18.20-22.00 (6 slots) 
Saturday afternoon = 14.00-18.00 (6 slots) 
 
Researchers to meet half an hour before to set up.  
 
R1 to speak to relevant receptionist about format of day, explain where study is taking place, and tell 
receptionist to ask participants to take a seat in reception and that they will be collected by a researcher. 
 




Week Date Year Time period Researchers Time slots 
1 Fri 11 Dec  Team Meeting SR, CE, NS, KY 0 
 Fri 11 Dec  Afternoon SR, CE, NS, KY 6 
 Sat 12 Dec  Afternoon SR, NS 6 
2 Mon 14 Dec  Evening SR, KY 6 
 Wed 16 Dec  Evening CE, NS 6 
 Thurs 17 Dec  Day CE, NS 11 
 Fri 18 Dec  Team Meeting SR, CE, NS, KY 0 
 Fri 18 Dec  Day SR, KY 10 
3 Mon 21 Dec  Day SR, KY 11 
4 Thurs 7 Jan 2016 Day CE, NS 11 
 Fri 8 Jan  Team Meeting SR, CE, NS, KY 0 
 Fri 8 Jan  Day SR, KY 10 
5 Mon 11 Jan  Morning SR  ? 
 Thurs 14 Jan  Day CE, NS 11 
 Fri 15 Jan  Team Meeting SR, CE, NS, KY 0 
 Fri 15 Jan  Day SR, KY 10 
6 Thurs 21 Jan  Day CE, NS 11 
 Fri 22 Jan  Team Meeting SR, CE, NS, KY 0 
 Fri 22 Jan  Day SR, KY 10 
7 Mon 25 Jan  Day SR  ? 
 Thurs 28 Jan  Day CE, NS 11 
 Fri 29 Jan  Team Meeting SR, CE, NS, KY 0 
 Fri 29 Jan  Day SR, KY 10 
      




THURSDAY/FRIDAY DAYS & WEDNESDAY EVENINGS 
 
 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 
09.20 T1                 
09.40 T2 T1                
10.00 T3 T2                
10.20  T3                
10.40 
  T1               
11.00 
  T2 T1              
11.20   T3 T2              
11.40    T3              
12.00 
    T1             
12.20 
    T2 T1            
12.40     T3 T2            





      T1           
14.40 
      T2 T1          
15.00       T3 T2          
15.20        T3          
15.40 
        T1         
16.00 
        T2 T1        
16.20         T3 T2        
16.40          T3        
17.00 
          T1       
17.20           T2       
17.40           T3       
18.00 BREAK 
18.20 
           T1      
18.40 
           T2 T1     
19.00            T3 T2     
19.20             T3     
19.40 
             T1    
20.00 
             T2 T1   
20.20              T3 T2   
20.40               T3   
21.00 
               T1  
21.20 
               T2 T1 
21.40                T3 T2 




ALTERNATIVE FRIDAY DAYS 
 
 P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 
09.20 T1    
      
09.40 T2 T1   
      
10.00 T3 T2         
10.20  T3         
10.40   T1  
      
11.00   T2 T1 
      
11.20   T3 T2       




TEAM MEETING 13.00 
13.20 
13.40 
    
T1      
14.00 
    
T2 T1     
14.20     T3 T2     
14.40      T3     
15.00 
    
  T1    
15.20 
    
  T2 T1   
15.40       T3 T2   
16.00        T3   
16.20 
    
    T1  
16.40 
    
    T2 T1 
17.00         T3 T2 





 P1 P2 P3 P4 P5 P6 
14.00 T1      
14.20 T2 T1     
14.40 T3 T2     
15.00  T3     
15.20   T1    
15.40   T2 T1   
16.00   T3 T2   
16.20    T3   
16.40     T1  
17.00     T2 T1 
17.20     T3 T2 








 P1 P2 P3 P4 P5 P6 
17.20 T1      
17.40 T2 T1     
18.00 T3 T2     
18.20  T3     
18.40   T1    
19.00   T2 T1   
19.20   T3 T2   
19.40    T3   
20.00     T1  
20.20     T2 T1 
20.40     T3 T2 
























VIRTUAL REALITY AND SOCIAL SITUATIONS STUDY 
 
• We are doing the Virtual Reality and Social Situations study at the 
IoPPN today 
 
• Participants will be reporting to reception 
 
• Participants may ask for Simon Riches or Lucia Valmaggia or say 
that they are here for the Virtual Reality study 
 
• Please ask them to take a seat in reception 
 















































































































































































































































































































3. Evaluating pre-therapy rates of prescribed psychotropic medication and post-therapy 
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ABSTRACT 
Background: Psychological therapies are the NICE-recommended first line treatment for 
common mental health problems. However, psychotropic medication is frequently prescribed 
before psychological therapy. In order to inform decisions about the mental health care 
provisions in the London borough of Southwark, an analysis of pre-therapy rates of 
prescribed psychotropic medication and post-therapy outcomes in the Southwark Improving 
Access to Psychological Therapies (IAPT) service was undertaken. This provides initial 
research required in order to develop a protocol for a medication support intervention for 
Southwark IAPT clinicians. Method: Routine service data was accessed and analysed using 
IAPTus Hypercube. Data accessed was medication prescription and adherence rate on 
entry to the service, overall and by year; demographics of prescribed patients, and pre-/post-
therapy change for prescription rate, depression, anxiety, and general functioning. Results: 
44% of patients entering Southwark IAPT between 2008 and 2014 (N=21,254) were 
prescribed medication at assessment. There was a significant yearly upward trend from 39% 
in 2008 to 46% in 2014. Overall, 11% of patients were medication non-adherent. Patients 
who are white, middle-aged, and unemployed or long-term sick or disabled were most likely 
to be prescribed on entry. The vast majority of patients retained their prescription status 
post-therapy, although the shift from prescribed to non-prescribed was slightly greater than 
from non-prescribed to prescribed. Symptoms for depression, anxiety and deficits in general 
functioning were all greater in prescribed patients on entry. The depression and general 
functioning change was higher in patients who were prescribed on entry, whereas the 
anxiety change was higher in patients who were non-prescribed on entry. Discussion: 
There are challenges implementing the NICE recommendation in Southwark. Opportunities 
for Southwark IAPT to offer greater support for people likely to be prescribed psychotropic 
medication are discussed. 
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A quarter of adults experience a common mental health problem each year in the UK. 
Treatment provision for this issue faces considerable psychological, social and economic 
challenges. Mental health problems cost the UK economy £70bn in treatment provision, 
which amounts to 4.5% of gross domestic product (OECD, 2014). In terms of treatment 
provision, psychological therapies have been recommended by the National Institute for 
Health and Care Excellence (NICE) as the first line of treatment for common mental health 
disorders, not only for their efficacy in treating common mental health problems but also for 
their cost efficiency (NICE, 2011). In particular, cognitive behaviour therapy (CBT) has been 
shown to be an effective psychological treatment for common mental health problems 
(Butler et al., 2006; Hofmann et al., 2012; Linden et al., 2004). In the mid-2000s, an 
economic case argued for the wider availability of CBT treatment (Layard et al., 2007). Since 
its introduction in 2008, the Improving Access to Psychological Therapies (IAPT) programme 
has aimed to implement the NICE guidelines in England by providing cost-effective first-line 
evidence-based psychological treatment for common mental health problems (Clark et al., 
2009; Gyani et al., 2013). According to IAPT, the programme is estimated to save the NHS 
up to £272 million and the wider public sector more than £700 million.  
 
Limited funding for mental health provisions in the UK (highlighted in a co-authored letter to 
NHS England by such organizations as Mind and Rethink Mental Illness, the Royal College 
of Psychiatrists and the Mental Health Network in March 2014) has meant that patients 
referred to IAPT services have encountered long waiting times between their initial referral to 
IAPT and commencing psychological treatment (HSCIC, 2015). This outcome has important 
consequences for the care pathway. Although many IAPT services offer self-referral as an 
alternative route of entry, GPs remain the main gateway for patients to enter mental health 
treatment. GPs can offer patients psychotropic medication and/or referral to psychological 
services to receive psychological therapy. NICE observe that limited provision of 
psychological interventions has meant that psychotropic medication is generally employed 
as the most common method of treatment for common mental health disorders in primary 
care, rather than psychological treatment (NICE, 2011).  
 
UK psychotropic medication prescription rates have increased in recent decades. A study of 
the general practice research database revealed that antidepressant prescribing nearly 
doubled between 1995 and 2004 (Moore et al., 2009). More recently, the Nuffield Trust and 
Health Foundation’s Quality Watch report found a 165% increase in antidepressants 
prescribing in England between 1998 and 2012, an average of 7.2 per cent a year, which 
escalated in particular after the 2008 financial crisis (Spence et al., 2014). 
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Failure to meet the NICE guidelines on implementing psychological therapies for common 
mental health problems is not the only challenge faced by health services and policymakers. 
Medication ‘non-compliance’ or ‘non-adherence’, i.e. patients not taking the medication that 
they have been prescribed, is a longstanding problem with antidepressants (Cramer et al., 
2008), which has important psychological and social consequences for patients, in terms of 
providing appropriate treatment provision, as well as economic consequences for the cost 
efficiency of NHS spending.  
 
The challenge of implementing the NICE guidelines for psychological therapies with limited 
funding is an issue for NHS services throughout the UK. These challenges raise important 
questions about the number of patients receiving medication rather than psychological 
therapy, and the extent of medication non-adherence. The present study evaluates the 
extent to which the NICE guidance of recommending psychological therapies as the first line 
of treatment for common mental health problems is implemented in a South London IAPT 
service. Southwark IAPT is a service that has been offering psychological support and 
therapy for adults with common mental health problems such as depression and anxiety 
since its inception in 2008. It offers individual and group psychological therapy, primarily 
CBT, although other approaches are provided; and is situated in the London borough of 
Southwark, which is a multicultural area of high population density. Southwark has a 
population estimate of 288,300 people, of which 49% are male and 51% are female, with a 
particularly large proportion of the population of Southwark aged between 25 and 34 (ONS, 
2011). According to the Nuffield Trust and Health Foundation report, antidepressant 
prescription rates are generally lower in London when compared with the rest of the UK. 
Their analysis shows that Southwark Primary Care Trust prescribed 94.3 items per 1,000 
people in quarter 3 of 2012/13. This contrasts with 71 items per 1,000 people in NHS Brent, 
which was lowest, and 331 items per 1,000 people in NHS Blackpool, which was highest 
(Spence et al., 2014). 
 
1.2 Stakeholder Involvement 
This study incorporated significant stakeholder involvement. Southwark IAPT has a Service 
User Feedback Forum at which staff members regularly consult service users to gain 
feedback on the service. The protocol for this study was presented by SR at the Service 
User Feedback Forum in March 2014. At this meeting, service user participants stated that 
they would like the service to provide greater support with medication cessation, side effects, 
withdrawal, and understanding how prescribed medication interacts with their psychological 
therapy. Participants highlighted that although psychotropic and therapeutic interventions 
are often presented collectively as ‘treatments’, there is often a disconnection between them, 
insofar as patients can end therapy but remain on antidepressants, which leaves patients 
without psychological support if they then discontinue medication. At this meeting it was 
agreed that the present study should identify the percentage of people who are prescribed 
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medication when they enter therapy at Southwark IAPT, in order to evaluate whether this is 
consistent with NICE guidance. In addition, it was agreed that a better understanding of 
medication adherence, the interaction of prescription rates with therapeutic outcomes, and 
demographic information of those prescribed medication on entry and discharge would 
enable Southwark IAPT to identify particular areas of concern and potential improvements 
within the service. It was agreed that if the present study could identify particular patient 
groups who may require greater support, then Southwark IAPT could use this data to carry 
out focus groups with specific patient groups in order to develop a protocol for a medication 
support intervention that could be delivered by Psychological Wellbeing Practitioners 
(PWPs). Such an intervention is not currently offered by Southwark IAPT. 
 
The study protocol and the guidance from the Service User Feedback Forum were 
subsequently presented by SR to Southwark IAPT clinicians at a staff meeting in March 
2014 in order to gain further feedback. The clinical staff agreed that the demographic 
information of those prescribed medication on entry would be important information for their 
clinical practice and that the development of a protocol for a medication support intervention 
would be an important addition to the service. 
 
1.3 Study aims 
The aims of the present study are to evaluate the pre-therapy rate of prescribed 
psychotropic medication, the demographics of those patients prescribed, and the post-
therapy outcomes in the Southwark IAPT service. This will inform decisions about the mental 
health care provisions in Southwark, identify the needs for better integration within the whole 
healthcare system, especially between Southwark IAPT and GPs, and provide the initial 
research required in order to develop a protocol for a medication support that can be used 




Patients are referred to Southwark IAPT with predominantly depression and anxiety 
spectrum problems, as well as sleep, anger management, and low self-esteem. Patients are 
referred to other services if they have a current diagnosis of psychosis, personality 
disorders, drug or alcohol dependency and high risk to self. Southwark IAPT offers a wide 
range of treatment options, with CBT most prominent. In this study, psychological or 
therapeutic treatment can refer to individual high intensity CBT, guided self-help, couples 
counselling, Dynamic Interpersonal Therapy, Eye Movement Desensitization and 
Reprocessing, Interpersonal therapy, and Cognitive Analytical Therapy; Sleep issues, 
Stress, Confidence and Anger workshops; or psycho-educational groups for Panic, Anxiety 
and Depression, Depression, Mindfulness-based Cognitive Therapy, Mindfulness for long-
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term health conditions, Compassion and relaxation training, post-natal depression, Changes 
for health; counselling, and behavioural couples therapy for depression. 
 
2.2 Analysis 
Data was accessed and analysed using the standard IAPT data analysis software 
programme IAPTus Hypercube, which is integrated with the IAPT electronic records system, 
IAPTus. The time period accessed was 2008 until 2014, using the date range of 1st January 
2008 until 31st December 2014. This time period covers the commissioning of the Southwark 
IAPT service in 2008 and includes all data available on the Southwark IAPT minimum data 
set until the most recent full calendar year. All data was accessed and analysed in an 
anonymized form between 18th and 20th January 2015. Researchers manually calculated 
means and collapsed data categories using Microsoft Excel in order to produce data tables. 
IAPTus Hypercube Active Filters for all analyses are provided in the Appendix. Southwark 
IAPT collects data on prescribed medication at Session 1 rather than initial referral. 
Therefore, attendance at Session 1 of psychological therapy has been used as the time 
point at which patients are said to ‘enter’ the service. The present sample therefore includes 
the subset of referrals that engaged with the service and attended Session 1, not the total 
number of referrals. 
 
Inferential statistics have been used to investigate significant differences. Due to the large 
sample size and the large number of tests, a significance level of p<0.01 is employed, in 
order to evaluate clinical importance. An online application (www.quantpsy.org) was used to 
calculate all Chi2 analyses.  
 
The analysis was conducted in four stages: 
 
2.3 Stage 1 (Prescription rate on entry) 
The number of patients prescribed and not prescribed medication on entry was identified, 
overall and by year. Southwark IAPT collects medication data in the categories of Prescribed 
and taking, Prescribed but not taking, Not Prescribed, Not stated (Person asked but declined 
to provide a response), and Unknown (Person asked and does not know or is not sure). In 
order to calculate the number of prescribed patients, the categories of ‘Prescribed and 
taking’ and ‘Prescribed but not taking’ were manually collated. 
 
2.4 Stage 2 (Adherence) 
Adherence and non-adherence rates were identified, overall and by year, within the category 
of those prescribed medication on entry. Southwark IAPT began recording medication 
adherence in 2011, so data is presented from this year forward. 
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2.5 Stage 3 (Demographics) 
Demographics (gender, age, ethnicity, employment status) of those prescribed and non-
prescribed on entry were identified. Southwark IAPT collects gender data in the binary 
categories of male and female, as well as recording if gender is unknown. Age data is 
collected by recording date of birth and IAPTus then calculates a patient’s age. In preparing 
the data, two manual collations of data were produced. The first divided patients into young 
(aged ≤34 years), middle-aged (35-64 years) and older adults (≥65 years). The second 
divided patients by ten year ages ranges (≤19, 20-29, 30-39, 40-49, 50-59, 60-69, 70-79 and 
≥80 years). Southwark IAPT collects ethnicity data in the categories of white, black or black 
British, Asian or Asian British, mixed, and other ethnic groups, as well as if ethnicity data is 
unknown by the patient, missing, or if the question is declined. Southwark IAPT collects 
employment data in the categories of employed full-time (FT), employed part-time (PT), 
student, retired, full-time homemaker or carer not seeking work, unpaid voluntary work and 
not seeking work, unpaid voluntary work and seeking work, unemployed and seeking work, 
unemployed and not seeking work and not receiving benefits, long-term (LT) sick or disabled 
receiving incapacity benefit/income support or both or employment and support allowance, 
and not stated (person was asked but declined to provide a response). In preparing the data, 
the categories of Unpaid voluntary work, not seeking work and Unpaid voluntary work, 
seeking work, and of Unemployed and seeking work and Unemployed, not seeking work, not 
receiving benefits have been manually collated and labeled as ‘Unpaid volunteer’ and 
‘Unemployed’ respectively. Lack of knowledge of a psychotropic medication prescription or 
lack of willingness to disclose prescription is collected in the minimum data set. This was 
identified for each demographic in the analysis.  
 
2.6 Stage 4 (Pre-/post-treatment changes) 
Pre- and post-treatment changes in outcomes measures and prescription rate were 
analysed. Changes in prescription status were identified across four possible categories (i.e. 
from prescribed to prescribed, prescribed to non-prescribed, non-prescribed to prescribed, 
and non-prescribed to non-prescribed) for the total number of people who completed 
treatment (i.e. if they attended 2 or more treatment sessions). 
 
Measures of depression, anxiety and social functioning were analysed pre- and post-therapy 
for those who were prescribed and non-prescribed. Southwark IAPT routinely uses the 
standard IAPT screening measures for initial screening and assessment and for ongoing 
assessment of patient outcomes. Pre- and post- matrices for the Patient Health 
Questionnaire (PHQ9), the Generalised Anxiety Disorder Assessment (GAD7), and the 
Work and Social Adjustment Scale (WSAS) were analysed to determine the effect of therapy 
on those prescribed and non-prescribed. Mean scores for first and last sessions were then 
manually calculated from the data in the pre- and post- matrices. The PHQ9 is a self-
administered measure, which scores each of the 9 DSM-IV criteria on a 4-point scale, from 
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“0” (not at all) to "3" (nearly every day), for the most recent two weeks. An example item is 
‘Little interest or pleasure in doing things’. The PHQ9 has been validated for use in primary 
care (Cameron et al., 2008). The GAD7 is a 7-item anxiety scale with good reliability, as well 
as criterion, construct, factorial, and procedural validity, which rates 7 items on a 4 point 
scale, from “0” (not at all) to "3" (nearly every day), for the most recent two weeks. An 
example item is ‘How often have you been bothered by feeling nervous, anxious or on 
edge?’ (Spitzer et al., 2006). The WSAS is a reliable and valid measure of general 
functioning, which scores on 5 items on a 9-point scale, from “0” (not at all) to "8" (very 
severely), for the most recent two weeks. An example item is ‘How much does your problem 
impair your ability to carry out home management (cleaning, tidying, shopping, cooking, 




In total, 21,254 patients were included in the study. This was the total number of patients 
who entered therapy at Southwark IAPT between 2008 and 2014. 7,210 (34%) of these 
patients were male and 14,038 (66%) were female. The mean age was 38.62. In terms of 
ethnicity, 12,948 (61%) patients were white, 3,039 (14%) were black/black British, 676 (3%) 
were Asian/Asian British, 885 (4%) were mixed, 854 (4%) were from other ethnic groups, 
208 (1%) declined to respond to a question about ethnicity, 28 (1%) did not know their 
ethnicity, and ethnicity data was missing in 2,616 (12%) cases. Diagnosis data was missing 
for 12,471 (58%) of all patients. See Table 1a (Appendix). When missing data is excluded, 
the data shows that 18% of patients had a depressive episode, 18% of patients had 
recurrent depressive disorder, 16% had mixed anxiety and depressive disorder, 11% had 
generalized anxiety disorder, 6% had post-traumatic stress disorder, 4% had social phobias, 
4% had obsessive-compulsive disorder, 4% had adjustment disorders, 3% had panic 












Depressive episode (N=1653) Recurrent depressive disorder (N=1591)
Mixed anxiety and depressive disorder (N=1429) Generalized anxiety disorder (N=1029)
Post-traumatic stress disorder (N=508) Social phobias (N=358)
Obsessive-compulsive disorder (N=332) Adjustment disorders (N=352)
Panic disorder (N=300) Other (N=1417)
 
Figure 1. Patient diagnoses at entry, with missing data excluded 
 
For the purpose of the Stage 4 analysis, the total number of people who completed therapy 
was 14,194. 
 
Clinician data entry errors were discovered in less than 1% of cases. A manual scan of all 
2008 data by researchers revealed that clinicians had recorded duplicate entries for first 
sessions in 2 cases out of the 242 total cases. Researchers inferred that a similar pattern of 
duplicate entries could explain data error in subsequent years. Missing data was recorded in 
all analyses. 
 
3.2 Stage 1 (Prescription rate on entry) 
In total, 9,352 (44%) patients had been prescribed medication on entry to Southwark IAPT. 
The prescription rate was 39% in 2008, 40% in 2009, 40% in 2010, 43% in 2011, 44% in 
2012, 45% in 2013, and 46% in 2014. In total, 11,158 (52%) patients were non-prescribed 
on entry. The remaining patients either declined to state if they were prescribed medication 




Figure 2. Percentage of prescribed patients, by year 2008-2014 
 
Chi2 analysis shows that the prescription rate differences between the years 2010-2013 and 
2010-2014 were statistically significant, at p<0.01 and p<0.001 respectively. 
 
3.3 Stage 2 (Adherence) 
In total, 6,910 (89%) prescribed patients were medication adherent and 847 (11%) were 
medication non-adherent. Divided by year, non-adherent patients totaled 33 (3%) in 2011, 





Figure 3. Non-adherence on entry in prescribed patients, by year 2011-2014 
 
Chi2 analysis shows that the prescription rate differences between the years 2011-2012, 
2011-2013 and 2011-2014 were statistically significant, all at p<0.001. Note that Southwark 
IAPT began recording medication adherence during 2011 so some people may not have 
been asked this question during this year. 
 
3.4 Stage 3 (Demographics) 
Gender 
3,232 (45%) male patients and 6, 119 (44%) female patients were prescribed on entry. See 


































Figure 4. Prescribed and non-prescribed patients by gender 
 




3,634 (38%) young people, 5,414 (50%) middle-aged people, and 303 (37%) older people 




Figure 5a. Age of prescribed patients on entry, by younger, middle-aged and older 
adults 
 
Chi2 analysis showed a statistically significant difference between younger people and 
middle-aged people, and between middle-aged people and older people, both at p<0.0001. 
 
When the data was divided into by ten year age ranges, 134 (27%) ≤19 year olds, 2,203 
(38%) 20-29 year olds, 2,443 (41%) 30-39 year olds, 2,345 (50%) 40-49 year olds, 1,614 
(56%) 50-59 year olds, 445 (48%) 60-69 year olds, 128 (36%) 70-79 year olds, and 39 




Figure 5b. Age of prescribed patients on entry, by ten-year age ranges 
 
Chi2 analysis showed that the differences are statistically significant at p<0.001. The trend 
line goes up and then down again.  
 
Ethnicity 
6,009 (46%) White patients, 1,225 (40%) Black/Black British patients, 352 (40%) Mixed 
patients, 344 (40%) Other patients, and 260 (36%) Asian patients were prescribed on entry. 




Figure 6. Ethnicity of patients prescribed on entry 
 
Chi2 analysis showed that there is a statistically significant difference in prescription rates on 




1,714 (71%) long term sick patients or disabled patients, 2,046 (51%) unemployed patients, 
75 (44%) unpaid volunteer patients, 508 (43%) fulltime homemakers or carer patients, 408 
(42%) retired patients, 3,032 (37%) fulltime employed patients, 957 (37%) part-time 
employed patients, and 556 (37%) student patients were prescribed on entry. See Table 7 




Figure 7. Employment status of prescribed patients on entry 
 
Chi2 analysis showed that there is a statistically significant difference in prescription rates 
between people who are long term sick or disabled and all other employment statuses, at 
p<0.005. 
 
Knowledge of prescription and willingness to disclose 
Overall, 550 (3%) people declined to state if they were prescribed psychotropic medication 
and 194 (1%) did not know. By year, 17 (7%) people in 2008, 111 (7%) people in 2009, and 
133 (6%) people in 2010 declined to state if they were prescribed medication. This figure 
remained at 3% or lower from 2011 onwards. 142 (4%) unemployed people, 45 (5%) retired 
people, 41 (5%) older adults, 36 (4%) 60-69 year olds, 20 (6%) 70-79 year olds, and 7 (5%) 
≥80 year olds declined to state if they were prescribed medication. 30 (6%) people of Other 
ethnicity and 12 (6%) people who declined to give their ethnicity declined to state if they 
were prescribed medication. 11 (2%) Asian people did not know if they were prescribed 
medication. In all other categories, figures for declining to state if they were prescribed 
medication or for not knowing about being prescribed medication remained at or below the 
total sample figures of 3% and 1% respectively. 
 
3.5 Stage 4 (Pre-/post-treatment change) 
Prescription rate 
Overall, 6,354 (45%) patients were non-prescribed on entry and remained non-prescribed on 
discharge; 4,701 (33%) were prescribed on entry and remained prescribed on discharge; 
225 
1,293 (9%) were prescribed on entry and non-prescribed on discharge; and 906 (6%) were 
non-prescribed on entry and prescribed on discharge. See Table 8 (Appendix) and Figure 8. 
 
 
Figure 8. Prescription status change pre-/post-therapy 
 
Outcome Measures 
The mean score for depression (PHQ9) was higher in prescribed patients (16.08) on entry 
than it was for non-prescribed patients (12.26). The mean score for anxiety (GAD7) was 
higher in prescribed patients (13.36) on entry than it was for non-prescribed patients (11.16). 
The mean score for general functioning (WSAS) was higher in prescribed patients (19.71) 





Figure 9a. Mean outcome measure scores on entry for prescribed and non-prescribed 
patients  
 
The post-treatment change in depression is greater in prescribed patients (-4.46) than it is in 
non-prescribed patients (-3.73); whereas, in anxiety, it is greater in non-prescribed patients 
(-3.39) than in prescribed patients (-3.29). The post-treatment change in social functioning is 
greater in prescribed patients (-3.75) than it is in non-prescribed patients (-3.57). See Table 




Figure 9b. Post-treatment improvement in mean outcome measure scores for 
prescribed and non-prescribed patients 
 
4. DISCUSSION  
4.1 Prescription rate 
NICE recommendations for psychological therapy as the first line treatment for mild to 
moderate mental health problems are a challenge for Southwark. Nearly half of all patients 
entering therapy at Southwark IAPT between 2008 and 2014 were prescribed psychotropic 
medication when entering psychological treatment. Prescription rates of psychotropic 
medication of those entering therapy increased yearly in all but one year from 2008 to the 
most recent calendar year, with the highest proportion of patients in the history of the service 
prescribed medication when they entered therapy in 2014. Although the prescription rate 
increase plateaued from 2011 to 2014, there was a statistically significant increase after 
2010. 
 
Although Southwark is a borough of comparatively fewer psychotropic medications 
prescriptions, it still appears to be characteristic of recent national increases in psychotropic 
prescriptions rates, with GPs prescribing medication to combat long waiting lists for 
psychological therapy. Furthermore, as a deprived, inner city borough, there may be greater 
severity of mental health problems within the Southwark population, in which case the 
prescription rate for Southwark IAPT may reflect the NICE recommendation of dual 
treatments for severe depression (NICE, 2011). Future research may investigate the 




Medication non-adherence was found to be a challenge for Southwark services. Non-
adherence at entry to Southwark IAPT has been greater than 10% since 2012. Although 
medication non-adherence has plateaued since 2012, there was a statistically significant 
increase after 2011. So although the evidence suggests that this problem is not increasing, 
the non-adherence rate raises questions about the medication support that Southwark IAPT 
might offer to patients in future, as well as economic concerns for local NHS services about 
unused medical resources. For example, this study found that nearly a thousand people in 
Southwark were being prescribed psychotropic medication that they were not taking 
between 2011 and 2014, and this figure includes only that subset of the Southwark 




The prescription status profiles for males and females profiles are very similar, which 




Middle-aged people were most likely to be prescribed psychotropic medication on entry to 
psychological therapy at Southwark IAPT, especially those in the 50-59 year old age range. 
When the data was divided into ten year age ranges, the youngest and oldest adults were 
least likely to be prescribed, with 27% of ≤19 year olds, and 29% of ≥80 year olds prescribed 
on entry. This suggests that middle-aged people are a group who might benefit from 
medication support in Southwark IAPT. 
 
Ethnicity 
NHS policy aims to improve mental health outcomes for BME communities. The Department 
of Health has highlighted ethnic inequalities in mental health service experience and 
outcome (NHS, 2003). More recently commissioner guidance included identifying and 
implementing specific measures to reduce ethnic inequalities in mental health (JCP-MH, 
2014). The results of the present study raise further questions about whether inequalities are 
being addressed given that White patients were statistically more likely to be prescribed on 
entry, than Black/Black British, Mixed, Other, and Asian/Asian British patients. The 
discrepancy in ethnicity and prescription status is a notable finding. However, it is impossible 
to determine from these results whether GPs have been less likely to prescribe psychotropic 
medication to BME communities or whether BME communities are less likely to accept 
psychotropic prescriptions. Furthermore, the 12% missing ethnicity data represents a 
limitation of the findings. However, future research may seek to understand the experience 
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There is strong evidence that employment is generally good for psychological wellbeing and 
recovery from mental health conditions (Slade, 2012; Waddell & Burton, 2006) and that 
unemployment can have a detrimental effect on mental health (Paul & Moser, 2009). The 
findings of this study are consistent with this research and noteworthy in the light of the 
original economic case for the IAPT programme. According to that case, increased access 
to psychological therapies would ‘pay for itself’ by reducing public costs (benefits, medical 
costs) and increasing revenues (taxes from return to work, increased productivity, etc.) 
(Clark, 2011). The study highlights that long term sick or disabled and unemployed patients 
are highly likely to be prescribed medication and therefore on dual treatments. This finding 
shows that they remain a key target group for IAPT to access, as well as highlighting the 
important role for vocational specialists working within IAPT. 
 
4.4 Pre-/post-treatment change 
Prescription rate 
Overall, the vast majority of patients retained their pre-treatment prescription status at 
discharge (i.e. the 45% who were non-prescribed and the 33% who were prescribed pre- 
and post-treatment). Far fewer were no longer prescribed at discharge or had gained a 
medication prescription during therapy. A slightly greater proportion moved from prescription 
to non-prescription, rather than from non-prescription to prescription, although this difference 
was small (9% compared with 6%). Overall, this study suggests there is little relationship 
between psychological therapy and prescription status change. However, it is important to 
consider that IAPT clinicians are focused on improving clinical outcomes, as typically 
measured by the PHQ9 and GAD7. It is not among their aims to address prescription status 
and dual treatment is recommended in more severe cases (NICE, 2011). 
 
Outcome Measures 
The mean scores for depression, anxiety and general functioning are all higher in prescribed 
patients on entry, which is likely to reflect greater severity of symptoms on all three 
measures in those who are prescribed. This outcome is consistent with the assumption that 
those prescribed medication are likely to have more severe symptoms. Post-treatment, 
prescribed patients improve more on depression and social functioning, whereas non-
prescribed patients improve more on anxiety. However, the differences on all measures are 
very small. This suggests that improvement rates in psychological therapy were not affected 
by prescription status. 
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Knowledge of prescription and willingness to disclose 
Patients’ willingness to disclose their prescription status is another important area. The study 
shows that patients have generally become more likely to disclose whether they are 
prescribed medication since 2008. Older adults and patients who are retired were marginally 
more likely to decline to state their prescription status. This may raise questions about 
whether stigma and sensitivity about psychotropic medication use is especially pronounced 
in older adults. This may be important for IAPT clinicians to consider, as well as an area for 
future research, especially as a recent meta-analysis found that late life depression is 
common (Luppa et al., 2012). However, older adults are also more likely to be taking 
medication for many conditions and, therefore, it may be more difficult for them to know 
whether a specific medication is for a mental or physical health condition. 
 
4.5 Limitations 
The study has several limitations given the homogeneity and heterogeneity of the sample. 
Firstly, Stage 4 of our analysis does not distinguish between the patient treatments. 
Although Southwark IAPT predominantly delivers CBT, there are a wide variety of 
psychological treatments, both in individual and group therapy, and for varying durations, 
undertaken by participants in the study. Some patients may have received more than one 
course of treatment. However, all patients received an evidence-based, IAPT-approved 
psychological treatment. Secondly, the study does not distinguish between different 
psychotropic medications or dosage. The Royal College of Psychiatrists cites almost thirty 
different kinds of antidepressants available in the UK today, although there are five main 
types: SSRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin and 
Noradrenaline Reuptake Inhibitors), NASSAs (Noradrenaline and Specific Serotoninergic 
Antidepressants), Tricyclics and MAOIs (Monoamine oxidase inhibitors). Participants are 
likely to be prescribed one of these medications. However, IAPTus Hypercube data analysis 
software does not provide direct comparisons of different medications with other factors. 
This is because recording the precise medication prescribed is not part of the IAPT minimum 
data set, even though clinicians may enter this data in their clinical notes. Thirdly, although 
most patients presented with depression or anxiety disorders, the fact that more than half of 
diagnosis data is missing means that we cannot draw diagnosis-specific conclusions. 
Fourthly, IAPT services modified their admission criteria during the time period under 
analysis so they were not always accessing on the same community groups.  
 
Further limitations apply to the way that IAPT services record clinical data. Firstly, Southwark 
IAPT collects routine data on prescribed medication at Session 1 rather than initial referral. 
The present sample therefore includes the subset of referrals that engaged with the service 
and attended Session 1, not the total number of referrals. In certain cases Southwark IAPT 
collects demographic information at initial referral, so a slight time discrepancy may occur 
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between these two sets of data. In the case of age, it is important to take this into account 
when comparing age with prescription. Although waiting lists times may impact on 
prescription rates, Southwark IAPT does not record waiting list times in a way that they can 
be directly compared with prescription rates. Future studies could examine the relationship 
between waiting list duration and psychotropic medication prescription. However, that is 
beyond the remit of the present study.  
 
4.6 Clinical applications and future research 
The findings of this study offer guidance on how Southwark IAPT could offer greater support 
for people likely to be prescribed psychotropic medication. Given that nearly half of all 
patients are prescribed psychotropic medication on entry to the service, Southwark IAPT 
could link with medical practitioners to discuss psychotropic medication issues and provide 
specialist support for patients. The service currently offers pre-therapy orientation sessions 
for patients on the waiting list which could incorporate further education about psychotropic 
medication. It could also be important to provide training on psychotropic medication for 
existing Southwark IAPT staff. 
 
As the most likely to be prescribed medication when entering psychological treatment in 
Southwark IAPT, people who are unemployed or long-term sick, middle-aged, and white 
would make an appropriate target for participants to take part in focus groups to explore their 
views on medication, their experience with GPs’ prescribing medication and making referrals 
for psychological therapy, and to develop protocols for medication support. Focus groups 
with BME communities and with service users on medication at the beginning and end of 
treatment could also provide further important data. Further statistical analysis could 
investigate the age effect and the long-term sick group. 
 
PWPs could take on further responsibilities to support medication adherence. Such 
protocols may aim to take into account any stigma or sensitivity in discussing medication, 
especially with older adults as they are less likely to disclose medication prescription. In 
relation to adherence, future research might further investigate non-adherence by surveying 
a sample of non-adherent patients to ascertain reasons for non-adherence. This research 
may consider whether patients do not find their medication effective, have worries about side 
effects, or other fears about psychotropic medication. This study shows that it is vital that 
GPs and IAPT are closely connected. A focus group of local GPs exploring prescribing 
habits for common mental health problems would be of interest in investigating the provision 
of treatment for patients. 
 
4.7 Dissemination 
This service evaluation project will be fed back to the clinical team, to local GPs, and to 




This service evaluation provided an excellent opportunity to develop leadership skills. It was 
important to engage the clinical team in the project, and to deliver presentations to both the 
clinical team and to service users. It also provided an excellent opportunity to liaise with and 
work directly with members of the team at all levels, as well as with the developers of 
IAPTus Hypercube, in order to arrive at a thorough understanding of the data. This role 
enabled me to learn about how this data can differ in relevance to staff who work, for 
example, at high intensity therapy, low intensity therapy, or employment support. The 
findings will influence change within the team by providing materials for a medication support 
protocol that can be implemented by PWPs, and by providing data that can inform 
discussions at board level so that Southwark IAPT and local GPs can work together to 
address the issues that have been identified. 
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Appendix I   IAPTus Hypercube active filters, data tables, and inferential statistics  
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The use of IAPTus filters simplifies the selection of relevant participants for the study. Each 
filter is selected to ensure that only relevant clients are included in the dataset. To ensure 
accuracy, there is often overlay of certain filters to ensure the appropriate information is 
collected. Each filter was clarified with an administrator from Mayden House, the company 
that designed and offers support for the IAPTus system. The following is an explanation of 
the Active Filters that were used: 
 
Treatment Type: IAPT 
This filter ensures that only including patients from IAPT treatment rather than non-IAPT 
treatment, i.e. vocational support, are included in the study. 
 
MDS/Non-MDS clinical contacts 
Each clinical session can be stored as a minimum data set (MDS) session or a non-MDS. 
The latter tends to be used by clinicians when there has not been a therapeutic contact but 
information which would be important to share is collected and recorded. 
 
MDS Clinical Sessions 
This filter ensures the selection of only MDS clinical contacts. 
 
IAPT Psychotropic Medication Usage:  
This filter provides a breakdown of the use of prescribed medication for the clinical contact In 
this case, the options are ‘Prescribed and taking’; ‘Prescribed but not taking’; ‘Not 
Prescribed’; ‘Not stated (Person asked but declined to provide a response)’; ‘Unknown 
(Person asked and does not know or is not sure)’. 
 
Employment Psychotropic Medication Usage 
This filter is automatically displayed by IAPTus Hypercube when using the IAPT 
Psychotropic Medication Usage filter. 
 
Complete vs Incomplete sessions: Show Complete Sessions only 
This filter ensures that the data only includes clinical contacts which have collected the MDS 
criteria and, therefore, excludes incomplete clinical contacts. 
 
IAPT Attendance 
This filter ensures that only sessions when the client attended (even if late) are included. In 
this case the options included are: Attended on time or, if late, before the relevant CARE 
PROFESSIONAL was ready to see the PATIENT; Arrived late, after the relevant CARE 
PROFESSIONAL was ready to see the PATIENT, but was seen; Employment Attendance.  
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Table 1a. Diagnosis of patients 2008-2014 
 
Diagnosis N (%) 
F10 - Mental and behavioural disorders due to use of alcohol 49 (0%) 
F31 - Bipolar affective disorder 39 (0%) 
F32 - Depressive episode 1653 (8%) 
F33 - Recurrent depressive disorder 1591 (7%) 
F40.0 - Agoraphobia (with or without history of panic disorder) 260 (1%) 
F40.1 - Social phobias 358 (2%) 
F40.2 - Specific (isolated) phobias 122 (1%) 
F41.1 - Generalized anxiety disorder 1029 (5%) 
F41.2 - Mixed anxiety and depressive disorder 1429 (7%) 
F42 - Obsessive-compulsive disorder 332 (2%) 
F43.1 - Post-traumatic stress disorder 508 (2%) 
F45 - Somatoform disorders 83 (0%) 
F50 - Eating disorders 56 (0%) 
F99 - Mental disorder, not otherwise specified 194 (1%) 
Z63.4 - Disappearance and death of family member 115 (1%) 
F41.0 - Panic disorder (episodic paroxysmal anxiety) 300 (1%) 
F34.1 - Dysthymia 26 (0%) 
F43.2 - Adjustment disorders 352 (2%) 
F45.2 - Hypochondriacal disorder 85 (0%) 
F12 - Mental and behavioural disorders due to use of cannabinoids 10 (0%) 
F19 - Mental and behavioural disorders due to multiple drug use and use of 
other psychoactive substances 
16 (0%) 
F20 - Schizophrenia 4 (0%) 
F21 - Schizotypal disorder 1 (0%) 
F22 - Persistent delusional disorders 4 (0%) 
F23 - Acute and transient psychotic disorders 7 (0%) 
F34 - Persistent mood (affective) disorders 100 (0%) 
F43 - Reaction to severe stress and adjustment disorders 175 (1%) 
F48 - Other neurotic disorders 24 (0%) 
F52 - Sexual dysfunction not due to a substance or known physiological 
condition 
8 (0%) 
F60 - Specific personality disorder 17 (0%) 
F63 - Habit and impulsive disorders 15 (0%) 
F64 - Gender identity disorders 3 (0%) 
F90 - Hyperkinetic disorder 4 (0%) 




Table 1b. Diagnosis of patients 2008-2014 with missing data excluded 
 
Diagnosis N (%) 
F32 - Depressive episode 1653 (18%) 
F33 - Recurrent depressive disorder 1591 (18%) 
F41.2 - Mixed anxiety and depressive disorder 1429 (16%) 
F41.1 - Generalized anxiety disorder 1029 (11%) 
F43.1 - Post-traumatic stress disorder 508 (6%) 
F40.1 - Social phobias 358 (4%) 
F42 - Obsessive-compulsive disorder 332 (4%) 
F43.2 - Adjustment disorders 352 (4%) 
F41.0 - Panic disorder (episodic paroxysmal anxiety) 300 (3%) 




Table 2. Prescription status for patients on entry, in total and by year 
Year N Prescribed (%) Non-prescribed (%) Declined (%) DNK (%) 
008 242 94 (39%) 131 (54%) 17 (7%) 0 (0%) 
2009 1515 604 (40%) 799 (53%) 111 (7%) 1 (0%) 
2010 2236 897 (40%) 1206 (54%) 133 (6%) 0 (0%) 
2011 2420 1036 (43%) 1306 (54%) 74 (3%) 4 (0%) 
2012 3874 1720 (44%) 2032 (52%) 75 (2%) 47 (1%) 
2013 4754 2148 (45%) 2505 (53%) 61 (1%) 40 (1%) 
2014 6213 2853 (46%) 3179 (51%) 79 (0%) 102 (0%) 




(1) Treatment type: IAPT. (2) IAPT Attendance: Attended on time or, if late, before the 
relevant CARE PROFESSIONAL was ready to see the PATIENT; Arrived late, after the 
relevant CARE PROFESSIONAL was ready to see the PATIENT, but was seen. (3) Group 
by: Clinical Session - Psychotropic Medication Usage. (4) MDS / Non-MDS clinical contacts: 
MDS Clinical Sessions. (5) IAPT Psychotropic Medication Usage: Prescribed and taking; 
Prescribed but not taking; Not Prescribed; Not stated (Person asked but declined to provide 
a response); Unknown (Person asked and does not know or is not sure). (6) Complete vs 
Incomplete sessions: Show Complete Sessions only. (7) First session Date between: 
01/01/2008 and: 31/12/2008 [2008 row]; 01/01/2009 and 31/12/2009 [2009 row]; 01/01/2010 
and 31/12/2010 [2010 row]; 01/01/2011 and 31/12/2011 [2011 row]; 01/01/2012 and 
31/12/2012 [2012 row]; 01/01/2013 and 31/12/2013 [2013 row]; 01/01/2014 and 31/12/2014 
[2014 row].  
 
Chi2 (1) analysis of prescribed patients between years 
2008-2009 = 0.13, p = 0.72; 2008-2010 = 0.06, p = 0.80; 2008-2011 = 0.50, p = 0.48; 2008-
2012 = 1.41, p = 0.23; 2008-2013 = 1.66, p = 0.19; 2008-2014 = 2.16, p = 0.10; 2009-2010 = 
0.05, p = 0.82; 2009-2011 = 0.50, p = 0.48; 2009-2012 = 3.21, p = 0.07; 2009-2013 = 4.21, 
p<0.05*; 2009-2014 = 8.25, p<0.005*; 2010-2011 = 1.13, p = 0.29; 2010-2012 = 5.54, 
p<0.05*; 2010-2013 = 7.21, p<0.01*; 2010-2014 = 13.54, p<0.001*; 2011-2012 = 1.50, p = 
0.22; 2011-2013 = 2.34, p = 0.13; 2011-2014 = 6.36, p<0.05*; 2012-2013 = 0.09, p = 0.77; 
2012-2014 = 1.97, p = 0.16; 2013-2014 = 1.36, p = 0.24. 
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Table 3. Adherence on entry, in total and by year 
Year N Adherent (%) Non-adherent (%) 
2011 1036 1003 (97%) 33 (3%) 
2012 1720 1525 (89%) 195 (11%) 
2013 2148 1885 (88%) 263 (12%) 
2014 2853 2497 (88%) 356 (12%) 




(1) Treatment type: IAPT. (2) IAPT Attendance: Attended on time or, if late, before the 
relevant CARE PROFESSIONAL was ready to see the PATIENT; Arrived late, after the 
relevant CARE PROFESSIONAL was ready to see the PATIENT, but was seen. (3) Group 
by: Clinical Session - Psychotropic Medication Usage. (4) MDS / Non-MDS clinical contacts: 
MDS Clinical Sessions. (5) IAPT Psychotropic Medication Usage: Prescribed and taking; 
Prescribed but not taking; Not Prescribed; Not stated (Person asked but declined to provide 
a response); Unknown (Person asked and does not know or is not sure). (6) Complete vs 
Incomplete sessions: Show Complete Sessions only. (7) First session Date between: 
01/01/2011 and 31/12/2011 [2011 row]; 01/01/2012 and 31/12/2012 [2012 row]; 01/01/2013 
and 31/12/2013 [2013 row]; 01/01/2014 and 31/12/2014 [2014 row]. 
 
Chi2 (1) analysis of adherence between years 
2011-2012 = 56.62, p<0.001*; 2011-2013 = 68.02, p<0.001*; 2011-2014 = 72.91, p<0.001*; 
2012-2013 = 0.75, p = 0.38; 2012-2014 = 1.32, p = 0.25; 2013-2014 = 0.06, p = 0.80. 
 
 
Table 4. Prescribed and non-prescribed patients on entry, by gender 
Gender N Prescribed (%) Non-prescribed (%) Declined (%) DNK (%) 
Male 7210 3232 (45%) 3722 (52%) 181 (3%)  75 (1%) 
Female 14038 6119 (44%) 7433 (53%) 367 (3%) 119 (1%) 
Unknown 6 1 (17%) 3 (50%) 2 (33%) 0 0(%) 
Total 21254 9352 (44%) 11158 (52%) 550 (3%) 194 (1%) 
 
Active filters 
(1) Treatment Type: IAPT. (2) IAPT Attendance: Attended on time or, if late, before the 
relevant CARE PROFESSIONAL was ready to see the PATIENT; Arrived late, after the 
relevant CARE PROFESSIONAL was ready to see the PATIENT, but was seen. (3) First 
session Date between: 01/01/2008 and 31/12/2014. (4) Employment Attendance: MDS / 
Non-MDS clinical contacts. (5) MDS Clinical Sessions. (6) IAPT Psychotropic Medication 
Usage: Prescribed and taking; Prescribed but not taking; Not Prescribed; Not stated (Person 
asked but declined to provide a response); Unknown (Person asked and does not know or is 
not sure). (7) Employment Psychotropic Medication Usage. (8) Complete vs Incomplete 
sessions: Show Complete Sessions only. (9) Group by Demographics – Gender. (10) Group 
by Clinical Session - Psychotropic Medication Usage. 
 
Chi2 (1) analysis of gender 
Male-female = 3.25, p = 0.07. 
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Table 5a. Age of prescribed and non-prescribed patients on entry by younger, middle-
aged and older adults 
Age N Prescribed (%) Non-prescribed (%) Declined (%) DNK (%) 
≤34 9592 3634 (38%) 5671 (59%) 212 (2%) 75 (1%) 
35-64 10840 5414 (50%) 5020 (46%) 297 (3%) 109 (1%) 
≥65 818 303 (37%) 464 (57%) 41 (5%) 10 (1%) 
Total 21250 9351 (44%) 11155 (52%) 550 (3%) 194 (1%) 
 
 
Table 5b. Age of prescribed and non-prescribed patients on entry, by ten year age 
ranges 
Age N Prescribed (%) Non-prescribed (%) Declined (%) DNK (%) 
≤19 501 134 (27%) 354 (71%) 8 (2%) 5 (1%) 
20-29 5799 2203 (38%) 3438 (59%) 114 (2%) 44 (1%) 
30-39 5978 2443 (41%) 3331 (56%) 157 (3%) 47 (1%) 
40-49 4680 2345 (50%) 2156 (46%) 130 (3%) 49 (1%) 
50-59 2872 1614 (56%) 1149 (40%) 78 (3%) 31 (1%) 
60-69 929 445 (48%) 435 (47%) 36 (4%) 13 (1%) 
70-79 358 128 (36%) 207 (58%) 20 (6%) 3 (2%) 
≥80 133 39 (29%) 85 (64%) 7 (5%) 2 (2%) 
Total 21250 9351 (44%) 11155 (52%) 550 (3%) 194 (1%) 
 
Active filters 
(1) Treatment Type: IAPT. (2) MDS / Non-MDS clinical contacts. (3) MDS Clinical Sessions. 
(4) IAPT Psychotropic Medication Usage: Prescribed and taking; Prescribed but not taking; 
Not Prescribed; Not stated (Person asked but declined to provide a response); Unknown 
(Person asked and does not know or is not sure). (5) Employment Psychotropic Medication 
Usage. (6) Complete vs Incomplete sessions: Show Complete Sessions only. (7) IAPT 
Attendance: Attended on time or, if late, before the relevant CARE PROFESSIONAL was 
ready to see the PATIENT; Arrived late, after the relevant CARE PROFESSIONAL was 
ready to see the PATIENT, but was seen; Employment Attendance. (8) Group by: 
Demographics - Age on Referral Date. (9) Group by: Clinical Session - Psychotropic 
Medication Usage. (10) First session Date between: 01/01/2008 and 31/12/2014. 
 
Chi2 (1) analysis of prescribed patients between young, middle-aged and older adults 
Young-(middle-aged) = 326.31, p<0.0001*; young-older = 0.06, p = 0.81; (middle-aged)-
older = 43.85, p<0.0001*. 
 
Chi2 (1) analysis of prescribed patients between ten year age ranges 
(≤19)-(20-29) = 25.59, p = 4.2e-7*; (≤19)-(30-39) = 40.98, p<0.001*; (≤19)-(40-49) = 106.93, 
p<0.001*; (≤19)-(50-59) = 159.88, p<0.001*; (≤19)-(60-69) = 68.68, p<0.001*; (≤19)-(70-79) 
= 10.58, p<0.005*; (≤19)-(≥80) = 0.777, p = 0.38. 
(20-29)-(30-39) = 12.54, p<0.001*; (20-29)-(40-49) =172.27, p<0.001*; (20-29)-(50-59) 
=280.44, p<0.001*; (20-29)-(60-69) = 41.85, p<0.001*; (20-29)-(70-79) =0.01, p =0.76; (20-
29)-(≥80) = 2,95, p = 0.09. 
(30-39)-(40-49) = 97.40, p<0.001*; (30-39)-(50-59) = 194.34, p<0.001*; (30-39)-(60-69) = 
21.20, p<0.001*; (30-39)-(70-79) = 2.19, p = 0.14; (30-39)-(≥80) = 5.87, p<0.05. 
(40-49)-(50-59) = 27.535, p = 1.5e-7*; (40-49)-(60-69) = 0.69, p = 0.41; (40-49)-(70-79) = 
24.08, p = 9.3e-7; (40-49)-(≥80) = 20.60, p<0.001*. 
(50-59)-(60-69) = 16.72, p<0.001*; (50-59)-(70-79) = 49.56, p<0.001*; (50-59)-(≥80) =35.25, 
p<0.001*. 
(60-69)-(70-79) =14.87, p<0.001*; (60-69)-(≥80) = 15.91, p<0.001*. 
(70-79)-(≥80) = 1.79, p = 0.18. 
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Table 6. Ethnicity of prescribed and non-prescribed patients on entry 
Ethnicity N Prescribed (%) Non-prescribed (%) Declined (%) DNK (%) 
White 12948 6009 (46%) 6564 (51%) 293 (2%) 82 (1%) 
Black 3039 1225 (40%) 1676 (55%) 103 (3%) 35 (1%) 
Asian 676 260 (38%) 388 (57%) 17 (3%) 11 (2%) 
Mixed 885 352 (40%) 506 (57%) 19 (2%) 8 (1%) 
Other 854 344 (40%) 472 (55%) 30 (4%) 8 (1%) 
Declined 208 79 (38%) 116 (56%) 12 (6%) 1 (0%) 
DNK 28 11 (39%) 14 (50%) 0 (0%) 3 (11%) 
Missing 2616 1072 (41%) 1422 (54%) 76 (3%) 46 (2%) 
Total 21254 9352 (44%) 11158 (52%) 550 (3%) 194 (1%) 
 
Active filters 
(1) Treatment Type: IAPT. (2) MDS / Non-MDS clinical contacts: MDS Clinical Sessions. (3) 
IAPT Psychotropic Medication Usage: Prescribed and taking; Prescribed but not taking; Not 
Prescribed; Not stated (Person asked but declined to provide a response); Unknown 
(Person asked and does not know or is not sure). (4) Employment. (5) Psychotropic 
Medication Usage. (6) Complete vs Incomplete sessions: Show Complete Sessions only. (7) 
IAPT Attendance: Attended on time or, if late, before the relevant CARE PROFESSIONAL 
was ready to see the PATIENT; Arrived late, after the relevant CARE PROFESSIONAL was 
ready to see the PATIENT, but was seen. (8) First session Date between: 01/01/2008 and 
31/12/2014. (9) Group by: Demographics - Ethnic Group. (10) Group by: Clinical Session - 
Psychotropic Medication Usage. 
 
Chi2 (1) analysis of prescribed patients between ethnic groups 
White-Black/Black British = 29.34, p = 6e-8*, White-Asian/Asian British = 14.54, p 
<0.01*, White-Mixed = 14.75, p <0.01*, White-Other = 9.76, p <0.01*, Black-Asian/Asian 
British = 0.96, p = 0.33, Black-Mixed = 0.39, p = 0.53, Black-Other = 0.001, p = 0.98, Asian-
Mixed = 0.13, p = 0.73, Asian-Other = 0.62, p = 0.43, Mixed-Other = 0.22, p = 0.64.  
 
 
Table 7. Employment status of prescribed and non-prescribed patients on entry 




(%) DNK (%) 
Employed FT 8233 3032 (37%) 4985 (61%) 163 (2%) 53 (1%) 
Employed PT 2608 957 (37%) 1555 (60%) 74 (3%) 22 (1%) 
Unemployed  4018 2046 (51%) 1800 (45%) 142 (4%) 30 (1%) 
Student 1505 556 (37%) 912 (61%) 28 (2%) 9 (1%) 
Retired 983 408 (42%) 518 (53%) 45 (5%) 12 (1%) 
FT homemaker/carer 1183 508 (43%) 633 (54%) 33 (3%) 9 (1%) 
LT sick/disabled 2410 1714 (71%) 627 (26%) 35 (1%) 34 (1%) 
Unpaid volunteer 171 75 (44%) 90 (53%) 5 (3%) 1 (1%) 
Declined to respond 139 54 (39%) 36 (26%) 26 (19%) 23 (17%) 
Missing 9 3 (33%) 5 (56%) 0 (0%) 1 (11%) 
Total 21259 9353 (44%) 11161 (53%) 551 (3%) 194 (1%) 
 
Active Filters 
(1) Treatment Type: IAPT. (2) MDS / Non-MDS clinical contacts: MDS Clinical Sessions. (3) 
IAPT Psychotropic Medication Usage: Prescribed and taking; Prescribed but not taking; Not 
Prescribed; Not stated (Person asked but declined to provide a response); Unknown 
(Person asked and does not know or is not sure). (4) Employment Psychotropic Medication 
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Usage. (5) Complete vs Incomplete sessions: Show Complete Sessions only. (5) IAPT 
Attendance: Attended on time or, if late, before the relevant CARE PROFESSIONAL was 
ready to see the PATIENT; Arrived late, after the relevant CARE PROFESSIONAL was 
ready to see the PATIENT, but was seen; Employment Attendance. (6) First session Date 
between: 01/01/2008 and 31/12/2014. (7) Group by: Clinical Session - Employment Status. 
(8) Group by: Clinical Session - Psychotropic Medication Usage. 
 
Chi2 (1) analysis of prescribed patients between employment status 
Employed FT-Employed PT = 0.16, p = 0.80; Employed FT-Unemployed = 251.07, 
p<0.001*; Employed FT-Student = 0.002, p = 0.96; Employed FT-Retired = 13.66, 
p<0.001*; Employed FT-FT homemaker/carer = 18.92, p<0.001*; Employed FT-LT 
sick/disabled = 914.48, p<0.001*; Employed FT-Unpaid volunteer = 4.00, p<0.05*. 
Employed PT-Unemployed = 139.03, p<0.001*; Employed PT-Student = 0.02, p = 0.89; 
Employed PT-Retired = 10.05, p<0.005*; Employed PT-FT homemaker/carer = 13.49, 
p<0.001*; Employed PT-LT sick/disabled = 603.95, p<0.001*; Employed PT-Unpaid 
volunteer = 3.54, p = 0.06. 
Unemployed-Student = 99.83, p<0.001*; Unemployed-Retired = 24.95, p = 5.9e-7*; 
Unemployed-FT homemaker/carer = 26.51, p = 2.6e-7*; Unemployed-LT sick/disabled = 
244.62, p<0.001*; Unemployed-Unpaid volunteer = 3.81, p = 0.05. 
Student-Retired = 9.03, p<0.005*; Student-FT homemaker/carer = 11.75, p<0.001*; 
Student-LT sick/disabled = 468.01, p<0.001*; Student-Unpaid volunteer = 3.59, p = 0.06. 
Retired-FT homemaker/carer = 0.04, p = 0.83; Retired-LT sick/disabled = 247.78, 
p<0.001*; Retired-Unpaid volunteer = 0.11, p = 0.74. 
FT homemaker/carer-LT sick/disabled = 273.52, p<0.001*; FT homemaker/carer-Unpaid 
volunteer = 0.05, p = 0.82.  
LT sick/disabled-Unpaid volunteer = 58.16, p<0.001*. 
 
 












 Medication status 
 
Prescribed Non-prescribed Declined DNK Total 
Prescribed 4701 (33%) 1293 (9%) 173 (1%) 39 (0%) 6206 
Non-prescribed 906 (6%) 6354 (45%) 243 (2%) 29 (0%) 7532 
Declined 75 (1%) 168 (1%) 95 (1%) 5 (0%) 343 
DNK 42 (0%) 59 (0%) 4 (0%) 8 (0%) 113 
Total 5724 7874 515 81 14194 
 
Active Filters 
(1) Treatment type: IAPT. (2) Data field: Use of Psychotropic Medication. (3) IAPT 
Attendance: Attended on time, Arrived late but was seen. (4) Employment Attendance. (5) 
Complete vs Incomplete sessions: Show Complete Sessions only. (6) MDS / Non-MDS 
clinical contacts: MDS Clinical Sessions. (7) Session Start Date: 01/01/2008. (8) Session 
End Date: 31/12/2014 
 
 
Table 9. Mean pre-/post-treatment scores and score changes for IAPT outcome 
measures 
Measure  Prescribed   Non-prescribed  
 N Entry Discharge Change  N Entry Discharge Change  
PHQ9 6650 16.08 11.82 -4.26  8502 12.26 8.53 -3.73  
GAD7 6649 13.36 10.07 -3.29  8501 11.16 7.77 -3.39  
WSAS 6645 19.71 15.95 -3.75  8498 15.42 11.85 -3.57  
 
Active filters. (1) Treatment type: IAPT; (2) First session date: starting 1/1/08 and ending 
31/12/14; (3) IAPT attendance: Attended on time or, if late was seen (4) MDS / Non-MDS 
clinical contacts: MDS Clinical Sessions (5) Complete vs Incomplete sessions: Show 
Complete Sessions only (6) Data field [PHQ9/GAD7/WSAS] (7) IAPT Psychotropic 
Medication Usage: Prescribed and taking, and Prescribed but not taking/Not Prescribed. 
 
